| Package | hl7.terminology.r4b |
| Type | CodeSystem |
| Id | v3-loinc |
| FHIR Version | R4B |
| Source | http://terminology.hl7.org/http://terminology.hl7.org/6.0.2/CodeSystem-v3-loinc.html |
| URL | http://loinc.org |
| Version | 3.1.0 |
| Status | active |
| Date | 2022-11-22 |
| Name | LOINC |
| Title | Logical Observation Identifiers, Names and Codes (LOINC) |
| Realm | uv |
| Authority | hl7 |
| Description | LOINC provides a set of universal names and ID codes for identifying laboratory and clinical test results.1,2 LOINC facilitates the exchange and pooling of results, such as blood hemoglobin, serum potassium, or vital signs, for clinical care, outcomes management, and research. LOINC's universal identifiers (names and codes) can be used in the context of order and observation exchanges between information systems that use syntax standards such as HL73, CEN TC251, ISO TC215, ASTM4, and DICOM. Specifically, the identifier can be used as the coded value for an observation in any other standard that uses the observation/observation value paradigm, whether messages, documents, application programming interface (API), etc. For example, LOINC codes are used widely in the OBX segment Observation Identifier field (OBX-3) of an ORU HL7 (HL7 version 2.x or ASTM 1238-9410) message that may be sent between a Clinical Laboratory Information Management Systems (LIMS) and Electronic Health Record Systems (EHR).5, 6 In this way, LOINC codes provide universal identifiers that allow the exchange of clinical data between heterogeneous computing environments. |
| Copyright | Per the LOINC License "Permission is hereby granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the Licensed Materials for any commercial or non-commercial purpose, subject to the following terms and conditions" Please also note that some content (for example some of the assessment scale content) within LOINC is subject to copyright from third parties and is present in LOINC with permission or under the applicable terms of use from the third party. Some included third party content requires attribution specific to a particular LOINC code or codes. Such third party content is identified in the LOINC Table and LOINC Table Core by the applicable copyright notice stored in the EXTERNAL_COPYRIGHT_NOTICE field. For further information and for details of how implementers should manage use of third party content (including license obligations) please see https://loinc.org/kb/license/ |
| Content | not-present |
| CodeSystem | |
| supplement | LOINC Code System Supplement |
| loinc-supplement-translations | SupplementalLoincTranslations |
| ConceptMap | |
| EMISSectionHeaders | EMIS Consultation Section Headers Mapping |
| PlaceOfInjuryCM | PlaceOfInjury Concept Map |
| ch-elm-expecting-organism-specification-to-results-completion-vs | CH ELM Expecting Organism Specification To Results Completion Vs |
| ch-elm-expecting-specimen-specification-to-results-completion-vs | CH ELM Expecting Specimen Specification To Results Completion Vs |
| ch-elm-results-geno-to-component-code | CH ELM Results Genotype To Component Code |
| ch-elm-results-geno-to-component-interpretation-code | CH ELM Results Genotyping To Component Interpretation Code |
| ch-elm-results-susc-to-component-code | CH ELM Results Susceptibility To Component Code |
| ch-elm-results-susc-to-component-interpretation-code | CH ELM Results Susceptibility To Component Interpretation Code |
| ch-elm-results-susc-to-component-observation-profile | CH ELM Results Susceptibility To Component Observation Profile |
| ch-elm-results-to-foph-patient-name-representation | CH ELM Results To FOPH Patient Name Representation |
| ch-elm-results-to-interpretation-code | CH ELM Results To Interpretation Code |
| ch-elm-results-to-observation-profile | CH ELM Results To Observation Profile |
| nhi-loinc | 臺灣健保署醫療服務給付項目對應LOINC |
| activitydefinition-code-to-do-missing-measurement | Activitydefinition-code to do missing measurement |
| activitydefinition-code-to-do-reminder | Activitydefinition-code to do reminder |
| activitydefinition-code-to-measurement-resource-type | Activitydefinition-code to measurement resource type |
| activitydefinition-code-to-observation-code | ActivityDefinition code to Observation code |
| activitydefinition-code-to-perform-sharing | Activitydefinition-code-to-perform-sharing |
| conceptmap-obs-code-to-ucum | Observation code to UCUM mapping |
| conceptmap-obs-code-to-value-type | conceptmap-obs-code-to-value-type |
| CF-ProblemCategory | C-CDA section to FHIR Condition category code |
| FC-ProblemCategory | FHIR Condition category to C-CDA section code |
| lab-test-type-covid19-loinc-to-icd11 | Lab Test – Type - Mapping LOINC to ICD-11 |
| lab-test-type-snomed-to-icd11 | Lab Test - Pathogen - Mapping SNOMED CT to ICD-11 |
| who-ddcc-map-ichi-loinc-type-of-test | ConceptMap from ICHI to LOINC for Type of Test |
| who-ddcc-map-loinc-sct-type-of-test | ConceptMap from LOINC to SNOMED CT for Type of Test |
| CGMSummaryToLoinc | Mapping from CGM Temporary Codes to LOINC |
| CIELtoLOINCObservationMap | CIEL to LOINC Observation Code Map |
| CIELtoLoincDiagnosticReportMap | CIEL → LOINC DiagnosticReport .code Map (breast-imaging + chest US) |
| direct-alerts | Direct ADT to Da Vinci Alerts ConceptMap |
| LOINC | LOINC |
| IMMZ.C.ConceptMap | ConceptMap to and from IMMZ.C DataElements |
| IMMZ.D.ConceptMap | ConceptMap to and from IMMZ.D DataElements |
| IMMZ.Z.ConceptMap | ConceptMap to and from IMMZ.Z DataElements |
| dna-change-type-map | DNA Change Type Map |
| KBV_CM_MIO_NFD_Pregnancy_Status_German | Aktueller Schwangerschaftsstatus |
| KBV_CM_Base_Terminology_Complete_German | KBV_CM_Base_Terminology_Complete_German |
| KBV_CM_Base_Apgar_Score_Identifier_German | KBV_CM_Base_Apgar_Score_Identifier_German |
| KBV_CM_Base_Body_Height_Snomed_German | KBV_CM_Base_Body_Height_Snomed_German |
| KBV_CM_Base_Body_Weight_Loinc_German | KBV_CM_Base_Body_Weight_Loinc_German |
| KBV_CM_MIO_LAB_Laboratory_Specialties_German | Laborbereich |
| tiplulaborcodes-loinc | ConceptMap zur Übersetzung von Tiplu Laborcodes in LOINC |
| KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_German | KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_German |
| KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_LOINC_Snomed | KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_LOINC_Snomed |
| KBV_CM_MIO_MR_Examination_Loinc_German | Laboruntersuchungen |
| twcdc-methoddetails | 檢驗方法細項代碼對應 |
| twcdc-samplingitem | 檢體種類代碼對應 |
| LOINCMaterialToSNOMEDMaterial | LOINCMaterialToSNOMEDMaterial |
| LOINCMethodToSNOMEDMethod | LOINCMethodToSNOMEDMethod |
| loinc-dicom | |
| KBV_CM_MIO_EMP_Overview | KBV_CM_MIO_EMP_Overview |
| severity-loinc-uv-ips | Severity Value Set Mappings - LOINC to FHIR |
| PositieCodelijst-to-LOINC | HCIM PositieCodelijst to LOINC |
| KBV_CM_MIO_TELE_Clinical_Course_German | KBV_CM_MIO_TELE_Clinical_Course_German |
| KBV_CM_MIO_TELE_Procedure_And_Recommendations_German | Weiteres Procedere und Empfehlung |
| ASS-X04-CorrespondanceType-Classe-CISIS | ASS_X04_CorrespondanceType_Classe_CISIS |
| ASS-X16-CorrespondanceType-Classe-DMP | ASS_X16_CorrespondanceType_Classe_DMP |
| StructureDefinition | |
| TipluObservationLaboruntersuchung | Tiplu Observation im Use Case Laboruntersuchung |
| profile-observation-vitals | Observation Vitals Patient Chart |
| ValueSet | |
| well-being-frequency | Well-Being Frequency Answers |
| well-being-satisfaction | Well-Being Satisfaction Answers |
| riap-observaciones-biopsia-VS | Set de Valores para Observaciones Biopsia |
| riap-reporte-biopsia-vs | Set de Valores de los Reportes de Biopsia |
| goal-attainment-scaling-score | Goal Attainment Scaling (GAS) Score |
| prom-target-measures | PROM Target Measure Scores |
| obsCode-loinc-uv-lab | Laboratory Code: LOINC |
| orderCodes-uv-lab | Laboratory Order |
| reportType-uv-lab | Laboratory Report Types |
| studyType-uv-lab | Laboratory Study Types |
| DocumentReferenceCategory | NPFS DocumentReference category |
| vrdr-place-of-injury-vs | Place of Injury ValueSet |
| VSTiposDocClinico | Tipos de Documentos Clínicos |
| cl-core-tipo-reporte | Set de Valores de Tipo de Reporte |
| cl-core-vs-signos-vitales | Set de Valores Signos Vitales |
| cz-lab-report-types-VS | Laboratory Report Types (CZ) |
| cz-lab-study-types-VS | Laboratory Study Types (CZ) |
| ImSectionEmptyReason | Reasons a section in an imaging report is empty. |
| ch-lab-order-study-types | Laboratory Study Types |
| ch-vacd-laboratory-serology-vs | Laboratory Serology for Immunization |
| ValueSet-education-level-person-vr | Value Set - Education Level Person Vital Records |
| testcode-mappings-livd | Test code mappings value set for LIVD |
| at-aps-problems | AT APS Problems |
| LOINCConsentDocumentTypes | LOINC Consent Document Types |
| us-core-diastolic-blood-pressure-code | Vital Signs Diastolic Blood Pressure Codes |
| us-core-mean-arterial-blood-pressure-code | Vital Signs Mean Arterial Blood Pressure Codes |
| us-core-modified-blood-pressure-code | Vital Signs Blood Pressure Codes |
| us-core-pulse-blood-pressure-code | Vital Signs Pulse Blood Pressure Codes |
| us-core-systolic-blood-pressure-code | Vital Signs Systolic Blood Pressure Codes |
| mcode-tnm-distant-metastases-staging-type-max-vs | TNM Distant Metastases Staging Type Maximum Value Set |
| mcode-tnm-primary-tumor-staging-type-max-vs | TNM Primary Tumor Staging Type Maximum Value Set |
| mcode-tnm-regional-nodes-staging-type-max-vs | TNM Regional Nodes Staging Type Maximum Value Set |
| mcode-tnm-stage-group-staging-type-max-vs | TNM Stage Group Staging Type Maximum Value Set |
| mcode-tumor-marker-test-vs | Tumor Marker Test Value Set |
| holter-event-component-codes | Holter Observation Component Codes |
| holter-report-code | Holter Report Code |
| observation-oct-macula | OCT Macula Observable Entities ValueSet |
| observation-oct-rnfl | OCT RNFL Observable Entities ValueSet |
| VS-GleasonGrade | Gleason Grade |
| ExampleCOVID19TestCodes | Covid-19 Example Test Codes |
| ExampleHbA1cTestCodes | Diabetes Example Test Codes |
| X12278DiagnosisInformationType | X12 278 Diagnosis Information Type |
| pas-loinc-attachment-codes | PAS LOINC Attachment Codes Value Set |
| toc-del-loinc-vs | Transitions of Care DEL LOINC Terms Value Set |
| toc-loinc-answered-by-LL5571-6-vs | Transitions of Care LOINC Terms Answered by LL5571-6 Answer List Value Set |
| mental-health-clinical-note-types | Mental Health Clinical Note Types |
| ch-elm-expecting-organism-specification | CH ELM Expecting Organism Specification |
| ch-elm-expecting-specimen-specification | CH ELM Expecting Specimen Specification |
| ch-elm-lab-study-types | CH ELM Lab Study Types |
| ch-elm-results-component-antibiotic-tb | CH ELM Results Antibiotic Tb |
| ch-elm-results-component-gene-tb | CH ELM Results Gene Tb |
| ch-elm-results-laboratory-observation-complete | CH ELM Results Laboratory Observation Complete |
| ch-elm-results-laboratory-observation-geno | CH ELM Results Laboratory Observation Genotyping |
| ch-elm-results-laboratory-observation-susc | CH ELM Results Laboratory Observation Susceptibility |
| ch-elm-results-laboratory-observation | CH ELM Results Laboratory Observation |
| ihe-ToDo-laughing-positions | The positions during laughing |
| australian-pronouns-1 | Australian Pronouns |
| valueset-calcium-LOINC | LOINC Codes for Serum Calcium |
| valueset-digoxin-LOINC | LOINC Codes for Digoxin Concentration |
| valueset-magnesium-LOINC | LOINC Codes for Serum Potassium |
| valueset-potassium-LOINC | LOINC Codes for Serum Potassium |
| valueset-renal-LOINC | LOINC Codes for Renal Function |
| Antepartum.Laboratory.VS | Antepartum Laboratory |
| pa-diagnosticreport-type | PA DiagnosticReport Types |
| pa-observation-code-activity | PA Observation Activity-related codes |
| pa-observation-code-evs | PA Observation Vital Sign Codes |
| pa-observation-code-time | PA Observation Time-related codes |
| pcd-sleep-observation-code | Patient contributed data: sleep observation code |
| rsg-source-document-type | AU Recorded Sex or Gender (RSG) Source Document Type |
| rsg-type | AU Recorded Sex or Gender Type |
| IHEXDSclassCode | IHE XDS Class Code |
| IHEXDStypeCode | IHE XDS Type Code |
| dna-change-type | LOINC-健保事前審查-基因突變類型值集 |
| gene-test-code | LOINC-健保事前審查-基因檢測代碼值集 |
| pat-ast | LOINC + NHI-健保事前審查-病人狀態評估項目值集 |
| report-type | LOINC-健保事前審查-報告類型值集 |
| specime-type | LOINC-健保事前審查-基因檢測檢體類型值集 |
| ihe-ToDo-laughing-positions | The positions during laughing |
| mcode-observation-codes-distant-metastases-vs | Observation Codes for Distant Metastases Category |
| mcode-observation-codes-primary-tumor-vs | Observation Codes for Primary Tumor Category |
| mcode-observation-codes-regional-nodes-vs | Observation Codes for Regional Node Category |
| smokingStatus-loinc-eu-i4rc | Smoking Status: LOINC |
| dk-ihe-typecode-vs | DK_IHE_TypeCode_VS |
| document-type | Document Type |
| observation-codes | Observation Codes |
| risultato-osservazione | Tipo Osservazione |
| sezione-referto-laboratorio | Sezioni Composition Lab Report |
| pronouns | Personal Pronouns |
| recorded-sex-or-gender-type | Recorded Sex Or Gender Type |
| v3-DocumentSectionType | DocumentSectionType |
| v3-HealthQualityMeasureDocument | HealthQualityMeasureDocument |
| v3-KnowledgeSubjectObservationValue | KnowledgeSubjectObservationValue |
| v3-LOINCObservationActContextAgeDefinitionCode | LOINCObservationActContextAgeDefinitionCode |
| v3-LogicalObservationIdentifierNamesAndCodes | LogicalObservationIdentifierNamesAndCodes |
| v3-LoincDocumentOntologyInternational | LoincDocumentOntologyInternational |
| v3-ObservationActContextAgeGroupType | ObservationActContextAgeGroupType |
| v3-QualityMeasureSectionType | QualityMeasureSectionType |
| v3-immunizationForecastDate | immunizationForecastDate |
| TNMStageGroupVS | Staging Type for Stage Group ValueSet |
| eltss-observation-code | Observation Code Value Set |
| valueset-chlamydia-example | Example Chlamydia Lab Obs Test Name Triggers for Public Health Reporting |
| cdex-loinc-attachment-codes | CDex LOINC Attachment Codes Value Set |
| 1.3.6.1.4.1.12009.10.2.5 | LOINC Imaging Document Codes |
| 2.16.840.1.113762.1.4.1099.10 | Care Plan Document Type |
| 2.16.840.1.113883.1.11.20.2.3 | ReferralDocumentType |
| 2.16.840.1.113883.1.11.20.2.4 | TransferDocumentType |
| 2.16.840.1.113883.1.11.20.22 | HPDocumentType |
| 2.16.840.1.113883.11.20.1.1 | SurgicalOperationNoteDocumentTypeCode |
| 2.16.840.1.113883.11.20.4.1 | DischargeSummaryDocumentTypeCode |
| 2.16.840.1.113883.11.20.6.1 | ProcedureNoteDocumentTypeCodes |
| 2.16.840.1.113883.11.20.8.1 | ProgressNoteDocumentTypeCode |
| 2.16.840.1.113883.11.20.9.31 | ConsultDocumentType |
| epiType | ePI document types |
| sectionCode | Section Codes |
| IHE.PCC.APGAR.VS | IHE PCC mPSC APGAR Assessment Type Value Set |
| IHE.PCC.VitalSigns.VS | IHE PCC Vital Signs Value Set |
| IHE.PCC.mPSC.VitalSigns.VS | IHE PCC mPSC Vital Signs Value Set |
| SDOHCC-ValueSetLOINCSNOMEDCT | SDOHCC ValueSet LOINC SNOMEDCT |
| SDOHCC-ValueSetPronounsValue | SDOHCC ValueSet Pronouns Value |
| sdc-profile-example | SDC-ValueSet AHRQ_Medication_Q1 |
| edd-method-uv-ips | Pregnancy Expected Delivery Date Method - IPS |
| pregnancies-summary-uv-ips | Pregnancy Outcome - IPS |
| problem-type-loinc | Problem Type (LOINC) |
| results-laboratory-pathology-observations-uv-ips | Results Laboratory/Pathology Observation - IPS |
| results-radiology-observations-uv-ips | Results Radiology Observation - IPS |
| results-radiology-txtobs-uv-ips | Results Radiology Textual Observation - IPS |
| ADIAttesterRoleTypeVS | Attester Role |
| ADIDocumentationTypeVS | Documentation Types |
| ADIHCADecisionsVS | Healthcare Agent Decisions |
| ADIInterventionPreferencesOrdinalVS | Intervention Preferences - Ordinal |
| LOINCPOLSTCPRAnswerList | LOINC POLST CPR Answer List |
| LOINCPOLSTDiscussPartAnswerList | LOINC POLST discuss part List |
| LOINCPOLSTInitialTxAnswerList | LOINC POLST Initial Tx Answer List |
| LOINCPOLSTMedAssistNutrAnswerList | LOINC POLST Med assist nutr Answer List |
| LOINCPOLSTReviewAnswerList | LOINC POLST review Answer List |
| fetal-rhd-antigen | CH EPREG VS: Fetal RhD Antigen |
| phenotypicFeatureVS | Observation Codes for status of a PhenotypicFeature |
| ImSectionEmptyReason | Reasons a section in an imaging report is empty. |
| LabTestTypeCovid19LoincValueSet | Lab Test - Type - COVID-19 - LOINC |
| LabTestTypeLoincValueSet | Lab Test - Type - Generic - LOINC |
| lab-obsCode-loinc-eu-lab | Laboratory Code: LOINC |
| lab-orderCodes-eu-lab | Laboratory Order |
| lab-reportType-eu-lab | Laboratory Report Types |
| lab-studyType-eu-lab | Laboratory Study Types |
| serviceRequestCodes | CRD Service Request Codes Value Set |
| all-urine-drug-screening-tests | All urine drug screening tests |
| amphetamine-urine-drug-screening-tests | Amphetamine-class drugs and metabolite urine tests |
| barbiturate-urine-drug-screening-tests | Barbiturate urine drug screening tests |
| benzodiazepine-urine-drug-screening-tests | Benzodiazepine urine drug screening tests |
| buprenorphine-urine-drug-screening-tests | Buprenorphine urine drug screening tests |
| cannabinoid-urine-drug-screening-tests | Cannabinoid class urine drug screening |
| cocaine-urine-drug-screening-tests | Cocaine urine drug screening tests |
| fentanyl-type-urine-drug-screening-tests | Fentanyl-type urine drug screening tests |
| general-opiate-urine-drug-screening-tests | General opiate urine drug screening tests |
| heroin-urine-drug-screening-tests | Heroin urine drug screening tests |
| methadone-urine-drug-screening-tests | Methadone urine drug screening tests |
| non-opioid-urine-drug-screening | Non-opioid drug urine screening |
| opiate-specific-urine-drug-screening-tests | Opiate specific urine drug screening tests |
| opioid-urine-drug-screening | Opioid drug urine screening |
| oxycodone-urine-drug-screening-tests | Oxycodone urine drug screening tests |
| pain-treatment-plan | Pain treatment plan |
| phencyclidine-urine-drug-screening-tests | Phencyclidine urine drug screening tests |
| synthetic-opioid-urine-drug-screening-tests | Synthetic opioid urine drug screening tests |
| xylazine-urine-drug-screening-tests | Xylazine drug urine screening tests |
| all-loinc-codes | All LOINC Codes |
| sghi-grade | Grade Value Sets |
| YN | Yes/No |
| YNU | Yes/No/Unknown |
| ethnicity | Ethnicity |
| LL2201-3 | LOINC® LL2201-3 - ValueSet về tình trạng hút thuốc |
| LL3639-3 | LOINC® LL3639-3 - ValueSet về trạng thái lây nhiễm |
| LL3976-9 | LOINC® LL3976-9 - ValueSet về tần suất hút thuốc |
| LL940-8 | LOINC® LL940-8 - ValueSet về tình trạng tiêm chủng |
| observation-codes | LOINC Codes |
| patient-history-social-factor-type | ValueSet dành cho loại tiền sử bệnh lý và đặc điểm xã hội |
| physical-exam-type | ValueSet dành cho loại thăm, khám lâm sàng |
| vn-core-diagnosticreport-code | ValueSet for Diagnostic Report Code |
| BreastImagingReportTypesVS | Breast Imaging Report Types ValueSet |
| pfe-body-structures-vs | Personal Functioning and Engagement Body Structures Value Set |
| pfe-communication-vs | Personal Functioning and Engagement Communication Value Set |
| pfe-domestic-life-vs | Personal Functioning and Engagement Domestic Life Value Set |
| pfe-functions-of-digestive-vs | Personal Functioning and Engagement Functions Of Digestive, Metabolic, and Endocrine Systems Value Set |
| pfe-genitourinary-vs | Personal Functioning and Engagement Genitourinary and Reproductive Functions Value Set |
| pfe-goals-mobility-vs | Personal Functioning and Engagement Goals Mobility Value Set |
| pfe-goals-panel-vs | Personal Functioning and Engagement Goals Panel Value Set |
| pfe-goals-self-care-vs | Personal Functioning and Engagement Goals Self-Care Value Set |
| pfe-learning-and-applying-knowledge-vs | Personal Functioning and Engagement Learning and Applying Knowledge Value Set |
| pfe-mental-functions-vs | Personal Functioning and Engagement Mental Functions Value Set |
| pfe-mobility-vs | Personal Functioning and Engagement Mobility Value Set |
| pfe-neuromusculoskeletal-vs | Personal Functioning and Engagement Neuromusculoskeletal and Movement Related Functions Value Set |
| pfe-panel-vs | Personal Functioning and Engagement Panel Value Set |
| pfe-products-and-technology-vs | Personal Functioning and Engagement Products and Technology Value Set |
| pfe-self-care-vs | Personal Functioning and Engagement Self-Care Value Set |
| pfe-sensory-functions-pain-clinical-test-vs | Personal Functioning and Engagement Sensory Functions and Pain Clinical Test Value Set |
| pfe-sensory-functions-pain-vs | Personal Functioning and Engagement Sensory Functions and Pain Value Set |
| pfe-skin-functions-vs | Personal Functioning and Engagement Functions of Skin and Related Structures Value Set |
| pfe-structures-voice-and-speech-vs | Personal Functioning and Engagement Structures Involved in Voice and Speech Value Set |
| pfe-voice-and-speech-vs | Personal Functioning and Engagement Voice and Speech Functions Value Set |
| sdoh-obs-snomed-loinc-eu-hdr | SDOH Observation codes |
| bdr-eventtypes | Birth Defect Report Event Types |
| condition-severity-uv-ips | Problem Severity |
| pregnancies-summary-uv-ips | IPS Pregnancies Summary |
| 2.16.840.1.113883.11.22.37--20170523000000 | IPS Results Organizer |
| observation-codes-uv-ips | IPS Results Observation |
| imaging-observations-uv-ips | IPS Results Radiology Observation |
| 2.16.840.1.113883.11.22.66--20240802105026 | IPS Results Radiology Textual Observations |
| 2.16.840.1.113883.11.22.72--20240802094107 | IPS Pregnancy Expected Delivery Date Method |
| apix-document-type | APIX Document Type Value Set |
| ch-lab-bloodgroup-antibody-screen-vs | CH LAB-Report BloodGroup Antibody Screen Test (LOINC codes) |
| observation-code-cdk-epi-2009 | CH LAB-Report Codes for eGFR in CKD-EPI |
| observation-code-cdk-epi-2021 | CH LAB-Report Codes for eGFR in CKD-EPI 2021 |
| observation-code-entsvol-ratio | CH LAB-Report Codes for Erythrocyte Distribuiton Width Test |
| observation-code-mdrd-male-female | CH LAB-Report Codes for eGFR (MDRD) |
| CardiacCTA | CTA Heart and Coronary arteries |
| ChronicLungDisease | Chronic Lung Disease |
| FamilyPrematureCAD | Family History of Premature CAD |
| NewYorkHeartAssociation | New York Heart Association Assessment Scale |
| NewYorkHeartAssociationAnswers | New York Heart Association OA Answer List |
| PriorCABG | Prior History of Coronary Artery Bypass Graft |
| RoseDyspneaQ | Rose Dyspnea Questions |
| SEattleAnginaQs | Seattle Angina Questions |
| SeattleAnginaAs | Seattle Angina Answers |
| StressTest | Cath PCI Selected Stress Test |
| ValvularStenosis | Valvular Stenosis |
| sensitive-care-team-codes | ValueSet - Sensitive CareTeam Codes |
| sensitive-condition-codes | ValueSet - Sensitive Condition Codes |
| sensitive-observation-codes | ValueSet - Sensitive Observation Codes |
| loinc-doc-section-code | LOINC Code Document Section值集 |
| loinc-document-classcodes | LOINC Document Class值集 |
| loinc-observation-code | LOINC實驗室檢驗檢查值集 |
| loinc-pregnancy-intent-code | LOINC + HL7 NullFlavor妊娠計畫值集 |
| loinc-survey-codes | LOINC篩檢與評估值集 |
| loinc-type-doc-code | LOINC Code Document Type值集 |
| smoking-status-type-code | SNOMED CT + LOINC 吸菸狀態種類向值集 |
| vital-signs-tw | LOINC生命體徵值集 |
| YN | Yes/No |
| YNU | Yes/No/Unknown |
| ethnicity | Ethnicity |
| splDocumentCodes | SPL Document Codes |
| splSectionCodes | SPL Section Codes |
| valueset-genericFacilityMessageTypes | Generic Facility Message Types |
| valueset-organizationSubmissionMessageTypes | Organization Submission Message Types |
| ValueSet-apgar-timing | APGAR Score Timing |
| cigarette-smoking-before-during-pregnancy | Cigarette Smoking Before and During Pregnancy |
| TNMStageGroupVS | Staging Type for Stage Group ValueSet |
| us-core-clinical-note-type | US Core Clinical Note Type |
| us-core-diagnosticreport-category | US Core Diagnostic Report Category Codes |
| us-core-diagnosticreport-report-and-note-codes | US Core Non Laboratory Codes |
| us-core-documentreference-type | US Core DocumentReference Type |
| us-core-goal-description | US Core Goal Codes |
| us-core-laboratory-test-codes | US Core Laboratory Test Codes |
| us-core-procedure-code | US Core Procedure Codes |
| dna-change-type | LOINC-健保NGS-基因突變類型值集 |
| gene-test-code | LOINC-健保NGS-基因檢測代碼值集 |
| specime-type | LOINC-健保NGS-基因檢測檢體類型值集 |
| cigarette-smoking-before-during-pregnancy | Cigarette Smoking Before and During Pregnancy |
| Ab-det-past-recent-infection-vs | Antibody Not Detected, Past/Recent Infection LOINC answer value set. |
| covid19-detected-genetic-mutation-la-codes-value-set | Detected Genetic Mutations LOINC answer codes value set |
| covid19-who-path-la-codes-value-set | World Health Organization, COVID-19 variant LOINC answer code value set |
| exposure-type-la-value-set | Exposure Type LOINC Answer Value Set |
| sars-cov2-clade-loinc-answer-value-set | SARS CoV 2 Clade Assignment LOINC Answer value set |
| sars-cov2-lineage-loinc-answer-value-set | SARS CoV 2 Lineage LOINC Answers |
| sars-cov2-rdrp-mutation-vs | SARS CoV 2 RdRp Gene Mutation value set |
| StdLabObsCoded-value-set | Standard Coded Lab Observation Code value set |
| StdLabObsOrdinal-value-set | Standard Coded Ordinal Lab Observation Code value set |
| loinc-doc-value-set | LOINC Document class value set |
| standard-lab-obs-narrative-value-set | Standard Lab Obs Narrative value set |
| standard-lab-obs-quantitative-value-set | Standard Lab Obs Quantitative Code value set |
| titer-lab-codes-value-set | Titer Lab Codes value set |
| dataelement-sdcobjectclass | DataElement SDC Object Class |
| dataelement-sdcobjectclassproperty | DataElement SDC Object Class Property |
| ihe-ToDo-laughing-positions | The positions during laughing |
| IMMZ.Z.DE11 | IMMZ.Z.DE11 ValueSet for Mumps-containing vaccines |
| IMMZ.Z.DE17 | IMMZ.Z.DE17 ValueSet for Rubella-containing vaccines |
| IMMZ.Z.DE3 | IMMZ.Z.DE3 ValueSet for Diphtheria-containing vaccines |
| IMMZ.Z.DE32 | IMMZ.Z.DE32 ValueSet for Measles and rubella-containing vaccines |
| IMMZ.Z.DE4 | IMMZ.Z.DE4 ValueSet for Hib-containing vaccines |
| IMMZ.Z.DE6 | IMMZ.Z.DE6 ValueSet for Hepatitis B-containing vaccines |
| IMMZ.Z.DE9 | IMMZ.Z.DE9 ValueSet for Measles-containing vaccines |
| genetic-therapeutic-implications-vs | Genetic Therapeutic Implications |
| molecular-biomarker-code-vs | Molecular Biomarker Codes |
| DocumentLOINCCodelist | Document Class & Type waardelijst |
| NDHCareTeamCategoryVS | NDH Care Team Category Value Set |
| pcd-sleep-observation-code | Patient contributed data: sleep observation code |
| Covid19Labs | COVID-19 Diagnostic Test |
| PatientsOnVentilator | Observations for Patients on a Ventilator |
| SARSCoV2GeneticLabs | SARSCoV2 Genetic Labs |
| SARSCoV2Labs | SARS CoV2 Labs |
| VTEReports | Codes for reports about VTE Diagnosics |
| VentilatorObservations | Ventilator Observations |
| loinc-report-type | LOINC-健保重大傷病-報告類型值集 |
| YN | Yes/No |
| YNU | Yes/No/Unknown |
| ethnicity | Ethnicity |
| Antepartum.Laboratory.VS | Antepartum Laboratory |
| argonaut-clinical-note-type | Argonaut DocumentReferences Type Value Set |
| diagnosticreport-category | Argonaut DiagnosticReport Category Value Set |
| ISiKSpecificGenericTempLoincVS | ISiK Specific Generische Koerpertemperatur LOINC Konzepte |
| ISiKSpecificKernTempLoincVS | ISiK Specific Kerntemperatur LOINC ValueSet |
| ObservationCodesCRP | ObservationCodesCRP |
| ObservationCodesGFR | ObservationCodesGFR |
| ObservationCodesHb | ObservationCodesHb |
| ObservationCodesPCT | ObservationCodesPCT |
| ObservationCodesSerumkreatinin | ObservationCodesSerumkreatinin |
| ObservationCodesTSH | ObservationCodesTSH |
| ObservationCodesThrombozyten | ObservationCodesThrombozyten |
| ObservationCodesTroponin | ObservationCodesTroponin |
| SchwangerschaftEtMethodeVS | Schwangerschaft Erwarteter Entbindungstermin Methode |
| SchwangerschaftsstatusVS | Schwangerschaftsstatus Valueset |
| StillstatusVS | Stillstatus LOINC Antwortoptionen |
| current-smoking-status-uv-ips | Current Smoking Status - IPS |
| vs-mii-icu-code-monitoring-und-vitaldaten-loinc | VS MII ICU Code Monitoring und Vitaldaten [LOINC] |
| mii-vs-mikrobio-barlett-score-loinc | MII VS Mikrobio Barlett Score [LOINC] |
| mii-vs-mikrobio-befundtyp-loinc | MII VS Mikrobio Befundtyp [LOINC] |
| mii-vs-mikrobio-empfindlichkeit-genotyp-loinc | MII VS Mikrobio Empfänglichkeit Genotyp [LOINC] |
| mii-vs-mikrobio-empfindlichkeit-phenotyp-loinc | MII VS Mikrobio Empfindlichkeit Phenotyp [LOINC] |
| mii-vs-mikrobio-keimzahl-loinc | MII VS Mikrobio Keimzahl [LOINC] |
| mii-vs-mikrobio-kulturtests-loinc | MII VS Mikrobio Kulturtests [LOINC] |
| mii-vs-mikrobio-mikroskopie-tests-loinc | MII VS Mikrobio Mikroskopie Tests [LOINC] |
| mii-vs-mikrobio-molekulare-diagnostik-loinc | MII VS Mikrobio Molekulare Diagnostik [LOINC] |
| mii-vs-mikrobio-mrgn-klasse-loinc | MII VS Mikrobio MRGN Klasse [LOINC] |
| mii-vs-mikrobio-resistenzgene-loinc | MII VS Mikrobio Resistenzgene [LOINC] |
| mii-vs-mikrobio-resistenzmutation-loinc | MII VS Mikrobio Resistenzmutation [LOINC] |
| mii-vs-mikrobio-serologie-immunologie-loinc | MII VS Mikrobio Serologie Immunologie [LOINC] |
| mii-vs-mikrobio-virulenz-loinc | MII VS Mikrobio Virulenz [LOINC] |
| document-ontology-part-type | Document Ontology Part Type EHR |
| epa-medication-management-note-vs | EPA Medication Management Note ValueSet |
| KBV_VS_MIO_NFD_Pregnancy_Status | Aktueller Schwangerschaftsstatus |
| Wundheilungsphasen | Wundheilungsphasen |
| contentVerbalAssessment | PosiThera - Inhalte verbaler Angaben |
| mii-vs-patho-all-loinc | MII VS Patho All [LOINC] |
| mii-vs-patho-composition-type-loinc | MII VS Patho Composition Type [LOINC] |
| mii-vs-patho-section-types-loinc | MII VS Patho Section Types [LOINC] |
| NICE-LaboratoryTestResultCodelist | NICE Laboratory Test Results |
| KBV_VS_Base_Apgar_Score_Identifier_LOINC | Apgar Score LOINC® |
| KBV_VS_Base_Breastfeeding_Status_LOINC | Stillzeitstatus LOINC® |
| KBV_VS_Base_Estimated_Date_of_Delivery_LOINC | Geschätzter Entbindungstermin LOINC® |
| KBV_VS_Base_Glucose_Concentration_LOINC | Blutzucker LOINC® |
| KBV_VS_Base_Pregnancy_Status_LOINC | Aktueller Schwangerschaftsstatus LOINC® |
| KBV_VS_Base_Apgar_Score_Identifier_Loinc | KBV_VS_Base_Apgar_Score_Identifier_Loinc |
| KBV_VS_Base_Body_Height_Loinc | Koerpergroesse |
| KBV_VS_Base_Body_Weight_Loinc | Loinccodes für die Koerpergroesse |
| sdc-profile-example | AHRQ Medication Q1 |
| type-document-reference-esms-valueset | DocumentReferenceTypeESMSValueSet |
| demog-alert-code | Demog Alert Code |
| composition-form-type-my-core | ValueSetCompositionFormType (MY Core) |
| loinc-my-core | ValueSetLoinc (MY Core) |
| observation-anthropometry-my-core | ValueSetObservationAnthropometry (MY Core) |
| observation-obstetric-us-my-core | ValueSetObservationObstetricUs (MY Core) |
| observation-panel-my-core | ValueSetObservationPanel (MY Core) |
| observation-vital-signs-my-core | ValueSetObservationVitalSigns (MY Core) |
| observation-vsc-bp-my-core | ValueSetObservationVSCBP (MY Core) |
| observation-vsc-hr-my-core | ValueSetObservationVSCHR (MY Core) |
| observation-vsc-so2-my-core | ValueSetObservationVSCSO2 (MY Core) |
| observation-vsc-t-my-core | ValueSetObservationVSCT (MY Core) |
| PocLisCodigoTest | PocLisCodigoTest |
| nfdi4health-vs-mds-time-units-ucum-loinc | NFDI4Health VS MDS Provenance Time Units [UCUM, LOINC] |
| KBV_VS_MIO_LAB_Laboratory_Specialties | Laborbereich |
| LL1023-2 | [PROMIS] Very poor|Poor|Fair|Good|Very good |
| LL2335-9 | Numeric rating scale from 0-10 |
| yesno | Yesno |
| sdohObservationCode | SDOH Observation Code |
| EkgLeads | EKG/ECG leads |
| VitalSignDE_Body_Height_Loinc | ValueSetVitalSignDE_Body_Height_Loinc |
| glasgow-coma-score-eye | VS Score Glasgow Coma Score Eye |
| glasgow-coma-score-motor | VS Score Glasgow Coma Score Motor |
| glasgow-coma-score-verbal | VS Score Glasgow Coma Score Verbal |
| TipluUnterstuetzteLaboratoryLoincCodesVS | ValueSet der von Tiplu unterstützten LOINC Codes |
| KBV_VS_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence | Titerbezeichnung |
| oncology-EstrogenReceptorInterpretationTestsVS | BC EstrogenReceptorInterpretationTestsVS ValueSet |
| oncology-HER2byFISHVSInterpretationTestsVS | BC HER2byFISHVSInterpretationTestsVS ValueSet |
| oncology-HER2byIHCInterpretationTestsVS | BC HER2byIHCInterpretationTestsVS ValueSet |
| oncology-HER2byIHCScoreVS | BC HER2byIHCScoreVS ValueSet |
| oncology-ProgesteroneReceptorInterpretationTestsVS | BC ProgesteroneReceptorInterpretationTestsVS ValueSet |
| bc-BirthObservation-code | bc-BirthObservation-code |
| bc-ChildObservation-code | bc-ChildObservation-code |
| bc-DeliveryObservation-code | bc-DeliveryObservation-code |
| bc-FetusObservation-code | bc-FetusObservation-code |
| bc-MaternalObservation-code | bc-MaternalObservation-code |
| bc-PregnancyObservation-code | bc-PregnancyObservation-code |
| exame | Exame |
| loinc-observation-clinical-code | LOINC臨床分類值集 |
| KBV_VS_MIO_MR_Examination_Loinc | Laboruntersuchungen |
| MaiaUnterstuetzteLoincCodes | ValueSet der von Maia unterstützten LOINC Codes |
| MaiaUnterstuetzteVitalparameterUndMesserteVS | ValueSet der von Maia unterstützten Vitalparameter und Messwerte |
| composition-form-type-id-core | ValueSetCompositionFormType (ID Core) |
| loinc-id-core | ValueSetLoinc (ID Core) |
| observation-anthropometry-id-core | ValueSetObservationAnthropometry (ID Core) |
| observation-obstetric-us-id-core | ValueSetObservationObstetricUs (ID Core) |
| observation-panel-id-core | ValueSetObservationPanel (ID Core) |
| observation-vital-signs-id-core | ValueSetObservationVitalSigns (ID Core) |
| observation-vsc-bp-id-core | ValueSetObservationVSCBP (ID Core) |
| observation-vsc-hr-id-core | ValueSetObservationVSCHR (ID Core) |
| observation-vsc-so2-id-core | ValueSetObservationVSCSO2 (ID Core) |
| observation-vsc-t-id-core | ValueSetObservationVSCT (ID Core) |
| HDBP0037-TestCode | HDBP0037-TestCode |
| 2.16.840.1.113883.2.4.3.11.60.140.11.14--20240226140032 | FACIT LL5215-0 (Not at all=0, Very much=4 ) |
| 2.16.840.1.113883.2.4.3.11.60.140.11.9--20240220101531 | Numeric Pain Rating Scale Answer List (LL2335-9) |
| tnm-klassifikation-typ-loinc | ValueSet TNM Klassification Typ LOINC |
| tnm-m-kategorie-typ-loinc | ValueSet TNM M-Kategorie Typ LOINC |
| tnm-n-kategorie-typ-loinc | ValueSet TNM N-Kategorie Typ LOINC |
| tnm-t-kategorie-typ-loinc | ValueSet TNM T-Kategorie Typ LOINC |
| doc-typecodes | ReferralDocumentType |
| JDV-J07-XdsTypeCode-CISIS | JDV_J07-XdsTypeCode-CISIS |
| JDV-J154-TypeGlucose-ENS | JDV_J154-TypeGlucose-ENS |
| JDV-J157-MomentGlucose-ENS | JDV_J157-MomentGlucose-ENS |
| JDV-J279-Loinc-UPNOS | JDV_J279-Loinc-UPNOS |
| JDV-J66-TypeCode-DMP | JDV_J66-TypeCode-DMP |
| krcore-vital-signs-codes | KR Core Vital Signs Codes |
| vs-mii-icu-code-monitoring-und-vitaldaten-loinc | VS MII ICU Code Monitoring und Vitaldaten [LOINC] |
| vs-mii-icu-code-observation-beatmung-loinc | VS MII ICU Code Observation Beatmung [LOINC] |
| vs-mii-icu-code-observation-bilanzen-loinc | VS MII ICU Code Observation Bilanzen [LOINC] |
| vs-mii-icu-code-observation-extrakorporale-verfahren-loinc | VS MII ICU Code Observation extrakorporale Verfahren [LOINC] |
| loinc-method-details-values | LOINC檢驗方法值集 |
| loinc-observation-category | LOINC實驗室檢驗檢查類型值集 |
| twcdc-loinc-code-values | CDC-LOINC實驗室通報項目值集 |
| answerSetLaboratoryTest-LOINC | LOINC-AnswerSet für Labortest |
| answerSetResistance-LOINC | LOINC-AnswerSet für Resistenz |
| laboratoryTestABVP | Labortest für Arboviren (sonstige) |
| laboratoryTestACBP | Labortest für Acinetobacter spp. bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation |
| laboratoryTestADEP | Labortest für Adenoviren; Meldepflicht bei akuter Infektion für Nachweise aus allen Körpermaterialien |
| laboratoryTestADVP | Labortest für Adenoviren; Meldepflicht nur für den direkten Nachweis im Konjunktivalabstrich |
| laboratoryTestASTP | Labortest für Astroviren |
| laboratoryTestBANP | Labortest für Bacillus anthracis |
| laboratoryTestBOBP | Labortest für (Lyme-) Borreliose, Borrelia burgdorferi |
| laboratoryTestBORP | Labortest für Borrelia recurrentis |
| laboratoryTestBOVP | Labortest für humanpathogene Bornaviren; Meldepflicht nur für den direkten Nachweis |
| laboratoryTestBPSP | Labortest für Bordetella pertussis, Bordetella parapertussis |
| laboratoryTestBRUP | Labortest für Brucella sp. |
| laboratoryTestCAMP | Labortest für Campylobacter spp. (darmpathogen) |
| laboratoryTestCAUP | Labortest für Candida auris; Meldepflicht nur für den direkten Nachweis |
| laboratoryTestCHLP | Labortest für Chlamydia psittaci |
| laboratoryTestCKVP | Labortest für Chikungunya-Virus |
| laboratoryTestCLOP | Labortest für Clostridium botulinum oder Toxinnachweis |
| laboratoryTestCLTP | Labortest für Tetanus, Clostridium tetani |
| laboratoryTestCORP | Labortest für Corynebacterium spp. (Toxin bildend) |
| laboratoryTestCOXP | Labortest für Coxiella burnetii |
| laboratoryTestCRYP | Labortest für humanpathogene Cryptosporidium sp. |
| laboratoryTestCVDP | Labortest für Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2) |
| laboratoryTestCVSP | Labortest für Severe-Acute-Respiratory-Syndrome-Coronavirus-1 (SARS-CoV-1) (2003) |
| laboratoryTestCYMP | Labortest für Cytomegalie, Cytomegalievirus |
| laboratoryTestDENP | Labortest für Denguevirus |
| laboratoryTestEAHP | Labortest für Amoebiasis, Entamoeba histolytica |
| laboratoryTestEBCP | Labortest für Enterobacterales bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation |
| laboratoryTestEBVP | Labortest für Ebolavirus |
| laboratoryTestECOP | Labortest für Escherichia coli (sonstige darmpathogene Stämme) |
| laboratoryTestEHCP | Labortest für Escherichia coli (enterohämorrhagische Stämme) (EHEC) |
| laboratoryTestETVP | Labortest für Enteroviren |
| laboratoryTestFRTP | Labortest für Francisella tularensis |
| laboratoryTestFSVP | Labortest für FSME-Virus |
| laboratoryTestGBSP | Labortest für Gruppe-B-Streptokokken (GBS); Meldepflicht nur für den direkten Nachweis bei Schwangeren und Neugeborenen |
| laboratoryTestGFVP | Labortest für Gelbfiebervirus |
| laboratoryTestGILP | Labortest für Giardia lamblia |
| laboratoryTestHAVP | Labortest für Hepatitis-A-Virus |
| laboratoryTestHBVP | Labortest für Hepatitis-B-Virus; Meldepflicht für alle Nachweise |
| laboratoryTestHCVP | Labortest für Hepatitis-C-Virus; Meldepflicht für alle Nachweise |
| laboratoryTestHDVP | Labortest für Hepatitis-D-Virus; Meldepflicht für alle Nachweise |
| laboratoryTestHEVP | Labortest für Hepatitis-E-Virus |
| laboratoryTestHFAP | Labortest für Andere Erreger hämorrhagischer Fieber |
| laboratoryTestHINP | Labortest für Haemophilus influenzae; Meldepflicht nur für den direkten Nachweis aus Liquor oder Blut |
| laboratoryTestHTVP | Labortest für Hantavirus |
| laboratoryTestINVP | Labortest für Influenzavirus; Meldepflicht nur für den direkten Nachweis |
| laboratoryTestLEGP | Labortest für Legionella sp. |
| laboratoryTestLEPP | Labortest für humanpathogene Leptospira sp. |
| laboratoryTestLISP | Labortest für Listeria monocytogenes; Meldepflicht nur für den direkten Nachweis aus Blut, Liquor oder anderen normalerweise sterilen Substraten sowie aus Abstrichen von Neugeborenen |
| laboratoryTestLSVP | Labortest für Lassavirus |
| laboratoryTestMBVP | Labortest für Marburgvirus |
| laboratoryTestMPMP | Labortest für Mycoplasmen |
| laboratoryTestMPVP | Labortest für Mumpsvirus |
| laboratoryTestMPXP | Labortest für Orthopockenviren (Mpoxvirus) |
| laboratoryTestMRAP | Labortest für Staphylococcus aureus (Methicillin-resistente Stämme); Meldepflicht nur für den Nachweis aus Blut oder Liquor |
| laboratoryTestMRSP | Labortest für Middle-East-Respiratory-Syndrome-Coronavirus (MERS-CoV) |
| laboratoryTestMSVP | Labortest für Masernvirus |
| laboratoryTestMYLP | Labortest für Mycobacterium leprae |
| laboratoryTestMYTP | Labortest für Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis; Meldepflicht für den direkten Erregernachweis sowie nachfolgend für das Ergebnis der Resistenzbestimmung; vorab auch für den Nachweis säurefester Stäbchen im Sputum |
| laboratoryTestNCVP | Labortest für Vibrio spp., humanpathogen (außer Erreger der Cholera); soweit ausschließlich eine Ohrinfektion vorliegt, nur bei Vibrio cholerae non O1/non-O139 |
| laboratoryTestNEIP | Labortest für Neisseria meningitidis; Meldepflicht nur für den direkten Nachweis aus Liquor, Blut, hämorrhagischen Hautinfiltraten oder anderen normalerweise sterilen Substraten |
| laboratoryTestNOVP | Labortest für Norovirus |
| laboratoryTestOPXP | Labortest für Orthopockenviren (sonstige Orthopockenviren) |
| laboratoryTestPINP | Labortest für Parainfluenzavirus |
| laboratoryTestPKVP | Labortest für Orthopockenviren (Variolavirus) |
| laboratoryTestPLAP | Labortest für Plasmodium spp. (Malaria) |
| laboratoryTestPOVP | Labortest für Poliovirus |
| laboratoryTestPVBP | Labortest für Ringelröteln, Parvovirus B 19 |
| laboratoryTestRBVP | Labortest für Rabiesvirus |
| laboratoryTestRICP | Labortest für Rickettsia prowazekii |
| laboratoryTestRSVP | Labortest für Respiratorisches-Synzytial-Virus |
| laboratoryTestRTVP | Labortest für Rotavirus |
| laboratoryTestRUVP | Labortest für Rubellavirus |
| laboratoryTestSALP | Labortest für Salmonella (sonstige) |
| laboratoryTestSHIP | Labortest für Shigella sp. |
| laboratoryTestSPAP | Labortest für Salmonella Paratyphi; Meldepflicht für alle direkten Nachweise |
| laboratoryTestSPNP | Labortest für Streptococcus pneumoniae; Meldepflicht nur für den direkten Nachweis aus Liquor, Blut, Gelenkpunktat oder anderen normalerweise sterilen Substraten |
| laboratoryTestSPYP | Labortest für Scharlach, Beta-hämolysierenden Streptokokken der Gruppe A |
| laboratoryTestSTYP | Labortest für Salmonella Typhi; Meldepflicht für alle direkten Nachweise |
| laboratoryTestTRIP | Labortest für Trichinella spiralis |
| laboratoryTestVCHP | Labortest für Vibrio cholerae |
| laboratoryTestVZVP | Labortest für Varizella-Zoster-Virus |
| laboratoryTestWBKP | Labortest für Krankheitserreger unter Berücksichtigung der Art der Krankheitserreger und der Häufigkeit ihres Nachweises wenn Hinweise auf eine schwerwiegende Gefahr für die Allgemeinheit bestehen |
| laboratoryTestWNVP | Labortest für West-Nil-Virus |
| laboratoryTestYENP | Labortest für Yersinia spp. (darmpathogen) |
| laboratoryTestYPSP | Labortest für Yersinia pestis |
| laboratoryTestZKVP | Labortest für Zika-Virus |
| resistance | Resistenz |
| resistanceGene | Resistenzdeterminante |
| VSTiposDocClinic | Tipos de Documentos Clínicos |
| elga-antibiogramm | ELGA_Antibiogramm |
| elga-laborparameter | ELGA_Laborparameter |
| elga-pregnanciessummary | ELGA_PregnanciesSummary |
| elga-pregnancystatus | ELGA_PregnancyStatus |
| elga-vitalparameterarten | ELGA_Vitalparameterarten |
| bp-components | Blood Pressure component codes |
| il-core-document-type | IL Core Document Type codes |
| il-core-observation-code | IL Core Observation Codes |
| il-core-observation-lab-code | IL Core Observation Lab Code |
| il-core-observation-value | IL Core Observation Value Codes |
| il-core-procedure-code | IL Core procedure Codes |
| loinc-rsna-radiology-playbook | ImagingProcedureCode |
| answerSetResistance | AnswerSet für Resistenz |
| laboratoryTestHFMP | Labortest für Hand-Fuß-Mund-Krankheit |
| pronouns | Person Pronouns |
| recordedgendertype | Recorded Gender Type Value Set |
| recordedgender | Recorded Gender Value Set |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.1--20200901000000 | AdemhalingScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.1--20200901000000 | AlertTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.2--20200901000000 | HartslagScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.4--20200901000000 | HuidskleurScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.5--20200901000000 | OnderzoekCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.5--20200901000000 | ReflexenScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.3--20200901000000 | SpierspanningScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.3--20200901000000 | TestCodeLOINCCodelijst |
| dk-core-LoincBasicObservation | DK Core LOINC Basic Observations |
| mcode-observation-codes-distant-metastases-vs | Observation Codes for Distant Metastases Category |
| mcode-observation-codes-primary-tumor-vs | Observation Codes for Primary Tumor Category |
| mcode-observation-codes-regional-nodes-vs | Observation Codes for Regional Node Category |
| mcode-observation-codes-stage-group-vs | Observation Codes for Stage Group Category |
| vs-docref-doctype-eu-pcsp | Document Type |
| mii-vs-mtb-molekulare-biomarker | MII VS Molekulare Biomarker |
| mii-vs-mtb-mmr-expression | MII VS Mismatch Repair Proteins Expression |
| mii-vs-mtb-msi | MII VS Mikrosatelliteninstabilität |
| ValueSet-Nombres-Examenes-LOINC | LOINC Value Set de Nombres de Exámenes |
| EMDAF_VS_Laborparameter | EMDAF_VS_Laborparameter |
| sect_CID_100.html | QuantitativeDiagnosticImagingProcedure |
| sect_CID_10046.html | GFRMeasurement |
| sect_CID_101.html | ImagingProcedure |
| sect_CID_109.html | DiagnosticImagingProcedurewithIVContrast |
| sect_CID_12003.html | OBGYNDate |
| sect_CID_12004.html | FetalBiometryRatio |
| sect_CID_12005.html | FetalBiometryMeasurement |
| sect_CID_12006.html | FetalLongBonesBiometryMeasurement |
| sect_CID_12007.html | FetalCraniumMeasurement |
| sect_CID_12008.html | OBGYNAmnioticSacMeasurement |
| sect_CID_12009.html | EarlyGestationBiometryMeasurement |
| sect_CID_12011.html | UltrasoundPelvisandUterusMeasurement |
| sect_CID_12012.html | OBEquation/Table |
| sect_CID_12013.html | GestationalAgeEquation/Table |
| sect_CID_12014.html | OBFetalBodyWeightEquation/Table |
| sect_CID_12015.html | FetalGrowthEquation/Table |
| sect_CID_12016.html | EstimatedFetalWeightPercentileEquation/Table |
| sect_CID_12018.html | OBGYNSummary |
| sect_CID_12019.html | OBGYNFetusSummary |
| sect_CID_12024.html | VascularUltrasoundReportDocumentTitle |
| sect_CID_12100.html | VascularUltrasoundReportDocumentTitle |
| sect_CID_12119.html | VascularUltrasoundProperty |
| sect_CID_12120.html | UltrasoundBloodVelocityMeasurement |
| sect_CID_12121.html | VascularIndex/Ratio |
| sect_CID_12122.html | OtherVascularProperty |
| sect_CID_12123.html | CarotidRatio |
| sect_CID_12124.html | RenalRatio |
| sect_CID_12200.html | EchocardiographyLeftVentricleMeasurement |
| sect_CID_12201.html | LeftVentricleLinearMeasurement |
| sect_CID_12202.html | LeftVentricleVolumeMeasurement |
| sect_CID_12203.html | LeftVentricleOtherMeasurement |
| sect_CID_12204.html | EchocardiographyRightVentricleMeasurement |
| sect_CID_12205.html | EchocardiographyLeftAtriumMeasurement |
| sect_CID_12206.html | EchocardiographyRightAtriumMeasurement |
| sect_CID_12207.html | EchocardiographyMitralValveMeasurement |
| sect_CID_12208.html | EchocardiographyTricuspidValveMeasurement |
| sect_CID_12209.html | EchocardiographyPulmonicValveMeasurement |
| sect_CID_12210.html | EchocardiographyPulmonaryArteryMeasurement |
| sect_CID_12211.html | EchocardiographyAorticValveMeasurement |
| sect_CID_12212.html | EchocardiographyAortaMeasurement |
| sect_CID_12214.html | EchocardiographyPulmonaryVeinMeasurement |
| sect_CID_12215.html | EchocardiographyVenaCavaMeasurement |
| sect_CID_12216.html | EchocardiographyHepaticVeinMeasurement |
| sect_CID_12217.html | EchocardiographyCardiacShuntMeasurement |
| sect_CID_12218.html | EchocardiographyCongenitalAnomalyMeasurement |
| sect_CID_12220.html | EchocardiographyCommonMeasurement |
| sect_CID_12222.html | OrificeFlowProperty |
| sect_CID_12250.html | CardiacUltrasoundCommonLinearMeasurement |
| sect_CID_12251.html | CardiacUltrasoundLinearValveMeasurement |
| sect_CID_12252.html | CardiacUltrasoundCardiacFunction |
| sect_CID_12253.html | CardiacUltrasoundAreaMeasurement |
| sect_CID_12254.html | CardiacUltrasoundHemodynamicMeasurement |
| sect_CID_12255.html | CardiacUltrasoundMyocardiumMeasurement |
| sect_CID_12257.html | CardiacUltrasoundLeftVentricleMeasurement |
| sect_CID_12258.html | CardiacUltrasoundRightVentricleMeasurement |
| sect_CID_12259.html | CardiacUltrasoundVentriclesMeasurement |
| sect_CID_12260.html | CardiacUltrasoundPulmonaryArteryMeasurement |
| sect_CID_12261.html | CardiacUltrasoundPulmonaryVein |
| sect_CID_12262.html | CardiacUltrasoundPulmonaryValveMeasurement |
| sect_CID_12263.html | CardiacUltrasoundVenousReturnPulmonaryMeasurement |
| sect_CID_12264.html | CardiacUltrasoundVenousReturnSystemicMeasurement |
| sect_CID_12265.html | CardiacUltrasoundAtriaandAtrialSeptumMeasurement |
| sect_CID_12266.html | CardiacUltrasoundMitralValveMeasurement |
| sect_CID_12267.html | CardiacUltrasoundTricuspidValveMeasurement |
| sect_CID_12268.html | CardiacUltrasoundAtrioventricularValveMeasurement |
| sect_CID_12269.html | CardiacUltrasoundInterventricularSeptumMeasurement |
| sect_CID_12270.html | CardiacUltrasoundAorticValveMeasurement |
| sect_CID_12271.html | CardiacUltrasoundOutflowTractMeasurement |
| sect_CID_12272.html | CardiacUltrasoundSemilunarValve,AnnulateandSinusMeasurement |
| sect_CID_12273.html | CardiacUltrasoundAorticSinotubularJunctionMeasurement |
| sect_CID_12274.html | CardiacUltrasoundAortaMeasurement |
| sect_CID_12275.html | CardiacUltrasoundCoronaryArteryMeasurement |
| sect_CID_12276.html | CardiacUltrasoundAortoPulmonaryConnectionMeasurement |
| sect_CID_12277.html | CardiacUltrasoundPericardiumandPleuraMeasurement |
| sect_CID_12279.html | CardiacUltrasoundFetalGeneralMeasurement |
| sect_CID_12300.html | CoreEchoMeasurement |
| sect_CID_12304.html | CardiovascularMeasuredProperty |
| sect_CID_12314.html | CommonFetalEchocardiographyMeasurements |
| sect_CID_12320.html | GeneralUltrasoundReportDocumentTitle |
| sect_CID_12333.html | StructuralHeartMeasurement |
| sect_CID_12337.html | StructuralHeartEchoMeasurement |
| sect_CID_3441.html | PatientAssessment |
| sect_CID_3455.html | IndexMethod |
| sect_CID_3467.html | EjectionFraction |
| sect_CID_3468.html | EDVolume |
| sect_CID_3469.html | ESVolume |
| sect_CID_3524.html | BloodGasPressure |
| sect_CID_3525.html | BloodGasContent |
| sect_CID_3526.html | BloodGasSaturation |
| sect_CID_3527.html | BloodBaseExcess |
| sect_CID_3528.html | BloodpH |
| sect_CID_3529.html | Arterial/VenousContent |
| sect_CID_3611.html | PressureMeasurement |
| sect_CID_3620.html | HemodynamicRatio |
| sect_CID_3833.html | CardiacEjectionFraction |
| sect_CID_3835.html | CardiacVolumeMeasurement |
| sect_CID_4110.html | TracerKineticModelingCovariate |
| sect_CID_6050.html | BreastProcedureReported |
| sect_CID_6052.html | BreastImagingReportSectionTitle |
| sect_CID_6053.html | BreastImagingReportElement |
| sect_CID_6083.html | ProceduresforBreast |
| sect_CID_6352.html | ProstateCancerDiagnosticBloodLabMeasurement |
| sect_CID_646.html | PreclinicalSmallAnimalImagingProcedure |
| sect_CID_7000.html | DiagnosticImagingReportDocumentTitle |
| sect_CID_7001.html | DiagnosticImagingReportHeading |
| sect_CID_7002.html | DiagnosticImagingReportElement |
| sect_CID_7061.html | ModelDocumentTitle |
| sect_CID_7448.html | ThirdPersonPronounSet |
| sect_CID_9509.html | PurposeofReferenceforRTPhysicianIntentInput |
| cyehr-vs-ehdsibloodpressure | Cyprus EHR Value Set: eHDSI Blood Pressure |
| cyehr-vs-ehdsidocumentcode | Cyprus EHR Value Set: eHDSI DocumentCode |
| cyehr-vs-ehdsihospitaldischargereporttype | Cyprus EHR Value Set: eHDSI Hospital Discharge Report Type |
| cyehr-vs-ehdsilaboratoryreporttype | Cyprus EHR Value Set: eHDSI Laboratory Report Type |
| cyehr-vs-ehdsimedicalimagestype | Cyprus EHR Value Set: eHDSI Medical Images Type |
| cyehr-vs-ehdsimedicalimagingreporttype | Cyprus EHR Value Set: eHDSI Medical Imaging Report Type |
| cyehr-vs-ehdsipregnancyinformation | Cyprus EHR Value Set: eHDSI Pregnancy Information |
| cyehr-vs-ehdsisection | Cyprus EHR Value Set: eHDSI Section |
| cyehr-vs-exercise | Cyprus EHR Value Set: Exercise |
| cyehr-vs-tobaccostatus | Cyprus EHR Value Set: Tobacco Status |
| cyehr-vs-exerciseintensity | Cyprus EHR Value Set: Exercise Intensity |
| cyehr-vs-diagnosiscategory | Cyprus EHR Value Set: Diagnosis Category |
| fiphr-vs-exerciseintensity | Value Set Finnish PHR Exercise Intensity |
| fiphr-vs-exercisetracking | Value Set Finnish PHR Exercise Tracking |
| fiphr-vs-fitnessresult | Value Set Finnish PHR Fitness Results |
| fiphr-vs-macronutrients | Value Set Finnish PHR Macronutrients |
| fiphr-vs-metbystandardrmr | Value Set Finnish PHR MET by Standard RMR |
| fiphr-vs-nutrition | Value Set Finnish PHR Nutrition |
| fiphr-vs-sourceforadjustedmet | Value Set Finnish PHR Source for Adjusted MET |
| fiphr-vs-sourceforestimatedmet | Value Set Finnish PHR Source for Estimated MET |
| fiphr-vs-sourceforreportedmet | Value Set Finnish PHR Source for Reported MET |
| fiphr-vs-vitalsigns | Value Set Finnish PHR Vital Signs |
| pronouns | Personal Pronouns |
| recorded-sex-or-gender-type | Recorded Sex Or Gender Type |
| v3-DocumentSectionType | DocumentSectionType |
| v3-HealthQualityMeasureDocument | HealthQualityMeasureDocument |
| v3-KnowledgeSubjectObservationValue | KnowledgeSubjectObservationValue |
| v3-LOINCObservationActContextAgeDefinitionCode | LOINCObservationActContextAgeDefinitionCode |
| v3-LogicalObservationIdentifierNamesAndCodes | LogicalObservationIdentifierNamesAndCodes |
| v3-LoincDocumentOntologyInternational | LoincDocumentOntologyInternational |
| v3-ObservationActContextAgeGroupType | ObservationActContextAgeGroupType |
| v3-QualityMeasureSectionType | QualityMeasureSectionType |
| v3-immunizationForecastDate | immunizationForecastDate |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.117 | Measured Height (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.118 | Pre-Pregnancy Weight (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.12 | 5 Min Apgar Score (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.120 | Mothers Delivery Weight (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.121 | Previous Other Pregnancy Outcomes (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.122 | Number of Previous Live Births Now Dead (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.123 | Number of Previous Live Births Now Living (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.124 | Obstetric Estimate of Gestation (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.13 | 10 Min Apgar Score (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.132 | Birth Plurality of Delivery (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.133 | First Prenatal Care Visit (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.135 | Number Prenatal Care Visits (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.148 | Number of Previous Cesareans (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.151 | Fetus Weight (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.164 | Number of Fetal Deaths This Delivery (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.179 | Stated Height (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.180 | Conception Date (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.184 | Birthplace Setting (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.185 | Time of Death (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.187 | Number of Preterm Births (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.191 | Institution Referred To (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.20 | Birth Weight (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.59 | Karyotype Result (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.67 | Date of Last Live Birth (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.68 | Number of Live Births (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.69 | Date of Last Menses (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.70 | Date of Last Other Pregnancy Outcome (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.71 | Number of Prior Pregnancies (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.8 | JCIH-EHDI Hearing Screen Left |
| 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.9 | JCIH-EHDI Hearing Screen Right |
| 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.17 | Laboratory Tests (HW) |
| 2.16.840.1.113883.10.14.1.1.13.14 | Placental Measurement (HL7) |
| 2.16.840.1.113883.3.88.12.80.46 | Document Class Value Set |
| 2.16.840.1.113883.3.88.12.80.47 | Document Type Value Set |
| 2.16.840.1.113883.3.88.12.80.62 | Vital Sign Result Value Set |
| 2.16.840.1.114222.4.11.1002 | Lab Test Result Name |
| 2.16.840.1.114222.4.11.1004 | Ordered Test |
| 2.16.840.1.114222.4.11.1071 | Drug Susceptibility Test Result Name |
| 2.16.840.1.114222.4.11.1073 | Microbiology Test Result Name |
| 2.16.840.1.114222.4.11.1107 | Notification Section Header |
| 2.16.840.1.114222.4.11.3000 | PHLIP Questions (Flu) |
| 2.16.840.1.114222.4.11.3016 | Lab Test Order (PHLIP Flu) |
| 2.16.840.1.114222.4.11.3019 | Resulted Lab Test Name (PHLIP Flu) |
| 2.16.840.1.114222.4.11.3043 | Lab Test Result Name (Hepatitis) |
| 2.16.840.1.114222.4.11.3205 | Lab Test Result Name (TB) |
| 2.16.840.1.114222.4.11.3206 | Lab Test Result Name (Acute Hepatitis B) |
| 2.16.840.1.114222.4.11.3207 | Lab Test Result Name (Anthrax) |
| 2.16.840.1.114222.4.11.3208 | Lab Test Result Name (Tularemia) |
| 2.16.840.1.114222.4.11.3224 | Blood or body fluid exposure event |
| 2.16.840.1.114222.4.11.3228 | Sociobehavioral risk factor |
| 2.16.840.1.114222.4.11.3245 | Radiology Lab Test (Flu) |
| 2.16.840.1.114222.4.11.3300 | Lab Test Procedure (Rubella) |
| 2.16.840.1.114222.4.11.3309 | Lab Test Procedure (Malaria) |
| 2.16.840.1.114222.4.11.3358 | Lab Test Name (NND) |
| 2.16.840.1.114222.4.11.3381 | Observation Identifier (IIS) |
| 2.16.840.1.114222.4.11.3589 | Observation Identifier (Syndromic Surveillance) |
| 2.16.840.1.114222.4.11.4117 | Lab Test Name (Amebiasis) |
| 2.16.840.1.114222.4.11.4118 | Lab Test Name (Anaplasma) |
| 2.16.840.1.114222.4.11.4119 | Lab Test Name (Anthrax) |
| 2.16.840.1.114222.4.11.4120 | Lab Test Name (Arbovirus) |
| 2.16.840.1.114222.4.11.4122 | Lab Test Name (Babesiosis) |
| 2.16.840.1.114222.4.11.4123 | Lab Test Name (Bartonellosis) |
| 2.16.840.1.114222.4.11.4124 | Lab Test Name (Blastomycosis) |
| 2.16.840.1.114222.4.11.4125 | Lab Test Name (Botulism) |
| 2.16.840.1.114222.4.11.4126 | Lab Test Name (Brucellosis) |
| 2.16.840.1.114222.4.11.4127 | Lab Test Name (California serogroup virus) |
| 2.16.840.1.114222.4.11.4128 | Lab Test Name (Campylobacteriosis) |
| 2.16.840.1.114222.4.11.4129 | Lab Test Name (Chagas) |
| 2.16.840.1.114222.4.11.4130 | Lab Test Name (Chancroid) |
| 2.16.840.1.114222.4.11.4131 | Lab Test Name (Chlamydia trachomatis) |
| 2.16.840.1.114222.4.11.4132 | Lab Test Name (Cholera) |
| 2.16.840.1.114222.4.11.4133 | Lab Test Name (Clostridium perfringens) |
| 2.16.840.1.114222.4.11.4134 | Lab Test Name (Coccidioidomycosis) |
| 2.16.840.1.114222.4.11.4135 | Lab Test Name (Colorado Tick Fever) |
| 2.16.840.1.114222.4.11.4137 | Lab Test Name (Cryptococcosis) |
| 2.16.840.1.114222.4.11.4138 | Lab Test Name (Cryptosporidiosis) |
| 2.16.840.1.114222.4.11.4139 | Lab Test Name (Cyclosporiasis) |
| 2.16.840.1.114222.4.11.4140 | Lab Test Name (Cysticercosis) |
| 2.16.840.1.114222.4.11.4141 | Lab Test Name (Dengue) |
| 2.16.840.1.114222.4.11.4142 | Lab Test Name (Diphtheria) |
| 2.16.840.1.114222.4.11.4143 | Lab Test Name (Eastern equine encephalitis virus) |
| 2.16.840.1.114222.4.11.4145 | Lab Test Name (E. coli STEC) |
| 2.16.840.1.114222.4.11.4146 | Lab Test Name (Ehrlichia chaffeensis) |
| 2.16.840.1.114222.4.11.4147 | Lab Test Name (Ehrlichia ewingii) |
| 2.16.840.1.114222.4.11.4148 | Lab Test Name (Ehrlichiosis Anaplasmosis) |
| 2.16.840.1.114222.4.11.4149 | Lab Test Name (Giardiasis) |
| 2.16.840.1.114222.4.11.4150 | Lab Test Name (Glanders) |
| 2.16.840.1.114222.4.11.4151 | Lab Test Name (Gonorrhea) |
| 2.16.840.1.114222.4.11.4152 | Lab Test Name (Granuloma Inguinale) |
| 2.16.840.1.114222.4.11.4153 | Lab Test Name (Haemophilus influenzae) |
| 2.16.840.1.114222.4.11.4155 | Lab Test Name (Hantavirus Pulmonary Syndrome) |
| 2.16.840.1.114222.4.11.4157 | Lab Test Name (Hepatitis A) |
| 2.16.840.1.114222.4.11.4158 | Lab Test Name (Hepatitis B) |
| 2.16.840.1.114222.4.11.4159 | Lab Test Name (Hepatitis C) |
| 2.16.840.1.114222.4.11.4160 | Lab Test Name (Hepatitis D) |
| 2.16.840.1.114222.4.11.4161 | Lab Test Name (Hepatitis E) |
| 2.16.840.1.114222.4.11.4162 | Lab Test Name (Herpes Simplex) |
| 2.16.840.1.114222.4.11.4163 | Lab Test Name (Histoplasmosis) |
| 2.16.840.1.114222.4.11.4164 | Lab Test Name (HIV) |
| 2.16.840.1.114222.4.11.4165 | Lab Test Name (Influenza A virus, H1N1 2009 strain) |
| 2.16.840.1.114222.4.11.4166 | Lab Test Name (Jamestown Canyon virus) |
| 2.16.840.1.114222.4.11.4167 | Lab Test Name (Legionellosis) |
| 2.16.840.1.114222.4.11.4168 | Lab Test Name (Leptospirosis) |
| 2.16.840.1.114222.4.11.4169 | Lab Test Name (Listeriosis) |
| 2.16.840.1.114222.4.11.4170 | Lab Test Name (Lyme disease) |
| 2.16.840.1.114222.4.11.4171 | Lab Test Name (Lymphogranuloma Venereum) |
| 2.16.840.1.114222.4.11.4172 | Lab Test Name (Malaria) |
| 2.16.840.1.114222.4.11.4174 | Lab Test Name (Measles) |
| 2.16.840.1.114222.4.11.4175 | Lab Test Name (Melioidosis) |
| 2.16.840.1.114222.4.11.4176 | Lab Test Name (Meningococcal Disease) |
| 2.16.840.1.114222.4.11.4177 | Lab Test Name (Monkeypox Orthopox) |
| 2.16.840.1.114222.4.11.4178 | Lab Test Name (MRSA) |
| 2.16.840.1.114222.4.11.4179 | Lab Test Name (Mumps) |
| 2.16.840.1.114222.4.11.4181 | Lab Test Name (Nongonococcal Urethritis) |
| 2.16.840.1.114222.4.11.4182 | Lab Test Name (Nontuberculous Mycobacteria) |
| 2.16.840.1.114222.4.11.4183 | Lab Test Name (Norovirus) |
| 2.16.840.1.114222.4.11.4184 | Lab Test Name (Pertussis) |
| 2.16.840.1.114222.4.11.4185 | Lab Test Name (Plague) |
| 2.16.840.1.114222.4.11.4186 | Lab Test Name (Polio) |
| 2.16.840.1.114222.4.11.4187 | Lab Test Name (Powassan virus) |
| 2.16.840.1.114222.4.11.4188 | Lab Test Name (Prion Disease) |
| 2.16.840.1.114222.4.11.4189 | Lab Test Name (Psittacosis) |
| 2.16.840.1.114222.4.11.4190 | Lab Test Name (Q Fever) |
| 2.16.840.1.114222.4.11.4191 | Lab Test Name (Rabies) |
| 2.16.840.1.114222.4.11.4192 | Lab Test Name (Relapsing Fever) |
| 2.16.840.1.114222.4.11.4193 | Lab Test Name (Respiratory Syncytial Virus) |
| 2.16.840.1.114222.4.11.4194 | Lab Test Name (Rickettsial infection, other) |
| 2.16.840.1.114222.4.11.4195 | Lab Test Name (Rift Valley Fever) |
| 2.16.840.1.114222.4.11.4196 | Lab Test Name (Rotavirus) |
| 2.16.840.1.114222.4.11.4197 | Lab Test Name (Rubella) |
| 2.16.840.1.114222.4.11.4198 | Lab Test Name (Salmonellosis) |
| 2.16.840.1.114222.4.11.4199 | Lab Test Name (SARS) |
| 2.16.840.1.114222.4.11.4200 | Lab Test Name (Shigella) |
| 2.16.840.1.114222.4.11.4201 | Lab Test Name (Smallpox) |
| 2.16.840.1.114222.4.11.4202 | Lab Test Name (Spotted fever rickettsiosis) |
| 2.16.840.1.114222.4.11.4203 | Lab Test Name (Staphylococcus aureus) |
| 2.16.840.1.114222.4.11.4204 | Lab Test Name (Staphylococcus aureus enterotoxin B) |
| 2.16.840.1.114222.4.11.4205 | Lab Test Name (Staphylococcus aureus food poisoning) |
| 2.16.840.1.114222.4.11.4206 | Lab Test Name (Staphylococcal TSS) |
| 2.16.840.1.114222.4.11.4207 | Lab Test Name (St. Louis encephalitis virus) |
| 2.16.840.1.114222.4.11.4208 | Lab Test Name (Streptococcus pneumoniae) |
| 2.16.840.1.114222.4.11.4210 | Lab Test Name (Streptococcus, group A) |
| 2.16.840.1.114222.4.11.4211 | Lab Test Name (Streptococcus, group B) |
| 2.16.840.1.114222.4.11.4212 | Lab Test Name (Syphilis) |
| 2.16.840.1.114222.4.11.4213 | Lab Test Name (Tetanus) |
| 2.16.840.1.114222.4.11.4214 | Lab Test Name (Toxoplasmosis) |
| 2.16.840.1.114222.4.11.4215 | Lab Test Name (Trichinellosis) |
| 2.16.840.1.114222.4.11.4216 | Lab Test Name (Tuberculosis) |
| 2.16.840.1.114222.4.11.4217 | Lab Test Name (Tularemia) |
| 2.16.840.1.114222.4.11.4218 | Lab Test Name (Typhoid Fever) |
| 2.16.840.1.114222.4.11.4219 | Lab Test Name (Typhus group rickettsiosis) |
| 2.16.840.1.114222.4.11.4220 | Lab Test Name (Vaccinia) |
| 2.16.840.1.114222.4.11.4221 | Lab Test Name (Vancomycin resistant Enterococcus) |
| 2.16.840.1.114222.4.11.4222 | Lab Test Name (Varicella) |
| 2.16.840.1.114222.4.11.4223 | Lab Test Name (Vesicular Stomatitis) |
| 2.16.840.1.114222.4.11.4224 | Lab Test Name (Non-Cholera Vibrio) |
| 2.16.840.1.114222.4.11.4225 | Lab Test Name (Viral Hemorrhagic Fever) |
| 2.16.840.1.114222.4.11.4228 | Lab Test Name (Western equine encephalitis virus) |
| 2.16.840.1.114222.4.11.4229 | Lab Test Name (West Nile virus) |
| 2.16.840.1.114222.4.11.4230 | Lab Test Name (Yellow Fever) |
| 2.16.840.1.114222.4.11.4231 | Lab Test Name (Yersiniosis) |
| 2.16.840.1.114222.4.11.4239 | Lab Test Name (Diabetes, hemoglobin A1c) |
| 2.16.840.1.114222.4.11.4240 | Lab Test Name (Asbestosis) |
| 2.16.840.1.114222.4.11.4241 | Lab Test Name (Berylliosis) |
| 2.16.840.1.114222.4.11.4242 | Lab Test Name (Ricin poisoning) |
| 2.16.840.1.114222.4.11.4243 | Lab Test Name (Mushroom poisoning) |
| 2.16.840.1.114222.4.11.4244 | Lab Test Name (Carbon monoxide poisoning) |
| 2.16.840.1.114222.4.11.4245 | Lab Test Name (Pesticide poisoning) |
| 2.16.840.1.114222.4.11.4246 | Lab Test Name (Arsenic poisoning) |
| 2.16.840.1.114222.4.11.4247 | Lab Test Name (Cadmium poisoning) |
| 2.16.840.1.114222.4.11.4248 | Lab Test Name (Lead poisoning) |
| 2.16.840.1.114222.4.11.4249 | Lab Test Name (Mercury poisoning) |
| 2.16.840.1.114222.4.11.4250 | Lab Test Name (Acid fast stain) |
| 2.16.840.1.114222.4.11.4251 | Lab Test Name (Bacteria) |
| 2.16.840.1.114222.4.11.4252 | Lab Test Name (Fungus) |
| 2.16.840.1.114222.4.11.4253 | Lab Test Name (Microorganism) |
| 2.16.840.1.114222.4.11.4254 | Lab Test Name (Mycobacteria) |
| 2.16.840.1.114222.4.11.4255 | Lab Test Name (Parasite) |
| 2.16.840.1.114222.4.11.4256 | Lab Test Name (Virus) |
| 2.16.840.1.114222.4.11.4257 | Lab Test Name (Antimicrobial susceptibility tests) |
| 2.16.840.1.114222.4.11.4258 | Lab Test Name (TB Antimicrobial susceptibility test) |
| 2.16.840.1.114222.4.11.5007 | Specimen Related Observations (PHLIP Sal) |
| 2.16.840.1.114222.4.11.5017 | Resulted Lab Test Name PHLIP Salmonella |
| 2.16.840.1.114222.4.11.6013 | Lab Test Type (Hepatitis) |
| 2.16.840.1.114222.4.11.6014 | Lab Test Type Enzymes (Hepatitis) |
| 2.16.840.1.114222.4.11.6053 | Lab Test Name (Reportable Conditions) |
| 2.16.840.1.114222.4.11.6055 | Lab Test Name (HEDIS) |
| 2.16.840.1.114222.4.11.7102 | VPD Lab Test Identifiers |
| 2.16.840.1.114222.4.11.7109 | VPD Lab Order Identifier |
| 2.16.840.1.114222.4.11.7155 | Height (NCHS) |
| 2.16.840.1.114222.4.11.7196 | Non Treponemal Serologic Test (STD) |
| 2.16.840.1.114222.4.11.7197 | Treponemal Serologic Test (STD) |
| 2.16.840.1.114222.4.11.7201 | Lab Tests (STD) |
| 2.16.840.1.114222.4.11.7208 | Newborn Vital Signs (NCHS) |
| 2.16.840.1.114222.4.11.7209 | Maternal Vital Signs (NCHS) |
| 2.16.840.1.114222.4.11.7210 | Apgar Assessments (NCHS) |
| 2.16.840.1.114222.4.11.7243 | Lab Test Name (Ebolavirus) |
| 2.16.840.1.114222.4.11.7246 | Vital Signs (Syndromic Surveillance) |
| 2.16.840.1.114222.4.11.7250 | Observation Identifiers (EVD Triage) |
| 2.16.840.1.114222.4.11.7267 | Death Report Observation Identifier (NCHS) |
| 2.16.840.1.114222.4.11.7268 | Data Elements (NND Gen V2) |
| 2.16.840.1.114222.4.11.7328 | 1 Min Apgar Score (NCHS) |
| 2.16.840.1.114222.4.11.7336 | Lab Test Type (Mumps) |
| 2.16.840.1.114222.4.11.7337 | Lab Test Type (Pertussis) |
| 2.16.840.1.114222.4.11.7339 | Lab Test Name (Chikungunya virus) |
| 2.16.840.1.114222.4.11.7340 | Lab Test Name (Junin Hemorrhagic fever) |
| 2.16.840.1.114222.4.11.7341 | Lab Test Name (Lassa fever) |
| 2.16.840.1.114222.4.11.7342 | Lab Test Name (Marburgvirus) |
| 2.16.840.1.114222.4.11.7352 | No Prenatal Care Visit (NCHS) |
| 2.16.840.1.114222.4.11.7401 | Triage System (NCHS) |
| 2.16.840.1.114222.4.11.7421 | Body Weight (NCHS) |
| 2.16.840.1.114222.4.11.7426 | Estimated Time Of Fetal Death (NCHS) |
| 2.16.840.1.114222.4.11.7430 | Histological Placental Exam Performed (NCHS) |
| 2.16.840.1.114222.4.11.7456 | Lab Test Type (Varicella) |
| 2.16.840.1.114222.4.11.7480 | Lab Test Name (Zika virus) |
| 2.16.840.1.114222.4.11.7515 | Data Elements (NND Hep Core) |
| 2.16.840.1.114222.4.11.7516 | Data Elements (NND Hep A Acute) |
| 2.16.840.1.114222.4.11.7517 | Data Elements (NND Hep B Acute) |
| 2.16.840.1.114222.4.11.7518 | Data Elements (NND Hep B Perinatal) |
| 2.16.840.1.114222.4.11.7519 | Data Elements (NND Hep B Chronic) |
| 2.16.840.1.114222.4.11.7520 | Data Elements (NND Hep C Acute) |
| 2.16.840.1.114222.4.11.7521 | Data Elements (NND Hep C Chronic) |
| 2.16.840.1.114222.4.11.7522 | Data Elements (NND Mumps) |
| 2.16.840.1.114222.4.11.7523 | Data Elements (NND Pertussis) |
| 2.16.840.1.114222.4.11.7524 | Data Elements (NND STD) |
| 2.16.840.1.114222.4.11.7525 | Data Elements (NND CS) |
| 2.16.840.1.114222.4.11.7542 | Lab Test Name (Hantavirus Infection) |
| 2.16.840.1.114222.4.11.7545 | Lab Test Type (Babesiosis) |
| 2.16.840.1.114222.4.11.7546 | NAT Tests (Zika) |
| 2.16.840.1.114222.4.11.7547 | IgM Ab Tests (Zika) |
| 2.16.840.1.114222.4.11.7548 | Neutralizing Ab Tests (Zika) |
| 2.16.840.1.114222.4.11.7549 | Test Type (Syphilis) |
| 2.16.840.1.114222.4.11.7550 | Lab Test Type (STD) |
| 2.16.840.1.114222.4.11.7555 | Susceptibility Test Type (STD) |
| 2.16.840.1.114222.4.11.7583 | Birth Reporting Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7584 | CCOFDI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7586 | JFDI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7587 | JLBI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7588 | PSFDI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7589 | PSFFDI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7590 | PSFLBI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7591 | PSLBI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7592 | PSMFDI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7594 | PSMLBI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7658 | CREI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7661 | Lab Test Type (Measles) |
| 2.16.840.1.114222.4.11.7663 | Data Elements (NND Malaria) |
| 2.16.840.1.114222.4.11.7664 | Data Elements (NND Babesiosis) |
| 2.16.840.1.114222.4.11.7665 | Data Elements (NND Varicella) |
| 2.16.840.1.114222.4.11.7743 | Lab Test Type (TB) |
| 2.16.840.1.114222.4.11.7760 | Susceptibility Test Type (TB) |
| 2.16.840.1.114222.4.11.7780 | Lab Test Name (Crimean-Congo hemorrhagic fever) |
| 2.16.840.1.114222.4.11.7811 | Data Elements (CRS) |
| 2.16.840.1.114222.4.11.7816 | Data Elements (Rubella) |
| 2.16.840.1.114222.4.11.7829 | Series Status (IIS) |
| 2.16.840.1.114222.4.11.7830 | Observation Identifier V2 (IIS) |
| 2.16.840.1.114222.4.11.7835 | Lab Test Type (TBRD) |
| 2.16.840.1.114222.4.11.7844 | Lab Test Type (Lyme) |
| 2.16.840.1.114222.4.11.7853 | MCDI Observation Identifier (NCHS) |
| 2.16.840.1.114222.4.11.7854 | FDDI Observation Identifier (NCHS) |
| 2.16.840.1.114222.4.11.7855 | DR Observation Identifier (NCHS) |
| 2.16.840.1.114222.4.11.7856 | JDI Death Report Observation Identifier (NCHS) |
| 2.16.840.1.114222.4.11.7857 | CREI Observation Identifier (NCHS) |
| 2.16.840.1.114222.4.11.7858 | CCOD Observation Identifier (NCHS) |
| 2.16.840.1.114222.4.11.7893 | Lab Test Name Carbapenem Resistant Enterobacteria |
| 2.16.840.1.114222.4.11.7894 | Lab Test Name (Candida Auris) |
| 2.16.840.1.114222.4.11.7897 | Lab Test Measurement (CO) |
| 2.16.840.1.114222.4.11.7948 | Lab Test Type (COVID-19) |
| 2.16.840.1.114222.4.11.7953 | Critical Infrastructure Sector (NND) |
| 2.16.840.1.114222.4.11.954 | BioSense Observations |
| IHEXDSclassCode | IHE XDS classCode |
| IHEXDStypeCode | IHE XDS typeCode |
| document-classcodes | Document Class Value Set |
| signal-filerepo-classification | Signal FileRepo Classification |
| KBV_VS_MIO_CMR_Percentile_Body_Measure_Loinc | Perzentilkörpermaß LOINC |
| document-category | DocumentCategory |
| provincial-document-type | Provincial Document Types |
| document-kind-of-document | Document KOD |
| LOINC-ontology-part-types | LOINCOntologyPartTypes |
| documentsubject-matter-domain | Document SMD |
| document-setting | Document Setting |
| document-role | Document Role |
| document-type-of-service | Document TOS |
| KBV_VS_MIO_EMP_Creatinine | Serumkreatinin |
| KBV_VS_MIO_EMP_Glomerular_Filtration_Rate | Glomeruläre Filtrationsrate (GFR) |
| vs-assessment-scales | Assessment Scales |
| vs-assessment | Assessment |
| vs-observations | Observations |
| ncpeh-healthcare-service-speciality-cs | NCPeH HealthcareService Speciality ValueSet |
| mi-document-type | Medical Imaging Document Type |
| provincial-document-types | Provincial Document Types |
| observation-ccdavitalsignresult | Argonaut Vital Sign Codes |
| GenomicTestTypes | Genomic Test Types Value Set |
| loinc-observation-category | LOINC實驗室檢驗檢查報告名稱值集 |
| loinc-observation-code | LOINC實驗室檢驗檢查值集 |
| eHDSILabCode | eHDSI Laboratory Codes |
| eHDSILabStudyType | eHDSI Laboratory Study Types |
| eHDSILaboratoryReportTypes | eHDSI Laboratory Report Types |
| testBakLOINC | Gegenstand der Laboruntersuchung BAK |
| testMykLOINC | Gegenstand der Laboruntersuchung MYK |
| testParLOINC | Gegenstand der Laboruntersuchung PAR |
| testResistenzMolekularLOINC | Gegenstand der Laboruntersuchung Resistenz Molekular |
| testResistenzPhaenotypischLOINC | Gegenstand der Laboruntersuchung Resistenz Phänotypisch |
| testResistenzklassifikationLOINC | Gegenstand der Laboruntersuchung Resistenzklassifikation |
| testResistenzmechanismusLOINC | Gegenstand der Laboruntersuchung Resistenzmechanismus |
| testVirLOINC | Gegenstand der Laboruntersuchung VIR |
| consent-vs | Consent codes from Loinc and Snomed-ct |
| eom-tumor-marker-result-valueset | TumorMarkerTestResultValueSet |
| hobbies | Hobbies |
| vs-meta-accident-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวข้องกับอุบัติเหตุ |
| vs-meta-cancer-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวข้องกับมะเร็ง |
| vs-meta-child-development-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับพัฒนาการเด็ก |
| vs-meta-functional-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวข้องกับสมรรถภาพของร่างกาย |
| vs-meta-lab-observations | Metadata: รหัสการตรวจทางห้องปฏิบัติการบางส่วน |
| vs-meta-ncd-observations | Metadata: รหัสการตรวจหรือบริการคัดกรองโรค NCD |
| vs-meta-neonate-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับทารกแรกคลอด |
| vs-meta-physical-observations | Metadata: รหัสการตรวจร่างกาย |
| vs-meta-pregnancy-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับการตั้งครรภ์ |
| vs-meta-social-observations | Metadata: รหัสการตรวจประวัติทางสังคม |
| vs-meta-vital-observations | Metadata: รหัสการตรวจสัญญาณชีพ |
| observation-codes | observation-codes |
| AlertType | AlertType |
| AppearanceScore | AppearanceScore |
| GrimaceScore | GrimaceScore |
| MusleToneScore | MusleToneScore |
| PanelOrBattery | PanelOrBattery |
| PulseScore | PulseScore |
| RespiratoryScore | RespiratoryScore |
| observation-codes | ObservationCodes |
| ndhm-body-measurement | Body Measurement |
| ndhm-general-assessment | General Assessment |
| ndhm-physical-activity | Physical Activity |
| ndhm-vital-signs | Vital Signs |
| ndhm-women-health | Women Health |
| blood-gas-analysis-combined | Blood Gas Analysis Combined |
| sars-cov-2-detection-combined | SARS-CoV-2 Detection Combined |
| lab-tests-gecco | Laboratory Tests GECCO |
| pregnancy-status | Pregnancy Status |
| smoking-status | Smoking Status |
| EAHB_VS_Befund_DurchgefuehrteBehandlungen | Direktverlegung nötig - Status |
| EAHB_VS_Indikation | Indikation |
| condition-severity-uv-ips | Problem Severity - IPS |
| current-smoking-status-uv-ips | Current Smoking Status - IPS |
| edd-method-uv-ips | Pregnancy Expected Delivery Date Method - IPS |
| pregnancies-summary-uv-ips | Pregnancies Summary - IPS |
| pregnancy-status-uv-ips | Pregnancy Status - IPS |
| problem-type-uv-ips | Problem Type - IPS |
| results-laboratory-observations-uv-ips | Results Laboratory Observation - IPS |
| results-pathology-observations-uv-ips | Results Pathology Observation - IPS |
| results-radiology-observations-uv-ips | Results Radiology Observation - IPS |
| results-radiology-txtobs-gps-dicom-loinc-uv-ips | Results Radiology Textual Observations (GPS-DICOM-LOINC) - IPS |
| covid-19-obs | COVID-19 related Observation codes |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.1--20150401000000 | AlertTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.3--20150401000000 | TestNaamCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.1--20171231000000 | AdemhalingScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.1--20171231000000 | AlertTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.53.11.1--20200618120422 | GlucoseMeetmomentenLOINCCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.2--20171231000000 | HartslagScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.4--20171231000000 | HuidskleurScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.5--20171231000000 | OnderzoekCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.5--20171231000000 | ReflexenScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.3--20171231000000 | SpierspanningScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.3--20171231000000 | TestCodeCodelijst |
| dataelement-sdcobjectclass | DataElement SDC Object Class |
| dataelement-sdcobjectclassproperty | DataElement SDC Object Class Property |
| il-hdp-document-types | ILHDP Document Reference Types |
| IVR-VS-patient | IVR valueset patient |
| mni-obs-laboratory | MedNet Interface (MNI) - Laboratory Observation ValueSet |
| BloodGlucoseMarkVS | BloodGlucoseMarkVS |
| dataelement-sdccode | DataElement SDC Concept |
| lab-orderCodes-it-lab | Codice Richiesta esame di Laboratorio [LOINC] |
| risultato-osservazione | Tipo Osservazione |
| sezione-referto-laboratorio | Sezioni Composition Lab Report |
| KBV_VS_MIO_TELE_Clinical_Course | Verlauf |
| KBV_VS_MIO_TELE_Procedure_And_Recommendations | Weiteres Procedere und Empfehlung |
| chronic-condition-set | ChronicConditions |
| fever-class | Feverclass |
| housing-situation | Housingsituation |
| occupation-class | Occupationclass |
| LL4129-4 | Pregnant|Not pregnant|Unknown |
| shared-location-class | Sharedlocationclass |
| yesno | Yesno |
| yesnodontknow | Yesnodontknow |
| vs-laboratory-observations | Laboratory Observations |
| laboratoryTestSARSCoV2 | SARS-CoV-2-Labortest |
| laboratoryTestWBGP | Labortest für die Meldepflicht von Krankheitserregern mit Hinweise auf eine schwerwiegende Gefahr für die Allgemeinheit |
| Laborbereich | MII VS Labor Laborbereich |
| ValueSetOrderCodes | MII VS Labor Order Codes |
| 1.2.91.13925.17760.19613338 | Immunoglobulin G Testing Grouping |
| 1.2.91.13925.17760.26878039 | Specific IgE Testing |
| 1.3.6.1.4.1.12009.10.2.5 | LOINC Imaging Document Codes |
| 1.3.6.1.4.1.6997.4.1.2.234.15.2.1.1.999.1 | Selected urine drug screens for opioids indicating testing is complete |
| 1.3.6.1.4.1.6997.4.1.2.234.999.2 | Selected urine screening for patients receiving opioid therapy |
| 1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.11.1.999.272 | Specific IgE Testing for Allergies |
| 1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.12.1.999.273 | Immunoglobulin G Testing |
| 1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.13.1.999.274 | Total IgE Testing |
| 1.3.6.1.4.1.6997.4.1.2.271.13.38167.1.1.999.594 | Complete Blood Count (with Diff) |
| 1.3.6.1.4.1.6997.4.1.2.271.13.38343.1.1.999.665 | Creatinine |
| 1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.698 | Clostridium Difficile Test |
| 1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.647 | Body Temperature |
| 1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.13.1.999.651 | Leukocyte count |
| 2.16.840.1.113762.1.4.1029.183 | Neonatal Moderate Neurological Complications with LOS Procedures |
| 2.16.840.1.113762.1.4.1029.184 | Neonatal Moderate Neurological Complications with LOS Procedures |
| 2.16.840.1.113762.1.4.1029.194 | Birth Weight |
| 2.16.840.1.113762.1.4.1032.21 | ALT |
| 2.16.840.1.113762.1.4.1032.28 | Urine drug screen for pain management |
| 2.16.840.1.113762.1.4.1032.298 | Cervical Cytology Test |
| 2.16.840.1.113762.1.4.1032.299 | HPV 16 Tests |
| 2.16.840.1.113762.1.4.1032.300 | HPV 18 Tests |
| 2.16.840.1.113762.1.4.1032.308 | Cardiovascular disease 10Y risk |
| 2.16.840.1.113762.1.4.1032.322 | Test 123 |
| 2.16.840.1.113762.1.4.1032.55 | Risk assessments relevant to pain management |
| 2.16.840.1.113762.1.4.1032.87 | Fasting Plasma Glucose |
| 2.16.840.1.113762.1.4.1032.88 | Waist Circumference |
| 2.16.840.1.113762.1.4.1032.94 | Glucose Tolerance Test Results |
| 2.16.840.1.113762.1.4.1045.114 | Hematocrit Lab Test |
| 2.16.840.1.113762.1.4.1045.117 | Potassium Lab Test |
| 2.16.840.1.113762.1.4.1045.119 | Sodium Lab Test |
| 2.16.840.1.113762.1.4.1045.127 | Platelet Count Lab Test |
| 2.16.840.1.113762.1.4.1045.129 | White Blood Cells Count Lab Test |
| 2.16.840.1.113762.1.4.1045.130 | Respiratory Rate |
| 2.16.840.1.113762.1.4.1045.134 | Glucose Lab Test |
| 2.16.840.1.113762.1.4.1045.139 | Bicarbonate Lab Test |
| 2.16.840.1.113762.1.4.1045.151 | Oxygen Saturation by Pulse Oximetry |
| 2.16.840.1.113762.1.4.1045.152 | Body Temperature |
| 2.16.840.1.113762.1.4.1045.159 | Body Weight |
| 2.16.840.1.113762.1.4.1045.163 | Systolic Blood Pressure |
| 2.16.840.1.113762.1.4.1045.26 | Estimated Gestational Age at Delivery |
| 2.16.840.1.113762.1.4.1046.35 | Healthcare Agent or Proxy Choices |
| 2.16.840.1.113762.1.4.1047.561 | Intraocular pressure |
| 2.16.840.1.113762.1.4.1047.617 | Vitreous exam findings |
| 2.16.840.1.113762.1.4.1056.50 | HIV Lab Tests |
| 2.16.840.1.113762.1.4.1056.71 | Human Immunodeficiency Virus (HIV) Viral Load |
| 2.16.840.1.113762.1.4.1078.1041 | Hemoglobin |
| 2.16.840.1.113762.1.4.1078.1042 | Hematocrit |
| 2.16.840.1.113762.1.4.1078.1047 | Ferritin |
| 2.16.840.1.113762.1.4.1078.197 | Blood (Serum and Plasma) Potassium |
| 2.16.840.1.113762.1.4.1078.202 | Serum Creatinine |
| 2.16.840.1.113762.1.4.1078.34 | Blood pressure panel |
| 2.16.840.1.113762.1.4.1078.35 | Systolic Blood Pressure |
| 2.16.840.1.113762.1.4.1078.397 | eGFR |
| 2.16.840.1.113762.1.4.1078.415 | LDL Cholesterol |
| 2.16.840.1.113762.1.4.1078.43 | Urinalysis |
| 2.16.840.1.113762.1.4.1078.442 | Blood Glucose |
| 2.16.840.1.113762.1.4.1078.517 | Hemoglobin A1c |
| 2.16.840.1.113762.1.4.1078.551 | Heart Rate |
| 2.16.840.1.113762.1.4.1078.599 | PIM_Vitamin B12 Level_LOINC_CPT |
| 2.16.840.1.113762.1.4.1078.600 | PIM_Vitamin B12 Level_LOINC |
| 2.16.840.1.113762.1.4.1078.629 | PIM_Refill_Request_Antilipemics_LFTs |
| 2.16.840.1.113762.1.4.1078.700 | PIM_DEXA_Scan |
| 2.16.840.1.113762.1.4.1078.701 | PIM_DEXA_Scan_CPT_LOINC |
| 2.16.840.1.113762.1.4.1078.746 | Influenza (Tests for influenza A or B virus Antigen) |
| 2.16.840.1.113762.1.4.1078.756 | Respiratory Rate LOINC |
| 2.16.840.1.113762.1.4.1078.757 | Respiratory Rate |
| 2.16.840.1.113762.1.4.1078.775 | Arterial oxygen saturation LOINC |
| 2.16.840.1.113762.1.4.1078.777 | Arterial oxygen saturation |
| 2.16.840.1.113762.1.4.1078.863 | PIM_Thyroid_Stimulating_Hormone_(TSH) |
| 2.16.840.1.113762.1.4.1078.864 | PIM_Triiodothyronine_(T3) |
| 2.16.840.1.113762.1.4.1078.865 | PIM_Thyroxine_(T4) |
| 2.16.840.1.113762.1.4.1078.866 | PIM_Magnesium_LOINC |
| 2.16.840.1.113762.1.4.1078.867 | PIM_BMP_CMP_LOINC |
| 2.16.840.1.113762.1.4.1078.868 | PIM_URIC_ACID_LOINC |
| 2.16.840.1.113762.1.4.1078.952 | OIA_Creatinine_Levels_LOINC |
| 2.16.840.1.113762.1.4.1078.969 | OIA_Microalbumin |
| 2.16.840.1.113762.1.4.1078.970 | OIA_LDL_Cholesterol |
| 2.16.840.1.113762.1.4.1078.98 | BMI LOINC |
| 2.16.840.1.113762.1.4.1095.21 | Nutrition Assessment |
| 2.16.840.1.113762.1.4.1095.29 | Malnutrition Assessment |
| 2.16.840.1.113762.1.4.1095.34 | Malnutrition Screening Finding of Not At Risk Result |
| 2.16.840.1.113762.1.4.1095.43 | Nutrition Assessment Status Finding of Severely Malnourished |
| 2.16.840.1.113762.1.4.1095.47 | Nutrition Assessment Status Finding of Moderately Malnourished |
| 2.16.840.1.113762.1.4.1095.74 | Nutrition Anthropometric Measure Panel LOINC |
| 2.16.840.1.113762.1.4.1095.75 | Nutrition Anthropometric Measurements Grouping |
| 2.16.840.1.113762.1.4.1095.78 | Food and Nutrition Related History LOINC |
| 2.16.840.1.113762.1.4.1095.82 | Food and Nutrition Related History Grouping |
| 2.16.840.1.113762.1.4.1095.89 | Malnutrition Screening Finding of At Risk Result |
| 2.16.840.1.113762.1.4.1095.92 | Malnutrition Risk Screening |
| 2.16.840.1.113762.1.4.1095.94 | Malnutrition Screening Finding of At Risk Result |
| 2.16.840.1.113762.1.4.1095.95 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished |
| 2.16.840.1.113762.1.4.1095.96 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished |
| 2.16.840.1.113762.1.4.1095.97 | Nutrition Assessment Status Finding of Severely Malnourished |
| 2.16.840.1.113762.1.4.1095.98 | Nutrition Assessment Status Finding of Moderately Malnourished |
| 2.16.840.1.113762.1.4.1096.225 | Laboratory results that are used in medication management |
| 2.16.840.1.113762.1.4.1096.240 | Medication Lists |
| 2.16.840.1.113762.1.4.1099.10 | Care Plan Document Type |
| 2.16.840.1.113762.1.4.1099.28 | Problem Type (LOINC) |
| 2.16.840.1.113762.1.4.1099.36 | Arthritis Feedback Types (LOINC) |
| 2.16.840.1.113762.1.4.1099.4 | DIRSectionTypeCodes LOINC |
| 2.16.840.1.113762.1.4.1099.49 | Disability Status Assessment |
| 2.16.840.1.113762.1.4.1099.55 | At Home In Vitro Patient Questions |
| 2.16.840.1.113762.1.4.1099.57 | Advance Directives Content Type |
| 2.16.840.1.113762.1.4.1111.163 | Emergency Department Evaluation |
| 2.16.840.1.113762.1.4.1115.10 | Care Experience Preferences at End of Life LOINC |
| 2.16.840.1.113762.1.4.1115.11 | Care Experience Preferences Grouping |
| 2.16.840.1.113762.1.4.1115.13 | Healthcare Agent Powers or Limitations Indicator |
| 2.16.840.1.113762.1.4.1115.14 | ADIClauseTypeVS |
| 2.16.840.1.113762.1.4.1115.15 | Upon Death Preferences |
| 2.16.840.1.113762.1.4.1115.17 | Preconditions for Treatment Preferences |
| 2.16.840.1.113762.1.4.1115.18 | Treatment Intervention Preferences at End of Life Ordinal LOINC |
| 2.16.840.1.113762.1.4.1115.19 | Obligation or Prohibition Instruction Type Grouping |
| 2.16.840.1.113762.1.4.1115.21 | Witness Categories |
| 2.16.840.1.113762.1.4.1115.22 | Advance Directive Document Types |
| 2.16.840.1.113762.1.4.1115.23 | AD Conditions and Prognosis Scenarios |
| 2.16.840.1.113762.1.4.1115.26 | Healthcare Agent or Advisor Indicator |
| 2.16.840.1.113762.1.4.1115.27 | Initial Treatment portable medical order options |
| 2.16.840.1.113762.1.4.1115.28 | Cardiopulmonary Resuscitation Order Options |
| 2.16.840.1.113762.1.4.1115.31 | Cardiopulmonary Resuscitation Procedures Grouping |
| 2.16.840.1.113762.1.4.1115.33 | Initial Treatment Portable Medical Order Procedures Grouping |
| 2.16.840.1.113762.1.4.1115.35 | Medically Assisted Nutrition Order Options |
| 2.16.840.1.113762.1.4.1115.36 | Medically Assisted Nutrition Portable Medical Order Procedures Grouping |
| 2.16.840.1.113762.1.4.1115.37 | Healthcare Agent Powers |
| 2.16.840.1.113762.1.4.1115.38 | Personal Health Goal Options LOINC |
| 2.16.840.1.113762.1.4.1115.39 | Personal Health Goal Options Grouping |
| 2.16.840.1.113762.1.4.1115.40 | Portable Medical Order Document Types |
| 2.16.840.1.113762.1.4.1115.41 | Advance Healthcare Directive Document Types Grouper |
| 2.16.840.1.113762.1.4.1115.6 | Personal Health Goals LOINC |
| 2.16.840.1.113762.1.4.1115.7 | Health Goals Grouping |
| 2.16.840.1.113762.1.4.1115.8 | Treatment Intervention Preferences at End of Life LOINC |
| 2.16.840.1.113762.1.4.1115.9 | Treatment Intervention Preferences Grouping |
| 2.16.840.1.113762.1.4.1116.161 | ECOG Performance Status |
| 2.16.840.1.113762.1.4.1116.162 | ECOG Performance Status |
| 2.16.840.1.113762.1.4.1125.7 | PROMIS Depression Assessment |
| 2.16.840.1.113762.1.4.1130.15 | Body Temperature |
| 2.16.840.1.113762.1.4.1130.20 | Clostridium difficile infection |
| 2.16.840.1.113762.1.4.1142.14 | C2S Cannabis Use Disorders |
| 2.16.840.1.113762.1.4.1142.21 | C2S Hallucinogens |
| 2.16.840.1.113762.1.4.1142.25 | C2S HIV/AIDS Information Sensitivity |
| 2.16.840.1.113762.1.4.1142.34 | C2S Mental Health Disorders |
| 2.16.840.1.113762.1.4.1142.40 | C2S Opioids |
| 2.16.840.1.113762.1.4.1142.5 | C2S Alcohol Use Disorders |
| 2.16.840.1.113762.1.4.1142.56 | C2S Substance Use Information Sensitivity |
| 2.16.840.1.113762.1.4.1142.58 | C2S Sensitive Categories |
| 2.16.840.1.113762.1.4.1142.9 | C2S Amphetamine Use Disorders |
| 2.16.840.1.113762.1.4.1146.10 | Diphtheria (Tests for Corynebacterium diphtheriae by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1002 | Tuberculosis (Tests for Mycobacterium species by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1017 | S. Typhi Infection (Tests for S. Typhi by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1040 | Organisms (Tests by Unspecified Method) |
| 2.16.840.1.113762.1.4.1146.1041 | Organisms (Tests by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.1044 | Candida auris Infection (Tests for Candida auris by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1045 | Candida auris Infection (Tests for Candida auris Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1076 | Opioid Overdose and Poisoning (Tests for Opioids [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.1106 | Listeriosis (Tests for Listeria monocytogenes Nucleic Acid in Specimen from Normally Sterile Site) |
| 2.16.840.1.113762.1.4.1146.1130 | Tickborne Relapsing Fever (Tests for Borrelia hermsii/miyamotoi/parkerii/turicatae Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1131 | Lyme Disease (Tests for Borrelia afzelii/garinii IgG Antibody by Immunoassay |
| 2.16.840.1.113762.1.4.1146.1138 | Staphylococcus Aureus (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1139 | VISA/VRSA (Tests for Vancomycin Resistance Gene) |
| 2.16.840.1.113762.1.4.1146.1142 | COVID_19 (Tests for SARS_CoV_2 Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1148 | Tests for Vancomycin Susceptibility [Ord] |
| 2.16.840.1.113762.1.4.1146.1149 | Proteinuria (Tests for Total Protein in 24H Urine) |
| 2.16.840.1.113762.1.4.1146.1150 | Thrombocytopenia (Tests for Platelets [#/volume] in Blood) |
| 2.16.840.1.113762.1.4.1146.1158 | COVID_19 (Tests for SARS_CoV_2 Antigen) |
| 2.16.840.1.113762.1.4.1146.1169 | Chikungunya Virus Disease (Tests for Chikungunya virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1180 | Chikungunya Virus Disease (Tests for Chikungunya Virus Antibody [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.1186 | Eastern Equine Encephalitis Virus Disease (Tests for Eastern Equine Encephalitis Virus Antibody [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.1188 | Western Equine Encephalitis Virus Disease (Tests for Western Equine Encephalitis Virus Antibody [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.1189 | California Serogroup Virus Diseases (Tests for California Serogroup Virus Antibody [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.1196 | Anthrax (Tests for Bacillus cereus by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1215 | Tests for carbapenemase production |
| 2.16.840.1.113762.1.4.1146.1216 | Tests for carbapenemase resistance mechanism |
| 2.16.840.1.113762.1.4.1146.1217 | Tests for carbapenem susceptibility [Meropenem, imipenem, and doripenem] |
| 2.16.840.1.113762.1.4.1146.1218 | Tests for carbapenem susceptibility [Ertapenem] |
| 2.16.840.1.113762.1.4.1146.1219 | Tests for Enterobacter spp., E. coli, or Klebsiella spp. by Culture and Identification Method |
| 2.16.840.1.113762.1.4.1146.1220 | NU_Tests for Enterobacteriaceae species by Culture and Identification Method |
| 2.16.840.1.113762.1.4.1146.1249 | Blastomycosis (Tests for Blastomyces species by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1250 | Non pestis Yersiniosis Infection (Tests for Yersinia non pestis species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1251 | Blastomycosis (Tests for Blastomyces species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1252 | Blastomycosis (Tests for Blastomyces species Antibody) |
| 2.16.840.1.113762.1.4.1146.1253 | Blastomycosis (Tests for Blastomyces species Antigen) |
| 2.16.840.1.113762.1.4.1146.1281 | Histoplasmosis (Tests for Histoplasma capsulatum H band or M band Antibody) |
| 2.16.840.1.113762.1.4.1146.1304 | Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species in Extrapulmonary Specimen by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1305 | Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species Nucleic Acid in Extrapulmonary Specimen) |
| 2.16.840.1.113762.1.4.1146.1306 | Body Temperature (Vital Sign) |
| 2.16.840.1.113762.1.4.1146.1307 | Respiratory Rate (Vital Sign) |
| 2.16.840.1.113762.1.4.1146.1312 | RSV (Tests for RSV Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1330 | Tobacco Smoking Status [Current] (Social History) (LOINC) |
| 2.16.840.1.113762.1.4.1146.1340 | Prion Disease (Tests for 14_3_3 Protein) |
| 2.16.840.1.113762.1.4.1146.1341 | Prion Disease (Tests for Abnormal Prion Protein) |
| 2.16.840.1.113762.1.4.1146.1359 | Hepatitis E (Tests for hepatitis E virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.1360 | Hepatitis E (Tests for hepatitis E virus Antibody) |
| 2.16.840.1.113762.1.4.1146.1364 | Organisms (Tests by Microscopic Observation by Gram Stain) |
| 2.16.840.1.113762.1.4.1146.1378 | Tests for Mycobacterium species Nucleic Acid in Unspecified XXX Specimen |
| 2.16.840.1.113762.1.4.1146.1400 | Colorado tick fever (Tests for Colorado Tick Fever Virus Antibody [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.1409 | COVID_19 (Tests for SARS_CoV_2 Genomic Sequence) |
| 2.16.840.1.113762.1.4.1146.1420 | Alpha gal syndrome (Tests for Alpha gal IgE Antibody [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.1452 | MRSA (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1453 | MRSA (Tests for Methicillin Resistance Gene) |
| 2.16.840.1.113762.1.4.1146.1454 | Staphylococcus aureus (Tests for Staph aureus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1458 | Tests for Cefoxitin Susceptibility [OrdQn] |
| 2.16.840.1.113762.1.4.1146.1459 | Organisms (Tests in Blood by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.1460 | Bacteria (Tests in Blood by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1461 | Organisms (Tests in Specimen from Normally Sterile Site by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.1462 | Staphylococcus aureus (Tests for Staph aureus Nucleic Acid in Blood) |
| 2.16.840.1.113762.1.4.1146.1465 | VRE (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1466 | Enterococcus species (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1476 | Amebiasis (Tests for Entamoeba histolytica Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1482 | Norovirus (Tests for Norovirus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1491 | C. diff infection (Tests for C diff Toxin Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1492 | C. diff infection (Tests for C diff Toxin Nucleic Acid in Stool) |
| 2.16.840.1.113762.1.4.1146.1509 | Arsenic Exposure and Toxicity (Tests for Arsenic [Quantitative] in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.1520 | Cryptococcosis (Tests for Cryptococcus species by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1523 | Cryptococcosis (Tests for Cryptococcus species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1524 | Cryptococcosis (Tests for Cryptococcus species Antigen) |
| 2.16.840.1.113762.1.4.1146.1528 | Mercury Exposure and Toxicity (Tests for Mercury [Quantitative] in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.1565 | Viruses [Causing Meningitis] (Tests for Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1566 | Viruses [Causing Meningitis] (Tests for Nucleic Acid in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.1567 | Bacteria [Causing Meningitis] (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1577 | Group A Streptococcus (Tests for Group A Strep by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1578 | Group B Streptococcus (Tests for Group B Strep by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1641 | Typhus Fever (Tests for Rickettsia Typhus Group IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.1642 | Typhus Fever (Tests for Rickettsia Typhus Group IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.1643 | Typhus Fever (Tests for Rickettsia Typhus Fever Group IgG Antibody [Quantitative] by Immunofluorescence) |
| 2.16.840.1.113762.1.4.1146.1654 | Chagas Disease (Tests for Trypanosoma cruzi Antibody) |
| 2.16.840.1.113762.1.4.1146.1676 | Tests for Acinetobacter baumannii Nucleic Acid |
| 2.16.840.1.113762.1.4.1146.1677 | Tests for Pseudomonas aeruginosa by Culture and Identification Method |
| 2.16.840.1.113762.1.4.1146.1678 | Tests for Pseudomonas aeruginosa Nucleic Acid |
| 2.16.840.1.113762.1.4.1146.1723 | Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1725 | Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1726 | Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus in Cerebrospinal Fluid Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1735 | Clostridium perfringens Infection (Tests for C perfringens by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1746 | Rotavirus Disease (Tests for Rotavirus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1753 | Staphylococcal Enterotoxin B Poisoning (Tests for Staph aureus Enterotoxin B Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1769 | Farmers Lung (Tests for Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody) |
| 2.16.840.1.113762.1.4.1146.1781 | Herpes (Tests for Herpes simplex virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1788 | Typhus Fever (Tests for Rickettsia Typhus Fever Group IgM Antibody [Quantitative] by Immunofluorescence) |
| 2.16.840.1.113762.1.4.1146.1803 | Bacteria (Tests in Sputum Specimen by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1819 | Louseborne relapsing fever (Tests for Borrelia species) |
| 2.16.840.1.113762.1.4.1146.1820 | Louseborne relapsing fever (Tests for Borrelia species in Blood) |
| 2.16.840.1.113762.1.4.1146.1846 | Leishmaniasis (Tests for Leishmania species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1847 | Leishmaniasis (Tests for Leishmania species Antibody) |
| 2.16.840.1.113762.1.4.1146.1848 | Leishmania species (Tests by Microscopic Observation in Tissue) |
| 2.16.840.1.113762.1.4.1146.1875 | Cysticercosis (Tests for Taenia solium Antibody) |
| 2.16.840.1.113762.1.4.1146.1880 | Tests for Enterobacter spp., E. coli, or Klebsiella spp. Nucleic Acid |
| 2.16.840.1.113762.1.4.1146.1881 | NU_Tests for Enterobacteriaceae species Nucleic Acid |
| 2.16.840.1.113762.1.4.1146.1897 | Toxoplasmosis (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.1898 | Toxoplasmosis (Tests for Toxoplasma gondii Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1901 | Toxoplasmosis (Tests for Toxoplasma gondii Antibody) |
| 2.16.840.1.113762.1.4.1146.1908 | Organisms (Tests by Electron Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.1919 | Fungi [Causing Meningitis] (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1933 | C reactive protein (Tests by Any Method) |
| 2.16.840.1.113762.1.4.1146.1934 | Lymphocytes [Concentration] (Tests by Any Method) |
| 2.16.840.1.113762.1.4.1146.1937 | Strongyloidiasis (Tests for Strongyloides Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1938 | Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.1939 | Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody in Blood) |
| 2.16.840.1.113762.1.4.1146.1940 | Organisms (Tests by Microscopic Observation in Stool) |
| 2.16.840.1.113762.1.4.1146.1944 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1945 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.1946 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Antibody) |
| 2.16.840.1.113762.1.4.1146.1952 | La Crosse Virus Diseases (Tests for La Crosse Virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1953 | Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1954 | La Crosse Virus Diseases (Tests for La Crosse Virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.1955 | Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.1956 | La Crosse Virus Diseases (Tests for La Crosse Virus Antibody) |
| 2.16.840.1.113762.1.4.1146.1957 | Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Antibody) |
| 2.16.840.1.113762.1.4.1146.1958 | Trivittatus Virus Diseases (Tests for Trivittatus Virus Antibody) |
| 2.16.840.1.113762.1.4.1146.1970 | NU_Hepatitis D Virus Infection (Tests for hepatitis D virus total or IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.1971 | Hepatitis D Virus Infection (Tests for hepatitis D virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.1972 | Hepatitis D Virus Infection (Tests for hepatitis D virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1976 | Baylisascariasis (Tests for Baylisascaris species Antibody) |
| 2.16.840.1.113762.1.4.1146.1983 | California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1984 | California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.1985 | California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Antibody) |
| 2.16.840.1.113762.1.4.1146.2002 | Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2003 | Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid in CSF or Blood) |
| 2.16.840.1.113762.1.4.1146.2004 | Lymphocytic Choriomeningitis (Tests for LCMV Antibody) |
| 2.16.840.1.113762.1.4.1146.2005 | Lymphocytic Choriomeningitis (Tests for LCMV Antibody in CSF or Serum) |
| 2.16.840.1.113762.1.4.1146.2009 | Angiostrongyliasis (Tests for Angiostrongylus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2010 | Eosinophils [Concentration] (Tests in CSF by Any Method) |
| 2.16.840.1.113762.1.4.1146.2011 | Eosinophils [Percentage] (Tests in CSF by Any Method) |
| 2.16.840.1.113762.1.4.1146.2012 | Mpox (Tests for mpox virus by Genomic Sequencing) |
| 2.16.840.1.113762.1.4.1146.2013 | Mpox (Test Panels for mpox virus by Genomic Sequencing) |
| 2.16.840.1.113762.1.4.1146.2039 | Bartonella quintana infection (Tests for Bartonella quintana Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2040 | Bartonella quintana infection (Tests for Bartonella quintana IgM Antibody in a clinical specimen by any method) |
| 2.16.840.1.113762.1.4.1146.2041 | Bartonella quintana infection (Tests for Bartonella quintana IgG or Total Antibody in a clinical specimen by any method) |
| 2.16.840.1.113762.1.4.1146.2042 | Bartonella henselae infection (Tests for Bartonella henselae Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2043 | Bartonella henselae infection (Tests for Bartonella henselae IgM Antibody in a clinical specimen by any method) |
| 2.16.840.1.113762.1.4.1146.2044 | Bartonella henselae infection (Tests for Bartonella henselae IgG or Total Antibody in a clinical specimen by any method) |
| 2.16.840.1.113762.1.4.1146.2045 | Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgM Antibody in a clinical specimen by any method) |
| 2.16.840.1.113762.1.4.1146.2046 | Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgG or Total Antibody in a clinical specimen by any method) |
| 2.16.840.1.113762.1.4.1146.2047 | Bartonellosis (Tests for Bartonella spp. Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2048 | Bartonellosis (Tests for Bartonella spp. IgM Antibody in a clinical specimen by any method) |
| 2.16.840.1.113762.1.4.1146.2049 | Bartonella spp. (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2050 | Bartonellosis (Tests for Bartonella spp. by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2051 | Bartonellosis (Tests for Bartonella spp. IgG or Total Antibody in a clinical specimen by any method) |
| 2.16.840.1.113762.1.4.1146.2058 | Echinococcosis (Tests for Echinococcus species Antibody) |
| 2.16.840.1.113762.1.4.1146.2059 | Echinococcus species (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2067 | Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species Nucleic Acid in a Pulmonary Specimen) |
| 2.16.840.1.113762.1.4.1146.2085 | Leukocytes [Concentration] (Tests in Blood by Any Method) |
| 2.16.840.1.113762.1.4.1146.2095 | Gonorrhea (Tests for Neisseria gonorrhoeae Antigen) |
| 2.16.840.1.113762.1.4.1146.2103 | Gamma Glutamyl Transferase in Serum (Tests for Gamma Glutamyl Transferase in Serum) |
| 2.16.840.1.113762.1.4.1146.2109 | Methemoglobinemia (Tests for Methemoglobin in Blood [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.2128 | Down Syndrome (Tests for Trisomy 21 Chromosomal Anomaly) |
| 2.16.840.1.113762.1.4.1146.2139 | Prion Disease (Tests for Abnormal PRNP Gene Variant) |
| 2.16.840.1.113762.1.4.1146.2149 | NU_Influenza (Test Panels for Novel influenza A virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2152 | Naegleria fowleri PAM (Test Panels for Naegleria fowleri Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2156 | Thyroid_stimulating hormone (TSH) [Quantitative] (Tests in serum or plasma by any method) |
| 2.16.840.1.113762.1.4.1146.2157 | Mpox (Combination Tests that include mpox virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2158 | Orthopox (Combination Tests that include Orthopoxvirus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2159 | Mpox (Test Panels for mpox virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.216 | Pertussis (Tests for Bordetella pertussis Antibody [Excluding Pertussis Toxin Antibody]) |
| 2.16.840.1.113762.1.4.1146.2160 | Orthopox (Test Panels for orthopoxvirus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2161 | COVID_19 (Combination Tests that include SARS_CoV_2 Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2166 | Hantavirus Infection (Test Panels for Hantavirus IgM IgG Total Antibody) |
| 2.16.840.1.113762.1.4.1146.2167 | Organisms (Tests in Cerebrospinal Fluid by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2168 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Unspecified Specimen by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2169 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Cerebrospinal Fluid by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2170 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis in Unspecified Specimen by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2171 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis in Unspecified Specimen by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2172 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2173 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2174 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2175 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2176 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2177 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2178 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Antigen in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2179 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Antigen in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2180 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Unspecified Specimen by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2181 | Organisms (Tests by Microscopic Observation in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.2183 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.2187 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.2188 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.2189 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Cerebrospinal Fluid by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2190 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.2192 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.2193 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.2194 | Organisms (Combination Tests by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2195 | Organisms (Combination Tests for Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2199 | NU_Organisms (Tests in Specimen from Wound by Culture and Identification Method |
| 2.16.840.1.113762.1.4.1146.2200 | Organisms (Tests by Animal Inoculation Method) |
| 2.16.840.1.113762.1.4.1146.2206 | Creatinine (Tests in Serum by Any Method) |
| 2.16.840.1.113762.1.4.1146.2207 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2208 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Blood) |
| 2.16.840.1.113762.1.4.1146.2210 | Histopathology or Cytopathology Tests by Microscopic Observation |
| 2.16.840.1.113762.1.4.1146.2211 | Ehrlichiosis (Tests for Ehrlichia species IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.2213 | Invasive Cronobacter Infection (Tests for Cronobacter species by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2222 | Organisms (Tests in Amniotic Fluid by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2223 | Congenital Cytomegalovirus (Tests for CMV Antigen by Immunohistochemical Stain) |
| 2.16.840.1.113762.1.4.1146.2224 | Congenital Cytomegalovirus (Tests for CMV Antigen in Tissue by Immunohistochemical Stain) |
| 2.16.840.1.113762.1.4.1146.2225 | Congenital Cytomegalovirus (Tests for CMV in Amniotic Fluid by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2226 | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid in Amniotic Fluid by NAAT) |
| 2.16.840.1.113762.1.4.1146.2227 | Congenital Cytomegalovirus (Tests for CMV Antigen in Whole Blood) |
| 2.16.840.1.113762.1.4.1146.2228 | Congenital Cytomegalovirus (Tests for CMV Antigen) |
| 2.16.840.1.113762.1.4.1146.2229 | Congenital Cytomegalovirus (Tests for CMV by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2230 | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid by NAAT) |
| 2.16.840.1.113762.1.4.1146.2235 | Toxoplasmosis (Tests for Toxoplasma gondii Antigen by Immunohistochemical Stain) |
| 2.16.840.1.113762.1.4.1146.2236 | Toxoplasmosis (Tests for Toxoplasma gondii Antigen in Tissue by Immunohistochemical Stain) |
| 2.16.840.1.113762.1.4.1146.2237 | Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody) |
| 2.16.840.1.113762.1.4.1146.2238 | Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody in Blood) |
| 2.16.840.1.113762.1.4.1146.2239 | Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.2240 | Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.2243 | Zika Virus Disease (Tests for Zika virus IgM Antibody in Blood or CSF) |
| 2.16.840.1.113762.1.4.1146.2244 | Candida species (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2245 | Organisms (Tests in Extrapulmonary Specimen by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2246 | Organisms (Tests for Nucleic Acid in Extrapulmonary Specimen) |
| 2.16.840.1.113762.1.4.1146.2248 | Plasmodium species (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2249 | Baylisascariasis (Tests for Baylisascaris species Antibody in Serum or CSF) |
| 2.16.840.1.113762.1.4.1146.2251 | Organisms (Tests in Sputum Specimen by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2252 | Organisms (Tests in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2253 | Organisms (Tests for Nucleic Acid in Lower Respiratory Specimen [Including Sputum] ) |
| 2.16.840.1.113762.1.4.1146.2254 | Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2257 | Organisms (Tests in Stool by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2293 | Opioids, Benzodiazepines, or Barbiturates (Tests by Any Method) |
| 2.16.840.1.113762.1.4.1146.2294 | NonOpioid, NonBenzodiazepine, and NonBarbiturate Substances (Tests by Any Method) |
| 2.16.840.1.113762.1.4.1146.2299 | Group A Streptococcus (Tests for Group A Strep in Specimen from Normally Sterile Site by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2300 | Babesia species (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2301 | Babesia species (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain) |
| 2.16.840.1.113762.1.4.1146.2302 | Babesia species (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain) |
| 2.16.840.1.113762.1.4.1146.2303 | Organisms (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain) |
| 2.16.840.1.113762.1.4.1146.2304 | Organisms (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain) |
| 2.16.840.1.113762.1.4.1146.2306 | Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2343 | Giardiasis (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2344 | Diphtheria (Tests for Diphtheria Toxin Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2345 | Lead in Blood (Tests for Lead in Venous Blood) |
| 2.16.840.1.113762.1.4.1146.2346 | Lead in Blood (Tests for Lead in Capillary Blood) |
| 2.16.840.1.113762.1.4.1146.2347 | Opioid Overdose and Poisoning (Test Panels for Opioids) |
| 2.16.840.1.113762.1.4.1146.2348 | Rubella (Test Panels for rubella virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.2351 | Shigellosis (Combination Tests that include Shigella species by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2352 | Acid Fast Bacilli (Tests by Microscopic Observation by Fite Stain) |
| 2.16.840.1.113762.1.4.1146.2353 | Acid Fast Bacilli (Tests by Microscopic Observation in Skin or Unspecified Tissue by Fite Stain) |
| 2.16.840.1.113762.1.4.1146.2354 | Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain) |
| 2.16.840.1.113762.1.4.1146.2355 | Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain in Skin) |
| 2.16.840.1.113762.1.4.1146.2357 | Organisms (Tests by Microscopic Observation in Skin) |
| 2.16.840.1.113762.1.4.1146.2359 | Organisms (Tests by Microscopic Observation in Unspecified Tissue) |
| 2.16.840.1.113762.1.4.1146.2360 | S. Paratyphi Infection (Tests for S. Paratyphi by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2361 | S. Paratyphi Infection (Tests for S. Paratyphi Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2379 | Group A Streptococcus (Tests for Group A Strep in Specimen from Nonsterile Site by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2380 | Organisms (Tests in Specimen from Nonsterile Site by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2382 | Chagas Disease (Tests for Trypanosoma cruzi in specimen from donor) |
| 2.16.840.1.113762.1.4.1146.2388 | Hansen’s Disease (Tests for M. leprae or M. lepromatosis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.239 | Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.240 | Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Antigen) |
| 2.16.840.1.113762.1.4.1146.2403 | NU_Hepatitis D Virus Infection (Tests for hepatitis D virus Antibody) |
| 2.16.840.1.113762.1.4.1146.2404 | Hepatitis D Virus Infection (Tests for hepatitis D virus IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.2405 | Hepatitis D Virus Infection (Test for hepatitis D virus Antigen) |
| 2.16.840.1.113762.1.4.1146.2406 | Hepatitis B Virus Infection (Combination Tests that include hepatitis B virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2409 | Babesiosis (Tests for B. microti IgG or Total Antibody [Titer]) |
| 2.16.840.1.113762.1.4.1146.2410 | Babesiosis (Tests for B. divergens IgG or Total Antibody [Titer]) |
| 2.16.840.1.113762.1.4.1146.2411 | Babesiosis (Tests for B. duncani IgG or Total Antibody [Titer]) |
| 2.16.840.1.113762.1.4.1146.2412 | Babesiosis (Tests for Babesia species IgG or Total Antibody) |
| 2.16.840.1.113762.1.4.1146.2413 | Brucellosis (Tests for Brucella species IgG Antibody by ELISA) |
| 2.16.840.1.113762.1.4.1146.2426 | Leptospira species (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2427 | Leptospirosis (Tests for Leptospira Antibody by Agglutination) |
| 2.16.840.1.113762.1.4.1146.2428 | Leptospirosis (Tests for Leptospira Antibody by Indirect Immunofluorescence) |
| 2.16.840.1.113762.1.4.1146.244 | Gonorrhea (Tests for Neisseria gonorrhoeae Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2440 | Anthrax (Tests for Bacillus anthracis Protective Antigen Antibody) |
| 2.16.840.1.113762.1.4.1146.2441 | Anthrax (Tests for Bacillus species by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2448 | Influenza (Tests for unspecified influenza virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2449 | Influenza (Tests for influenza B virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2450 | Influenza (Tests for unspecified influenza virus Antigen) |
| 2.16.840.1.113762.1.4.1146.2451 | Influenza (Tests for influenza B virus Antigen) |
| 2.16.840.1.113762.1.4.1146.2454 | Influenza (Tests for unspecified influenza virus by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2455 | Influenza (Tests for influenza B virus by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2456 | Hepatitis B Virus Infection (Tests for Hepatitis B Virus Total Core Antibody) |
| 2.16.840.1.113762.1.4.1146.2457 | Hepatitis C Virus Infection (Combination Tests that include hepatitis C virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2458 | Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2459 | Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid in Blood) |
| 2.16.840.1.113762.1.4.1146.2460 | Borrelia species (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2461 | Borrelia species (Tests by Microscopic Observation in Blood) |
| 2.16.840.1.113762.1.4.1146.2462 | Spirochetes (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2465 | CRE (Tests for Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2466 | CRE (Tests for Proteus spp., Providencia spp., and Morganella spp. by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2467 | CRE (Tests for Enterobacterales species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2468 | CRE (Combination Tests that include Enterobacterales by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2469 | Tests for Carbapenem Susceptibility [Meropenem and Doripenem] |
| 2.16.840.1.113762.1.4.1146.2505 | Trisomy 13 (Tests for Trisomy 13 Chromosomal Anomaly) |
| 2.16.840.1.113762.1.4.1146.2508 | Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative] in Blood) |
| 2.16.840.1.113762.1.4.1146.2509 | Galactosemia (Tests for Galactokinase (GALK) [Quantitative] in Blood) |
| 2.16.840.1.113762.1.4.1146.2510 | Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative] in Blood) |
| 2.16.840.1.113762.1.4.1146.2511 | Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.2512 | Galactosemia (Tests for Galactokinase (GALK) [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.2513 | Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.2514 | Galactosemia (Tests for GALT gene allele 1) |
| 2.16.840.1.113762.1.4.1146.2515 | Galactosemia (Tests for GALT gene allele 2) |
| 2.16.840.1.113762.1.4.1146.2522 | Trisomy 18 (Tests for Trisomy 18 Chromosomal Anomaly) |
| 2.16.840.1.113762.1.4.1146.2523 | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2524 | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2525 | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Antigen) |
| 2.16.840.1.113762.1.4.1146.2526 | Chlamydia trachomatis Infection (Combination Tests that include Chlamydia trachomatis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2530 | Gonorrhea (Combination Tests that include Neisseria Gonorrhea Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2532 | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2533 | Congenital Cytomegalovirus (Tests for CMV Antibody) |
| 2.16.840.1.113762.1.4.1146.268 | Mumps (Tests for mumps virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.282 | Varicella (Tests for Varicella zoster virus by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.283 | Varicella (Tests for Varicella zoster virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.297 | Measles (Tests for measles virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.299 | Measles (Tests for measles virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.301 | Shigellosis (Tests for Shigella species by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.305 | Organisms (Tests by Microscopic Observation in Specimen from Normally Sterile Site by Gram Stain) |
| 2.16.840.1.113762.1.4.1146.307 | Leptospirosis (Tests for Leptospira IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.308 | Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.310 | Bacteria (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.311 | Viruses (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.316 | Rubella (Tests for rubella virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.317 | Shigellosis (Tests for Shigella species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.319 | Fungi (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.335 | Influenza (Tests for influenza A virus by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.336 | Influenza (Tests for influenza A or B virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.342 | Campylobacteriosis (Tests for Campylobacter species by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.343 | Campylobacteriosis (Tests for Campylobacter species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.344 | Campylobacteriosis (Tests for Campylobacter species Antigen) |
| 2.16.840.1.113762.1.4.1146.349 | Hepatitis A (Tests for hepatitis A virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.372 | Cryptosporidiosis (Tests for Cryptosporidium species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.376 | Cyclosporiasis (Tests for Cyclospora cayetanensis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.379 | Giardiasis (Tests for Giardia species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.384 | Listeriosis (Tests for Listeria monocytogenes Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.388 | Vibriosis (Tests for Vibrionaceae species [except Toxigenic Vibrio cholera O1 and O139] Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.390 | Trichinellosis (Tests for Trichinella species Antibody) |
| 2.16.840.1.113762.1.4.1146.398 | Hepatitis C Virus Infection (Tests for hepatitis C virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.399 | Hepatitis C Virus Infection (Tests for hepatitis C virus Antigen) |
| 2.16.840.1.113762.1.4.1146.400 | Hepatitis B Virus Infection (Tests for hepatitis B virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.401 | Hepatitis B Virus Infection (Tests for hepatitis B virus surface Antigen) |
| 2.16.840.1.113762.1.4.1146.403 | Hepatitis B Virus Infection (Tests for hepatitis B virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.407 | Hepatitis C Virus Infection (Tests for hepatitis C virus Antibody) |
| 2.16.840.1.113762.1.4.1146.427 | STEC Infection (Tests for Shiga toxin genes, or STEC, EHEC, or E. coli O157 Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.436 | Coccidioidomycosis (Tests for Coccidioides species IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.437 | Coccidioidomycosis (Tests for Coccidioides species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.438 | Coccidioidomycosis (Tests for Coccidioides species Antigen) |
| 2.16.840.1.113762.1.4.1146.445 | Legionellosis (Tests for Legionella species Antigen) |
| 2.16.840.1.113762.1.4.1146.446 | Legionellosis (Tests for Legionella species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.464 | Malaria (Tests for Plasmodium species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.468 | Leptospirosis (Tests for Leptospira Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.471 | Leptospirosis (Tests for Leptospira Antibody [Quantitative] by Agglutination) |
| 2.16.840.1.113762.1.4.1146.472 | Leptospirosis (Tests for Leptospira Antibody) |
| 2.16.840.1.113762.1.4.1146.476 | Babesia species (Tests by Microscopic Observation in Blood) |
| 2.16.840.1.113762.1.4.1146.478 | Anthrax (Tests for Bacillus anthracis by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.479 | Anthrax (Tests for Bacillus anthracis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.480 | Anthrax (Tests for Bacillus anthracis Antigen) |
| 2.16.840.1.113762.1.4.1146.481 | Anthrax (Tests for Bacillus anthracis Antibody) |
| 2.16.840.1.113762.1.4.1146.496 | Q Fever (Tests for Coxiella burnetii IgM IgG Antibody [Excluding Quantitative IFA Tests for IgG Antibody against Phase I or II Antigen]) |
| 2.16.840.1.113762.1.4.1146.500 | Q Fever (Tests for Coxiella burnetii Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.512 | Brucellosis (Tests for Brucella species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.515 | Brucellosis (Tests for Brucella species Antibody [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.519 | Dengue Virus Infection (Tests for dengue virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.523 | Dengue Virus Infection (Tests for dengue virus Antigen) |
| 2.16.840.1.113762.1.4.1146.524 | Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.525 | Dengue Virus Infection (Tests for dengue virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.527 | Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.530 | Borrelia species (Tests for Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.531 | Lyme Disease (Tests for Borrelia burgdorferi IgM IgG Antibody by Immunoblot) |
| 2.16.840.1.113762.1.4.1146.532 | Lyme Disease (Tests for Borrelia burgdorferi Antibody by Immunoassay) |
| 2.16.840.1.113762.1.4.1146.548 | St. Louis Encephalitis Virus Infection (Tests for Saint Louis encephalitis virus Antibody [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.550 | Syphilis (Tests for Treponema pallidum Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.553 | Anaplasma species (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.555 | Yellow Fever (Tests for yellow fever virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.557 | Yellow Fever (Tests for yellow fever virus Antibody [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.560 | West Nile Virus Infection (Tests for West Nile virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.569 | Plague (Tests for Yersinia pestis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.575 | Arboviral Disease [Other] (Tests for Arbovirus [Other] Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.576 | Arboviral Disease [Other] (Tests for Arbovirus [Other] Antigen) |
| 2.16.840.1.113762.1.4.1146.577 | Arboviral Disease [Other] (Tests for Arbovirus [Other] IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.578 | Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.579 | Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.58 | Pertussis (Tests for Bordetella pertussis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.581 | Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.584 | Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.595 | Tularemia (Tests for Francisella tularensis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.598 | Tularemia (Tests for Francisella tularensis Antibody) |
| 2.16.840.1.113762.1.4.1146.605 | Organisms (Tests by Microscopic Observation by Acid Fast Stain) |
| 2.16.840.1.113762.1.4.1146.614 | Pertussis (Tests for Bordetella pertussis Toxin Antibody) |
| 2.16.840.1.113762.1.4.1146.645 | Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.652 | Bacteria (Tests in Specimen from Normally Sterile Site by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.70 | Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.705 | Syphilis (Tests for Treponemal or Non Treponemal Antibody) |
| 2.16.840.1.113762.1.4.1146.71 | Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.728 | HIV Infection (Tests for HIV Nucleic Acid [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.730 | HIV Infection (Tests for HIV Antibody) |
| 2.16.840.1.113762.1.4.1146.744 | Coccidioidomycosis (Tests for Coccidioides species IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.746 | Treponema pallidum (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.762 | Mumps (Test Panels for mumps virus IgM IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.764 | Mumps (Tests for mumps virus IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.770 | Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid in Specimen from Normally Sterile Site) |
| 2.16.840.1.113762.1.4.1146.773 | Invasive Haemophilus influenzae Disease (Tests for Haemophilus influenzae Nucleic Acid in Specimen from Normally Sterile Site) |
| 2.16.840.1.113762.1.4.1146.782 | Rubella (Test Panels for rubella virus IgM IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.785 | Opioid Overdose and Poisoning (Tests for Opioids [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.797 | Influenza (Tests for influenza A or B virus by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.798 | Influenza (Tests for influenza A virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.799 | Influenza (Tests for influenza A virus Antigen) |
| 2.16.840.1.113762.1.4.1146.802 | Influenza (Tests for Novel influenza A virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.803 | Tests by Microscopic Observation in Tissue by H&E or PAS Stain |
| 2.16.840.1.113762.1.4.1146.815 | NU_Anaplasmosis (Tests for Anaplasma species Antibody [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.816 | Rubella (Tests for rubella virus IgG Antibody [Ratio] in Serum) |
| 2.16.840.1.113762.1.4.1146.818 | Measles (Tests for measles virus IgG Antibody [Ratio] in Serum) |
| 2.16.840.1.113762.1.4.1146.820 | Rubella (Tests for rubella virus IgG Antibody [Quantitative] in Serum) |
| 2.16.840.1.113762.1.4.1146.824 | Computerized Tomography of Chest (Imaging) |
| 2.16.840.1.113762.1.4.1146.830 | Poliovirus Infection (Tests for Poliovirus Antibody Titer in Serum Specimen) |
| 2.16.840.1.113762.1.4.1146.841 | Tuberculosis (Interferon Gamma Release Assays) |
| 2.16.840.1.113762.1.4.1146.842 | Tests by Microscopic Observation in Tissue |
| 2.16.840.1.113762.1.4.1146.846 | SARS (Tests for SARS_CoV by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.847 | SARS (Tests for SARS_CoV Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.878 | MERS (Tests for MERS_CoV Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.884 | Tests by Microscopic Observation in Blood |
| 2.16.840.1.113762.1.4.1146.889 | Hantavirus Infection (Tests for Hantavirus IgM IgG Total Antibody) |
| 2.16.840.1.113762.1.4.1146.892 | Organisms (Tests by Microscopic Observation in Tissue by Acid Fast Stain) |
| 2.16.840.1.113762.1.4.1146.896 | Tests by Microscopic Observation in Blood Smear |
| 2.16.840.1.113762.1.4.1146.897 | Dengue Virus Infection (Test Panels for dengue virus IgM IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.9 | Xray of Chest (Imaging) |
| 2.16.840.1.113762.1.4.1146.900 | Organisms (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.989 | Tests for Mycobacterium species by Culture and Identification Method |
| 2.16.840.1.113762.1.4.1146.994 | Organisms (Tests for Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.998 | Shigellosis (Tests for Enteroinvasive E. coli Nucleic Acid) |
| 2.16.840.1.113762.1.4.1147.109 | Pressure Injury Stage 2, 3, 4 or Unstageable |
| 2.16.840.1.113762.1.4.1147.113 | Pressure Injury Stage 2, 3, 4 or Unstageable |
| 2.16.840.1.113762.1.4.1147.160 | Abdominal or Pelvic CT Scan with Contrast |
| 2.16.840.1.113762.1.4.1147.164 | Ultrasound of Lower Extremities |
| 2.16.840.1.113762.1.4.1147.165 | Ultrasound of Lower Extremities |
| 2.16.840.1.113762.1.4.1147.183 | Anti Factor Xa Assay |
| 2.16.840.1.113762.1.4.1151.38 | DEXA Dual Energy Xray Absorptiometry, Bone Density for Urology Care |
| 2.16.840.1.113762.1.4.1160.30 | Prediabetes HbA1c Tests |
| 2.16.840.1.113762.1.4.1160.32 | Prediabetes HbA1c Tests |
| 2.16.840.1.113762.1.4.1160.33 | Prediabetes Oral Glucose Tolerance Tests |
| 2.16.840.1.113762.1.4.1160.35 | Prediabetes Oral Glucose Tolerance Tests |
| 2.16.840.1.113762.1.4.1160.36 | Prediabetes Fasting plasma glucose or Plasma Glucose Tests |
| 2.16.840.1.113762.1.4.1160.38 | Prediabetes Fasting plasma glucose or Plasma Glucose Tests |
| 2.16.840.1.113762.1.4.1160.4 | Glycemic Screening Tests |
| 2.16.840.1.113762.1.4.1160.5 | Glycemic Screening Tests |
| 2.16.840.1.113762.1.4.1160.88 | Direct LDL Cholesterol |
| 2.16.840.1.113762.1.4.1160.89 | Calculated LDL Cholesterol |
| 2.16.840.1.113762.1.4.1164.68 | BMI greater than 40 |
| 2.16.840.1.113762.1.4.1164.69 | Morbid Obesity |
| 2.16.840.1.113762.1.4.1166.10 | Pap Smear Tests |
| 2.16.840.1.113762.1.4.1166.11 | HIV Tests |
| 2.16.840.1.113762.1.4.1166.115 | Self Identified Need for Contraception (SINC) |
| 2.16.840.1.113762.1.4.1166.117 | Syphilis Tests |
| 2.16.840.1.113762.1.4.1166.12 | Human Papilloma Virus Tests |
| 2.16.840.1.113762.1.4.1166.13 | Chlamydia Trachomatis Tests |
| 2.16.840.1.113762.1.4.1166.14 | Neisseria Gonorrhoeae Tests |
| 2.16.840.1.113762.1.4.1166.15 | Chlamydia trachomatis and Neisseria Gonorrhoeae combined Tests |
| 2.16.840.1.113762.1.4.1166.150 | Contraceptive Patch LOINC |
| 2.16.840.1.113762.1.4.1166.160 | Contraceptive Ring LOINC |
| 2.16.840.1.113762.1.4.1166.167 | Contraceptive Implant LOINC |
| 2.16.840.1.113762.1.4.1166.188 | Injectable Contraceptive LOINC |
| 2.16.840.1.113762.1.4.1166.196 | Oral Contraceptive Pill LOINC |
| 2.16.840.1.113762.1.4.1166.211 | Contraceptive discussion |
| 2.16.840.1.113762.1.4.1166.80 | Intrauterine Devices LOINC |
| 2.16.840.1.113762.1.4.1166.98 | Female Sterilization LOINC |
| 2.16.840.1.113762.1.4.1170.32 | Healthcare Agent and Power of Attorney Documentation |
| 2.16.840.1.113762.1.4.1170.33 | Advance Directive Documentation |
| 2.16.840.1.113762.1.4.1170.36 | Portable Medical Order(s) Documentation |
| 2.16.840.1.113762.1.4.1170.42 | Healthcare Agent & Power of Attorney Documentation |
| 2.16.840.1.113762.1.4.1170.43 | Advance Directive Documentation |
| 2.16.840.1.113762.1.4.1170.48 | Portable Medical Order(s) Documentation |
| 2.16.840.1.113762.1.4.1170.58 | Goals, preferences, and priorities for medical treatment |
| 2.16.840.1.113762.1.4.1178.25 | 2 Hour Blood Glucose Test |
| 2.16.840.1.113762.1.4.1178.26 | NYHA Functional Classification |
| 2.16.840.1.113762.1.4.1178.3 | Cholesterol non HDL Laboratory Test |
| 2.16.840.1.113762.1.4.1178.49 | Minnesota Living with Heart Failure Questionnaire |
| 2.16.840.1.113762.1.4.1178.50 | Kansas City Cardiomyopathy Questionnaire |
| 2.16.840.1.113762.1.4.1178.86 | Serum Creatinine |
| 2.16.840.1.113762.1.4.1178.87 | Urine Creatinine |
| 2.16.840.1.113762.1.4.1178.88 | Urine Albumin |
| 2.16.840.1.113762.1.4.1190.21 | NHSNPopulationSummaryReportTypeCode(LOINC) |
| 2.16.840.1.113762.1.4.1190.38 | Blood Glucose Laboratory and Point of Care Tests |
| 2.16.840.1.113762.1.4.1190.62 | Lab Tests for Clostridioides difficile |
| 2.16.840.1.113762.1.4.1190.63 | Bacterial and Fungal Blood Culture Tests |
| 2.16.840.1.113762.1.4.1196.1344 | Tests for Neisseria gonorrhoeae of unspecified site reported by presence |
| 2.16.840.1.113762.1.4.1196.1352 | Body weight |
| 2.16.840.1.113762.1.4.1196.3483 | Financial Insecurity Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1196.3484 | Food Insecurity Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1196.3485 | Health Literacy Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1196.3486 | Homelessness Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1196.3487 | Housing Instability Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1196.3488 | Less Than High School Education Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1196.3519 | Health Insurance Coverage Status Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1196.3520 | Inadequate Housing Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1196.4474 | HIV Laboratory Based Tests |
| 2.16.840.1.113762.1.4.1206.57 | Colorectal Screening |
| 2.16.840.1.113762.1.4.1206.59 | Screening Mammogram (LOINC) |
| 2.16.840.1.113762.1.4.1206.61 | Screening Mammogram (Grouping) |
| 2.16.840.1.113762.1.4.1206.63 | Diagnostic Mammography (LOINC) |
| 2.16.840.1.113762.1.4.1206.65 | Diagnostic Mammography |
| 2.16.840.1.113762.1.4.1219.106 | pH, Hematocrit, Partial Pressure Carbon Dioxide, Partial Pressure Oxygen or Bicarbonate Laboratory Test for Breathing Assistance Device Evaluation Excluding Oxygen Saturation |
| 2.16.840.1.113762.1.4.1219.123 | Apnea Hypopnea Index Rate Measurement |
| 2.16.840.1.113762.1.4.1219.124 | Forced Expiratory Volume in One Second (FEV1)/Forced Vital Capacity (FVC) Measurement |
| 2.16.840.1.113762.1.4.1219.125 | Maximal Inspiratory Pressure Measurement |
| 2.16.840.1.113762.1.4.1219.126 | Forced Vital Capacity (FVC) Measurement by Spirometry |
| 2.16.840.1.113762.1.4.1219.127 | Oxygen Saturation Measurement At Rest |
| 2.16.840.1.113762.1.4.1219.131 | Forced Vital Capacity (FVC) Measurement Prediction |
| 2.16.840.1.113762.1.4.1219.132 | Oxygen Saturation Laboratory Test and Setting for Breathing Assistance Device Evaluation |
| 2.16.840.1.113762.1.4.1219.133 | Respiratory Disturbance Index |
| 2.16.840.1.113762.1.4.1219.94 | Laboratory Test for Home Glucose Monitor Evaluation |
| 2.16.840.1.113762.1.4.1221.135 | Last Menstrual Period (LMP) |
| 2.16.840.1.113762.1.4.1221.172 | Contraception, Counseling |
| 2.16.840.1.113762.1.4.1221.174 | Contraception, Counseling |
| 2.16.840.1.113762.1.4.1221.204 | Pregnancy Labs, Blood/Serum/Plasma/Urine |
| 2.16.840.1.113762.1.4.1222.1005 | Sexual Satisfaction |
| 2.16.840.1.113762.1.4.1222.1015 | Substance Use |
| 2.16.840.1.113762.1.4.1222.1016 | Tobacco Use |
| 2.16.840.1.113762.1.4.1222.1020 | Screen Time |
| 2.16.840.1.113762.1.4.1222.1022 | Fluid Management |
| 2.16.840.1.113762.1.4.1222.1023 | Fat Intake |
| 2.16.840.1.113762.1.4.1222.1024 | Unsaturated Fat Intake |
| 2.16.840.1.113762.1.4.1222.1025 | Saturated Fat Intake |
| 2.16.840.1.113762.1.4.1222.1026 | Carbohydrate Intake |
| 2.16.840.1.113762.1.4.1222.1027 | Salt Intake |
| 2.16.840.1.113762.1.4.1222.1028 | Vegetable Intake |
| 2.16.840.1.113762.1.4.1222.1029 | Fruit Intake |
| 2.16.840.1.113762.1.4.1222.1030 | English Proficiency |
| 2.16.840.1.113762.1.4.1222.1042 | Neglect |
| 2.16.840.1.113762.1.4.1222.1048 | Current or Former Occupation |
| 2.16.840.1.113762.1.4.1222.1050 | Work Productivity |
| 2.16.840.1.113762.1.4.1222.1053 | Income Level |
| 2.16.840.1.113762.1.4.1222.1057 | Caregiver Characteristics |
| 2.16.840.1.113762.1.4.1222.1058 | Caregiver Availability |
| 2.16.840.1.113762.1.4.1222.1060 | Living Situation |
| 2.16.840.1.113762.1.4.1222.1064 | Marital or Spousal Status |
| 2.16.840.1.113762.1.4.1222.1065 | Dependents in Home |
| 2.16.840.1.113762.1.4.1222.1068 | Physical Activity Level |
| 2.16.840.1.113762.1.4.1222.1069 | Leisure Activity Engagement |
| 2.16.840.1.113762.1.4.1222.1075 | Exposure to Environmental Hazards |
| 2.16.840.1.113762.1.4.1222.1076 | Neighborhood Safety |
| 2.16.840.1.113762.1.4.1222.1080 | Experiences of Discrimination |
| 2.16.840.1.113762.1.4.1222.1082 | Criminal Justice Involvement or Incarceration |
| 2.16.840.1.113762.1.4.1222.1083 | Immigration Status |
| 2.16.840.1.113762.1.4.1222.111 | Creatinine in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.113 | Blood Urea Nitrogen |
| 2.16.840.1.113762.1.4.1222.114 | Hemoglobin |
| 2.16.840.1.113762.1.4.1222.118 | Iron Saturation (Transferrin Saturation/TSAT) |
| 2.16.840.1.113762.1.4.1222.119 | Hemoglobin A1C |
| 2.16.840.1.113762.1.4.1222.1197 | Sleep Behavior |
| 2.16.840.1.113762.1.4.1222.120 | Potassium in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.122 | Corrected Calcium |
| 2.16.840.1.113762.1.4.1222.123 | Phosphorus in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.126 | Vitamin D Levels |
| 2.16.840.1.113762.1.4.1222.128 | KT/V Hemodialysis Ratio |
| 2.16.840.1.113762.1.4.1222.129 | Intact Parathyroid Hormone |
| 2.16.840.1.113762.1.4.1222.130 | Bicarbonate in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.131 | Sodium in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.132 | Chloride in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.135 | High Density Lipoprotein |
| 2.16.840.1.113762.1.4.1222.137 | Triglyceride in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.138 | Cystatin C |
| 2.16.840.1.113762.1.4.1222.139 | Total Cholesterol |
| 2.16.840.1.113762.1.4.1222.140 | Ferritin |
| 2.16.840.1.113762.1.4.1222.141 | Red Blood Cell Count (Erythrocytes) |
| 2.16.840.1.113762.1.4.1222.142 | White Blood Cell (Leukocytes) Count |
| 2.16.840.1.113762.1.4.1222.143 | Hematocrit |
| 2.16.840.1.113762.1.4.1222.144 | Mean Corpuscular Volume |
| 2.16.840.1.113762.1.4.1222.145 | Mean Corpuscular Hemoglobin Concentration |
| 2.16.840.1.113762.1.4.1222.146 | Platelet Count |
| 2.16.840.1.113762.1.4.1222.147 | Erythrocyte Distribution Width |
| 2.16.840.1.113762.1.4.1222.148 | Platelet Distribution Width |
| 2.16.840.1.113762.1.4.1222.149 | Platelet Mean Volume |
| 2.16.840.1.113762.1.4.1222.150 | Estimated Average Glucose |
| 2.16.840.1.113762.1.4.1222.151 | Albumin in Blood, Plasma, or Serum |
| 2.16.840.1.113762.1.4.1222.153 | Anion Gap |
| 2.16.840.1.113762.1.4.1222.154 | Urine Urea Nitrogen |
| 2.16.840.1.113762.1.4.1222.155 | Bone Density |
| 2.16.840.1.113762.1.4.1222.156 | Bone Survey X Rays |
| 2.16.840.1.113762.1.4.1222.1568 | Low Density Lipoprotein |
| 2.16.840.1.113762.1.4.1222.1569 | Physical findings of the abdomen |
| 2.16.840.1.113762.1.4.1222.1571 | Chest US |
| 2.16.840.1.113762.1.4.1222.1572 | Sleep Disorder Assessment |
| 2.16.840.1.113762.1.4.1222.1573 | Cerebral Spinal Fluid (CSF) Analysis |
| 2.16.840.1.113762.1.4.1222.1574 | Comprehensive Metabolic Panel (CMP) |
| 2.16.840.1.113762.1.4.1222.1575 | Arterial Blood Gas (ABG) |
| 2.16.840.1.113762.1.4.1222.1576 | Coagulation Assay (PT, aPTT, Fibrinogen) |
| 2.16.840.1.113762.1.4.1222.1577 | D Dimer Test |
| 2.16.840.1.113762.1.4.1222.1578 | Procalcitonin in Blood, Serum, or Plasma |
| 2.16.840.1.113762.1.4.1222.1579 | Creatine Kinase (CK, CK MB) in Blood, Serum, or Plasma |
| 2.16.840.1.113762.1.4.1222.1580 | COVID 19 (SARS CoV 2), SARS CoV, Influenza virus A and B Tests |
| 2.16.840.1.113762.1.4.1222.1581 | Microorganisms Detection by Blood Culture |
| 2.16.840.1.113762.1.4.1222.1582 | Microorganisms Detection by Sputum Culture |
| 2.16.840.1.113762.1.4.1222.1583 | Cystography |
| 2.16.840.1.113762.1.4.1222.1584 | Cognitive Health Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1585 | Alcohol Use Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1586 | Functional Status Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1587 | Kidney Disease Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1588 | Long Covid Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1589 | Nutrition Status Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1590 | Pain Perception Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1591 | Patient Goal Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1592 | Social Determinant of Health Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1593 | Covid 19 Related Health Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1594 | Caregiver Considerations Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1597 | Drugs of Abuse Screen |
| 2.16.840.1.113762.1.4.1222.1598 | Criminal Justice Involvement or Incarceration History |
| 2.16.840.1.113762.1.4.1222.1607 | Alanine Aminotransferase (ALT) in Blood, Plasma, or Serum |
| 2.16.840.1.113762.1.4.1222.1608 | Aspartate Aminotransferase (AST) in Blood, Plasma, or Serum |
| 2.16.840.1.113762.1.4.1222.1609 | Erythrocyte Sedimentation Rate (ESR) in Blood |
| 2.16.840.1.113762.1.4.1222.1610 | Oxygen Saturation in Blood |
| 2.16.840.1.113762.1.4.1222.176 | Urine Sediment |
| 2.16.840.1.113762.1.4.1222.179 | Estimated Glomerular Filtration Rate (eGFR) |
| 2.16.840.1.113762.1.4.1222.450 | CKD Progression Risk |
| 2.16.840.1.113762.1.4.1222.582 | Framingham Risk Assessments |
| 2.16.840.1.113762.1.4.1222.583 | American College of Cardiology or American Heart Association Ascvd Risk Score (acc/aha Ascvd Risk) |
| 2.16.840.1.113762.1.4.1222.591 | Cannabis Use |
| 2.16.840.1.113762.1.4.1222.702 | Binge Drinking |
| 2.16.840.1.113762.1.4.1222.703 | Binge Drinking |
| 2.16.840.1.113762.1.4.1222.706 | Drug Misuse |
| 2.16.840.1.113762.1.4.1222.711 | Fall Risk |
| 2.16.840.1.113762.1.4.1222.790 | Urine Protein to Creatinine Ratio (UPCR) |
| 2.16.840.1.113762.1.4.1222.791 | 24 Hour Urine Volume |
| 2.16.840.1.113762.1.4.1222.792 | 24 Hour Urine Protein Excretion |
| 2.16.840.1.113762.1.4.1222.793 | Total Carbon Dioxide or Bicarbonate in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.794 | Calcium (Not Corrected for Serum Albumin) in Blood, Plasms, or Serum |
| 2.16.840.1.113762.1.4.1222.795 | B Type Natriuretic Peptide [Bnp] in Blood, Serum or Plasma |
| 2.16.840.1.113762.1.4.1222.797 | N Terminal Pro_B_Type Natriuretic Peptide [Nt_Probnp] in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.801 | High Sensitivity Troponin |
| 2.16.840.1.113762.1.4.1222.804 | Aspartate Transaminase or Alanine Aminotransferase Ratio |
| 2.16.840.1.113762.1.4.1222.805 | Alkaline Phosphatase (Alp) in Blood, Serum or Plasma |
| 2.16.840.1.113762.1.4.1222.806 | Gamma Glutamyl Transpeptidase (Ggt) in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.807 | Triiodothyronine in serum or plasma |
| 2.16.840.1.113762.1.4.1222.808 | Fasting Blood Glucose |
| 2.16.840.1.113762.1.4.1222.809 | Random Blood Glucose Test |
| 2.16.840.1.113762.1.4.1222.810 | Uric Acid (Urate) in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.811 | Aldosterone/Renin Ratio |
| 2.16.840.1.113762.1.4.1222.812 | Serum Rheumatoid Factor |
| 2.16.840.1.113762.1.4.1222.813 | Blood Ethanol Level |
| 2.16.840.1.113762.1.4.1222.814 | Drugs of Abuse Screen in Hair |
| 2.16.840.1.113762.1.4.1222.815 | Drugs of Abuse Screen in Urine |
| 2.16.840.1.113762.1.4.1222.816 | Drugs of Abuse Screen in Blood |
| 2.16.840.1.113762.1.4.1222.817 | Drugs of Abuse Screen in Tissue |
| 2.16.840.1.113762.1.4.1222.818 | Drugs of Abuse Screen in Body Fluid |
| 2.16.840.1.113762.1.4.1222.819 | Urea Reduction Ratio |
| 2.16.840.1.113762.1.4.1222.822 | Bowel Sounds |
| 2.16.840.1.113762.1.4.1222.823 | Uroflowmetry |
| 2.16.840.1.113762.1.4.1222.826 | Gait Quality |
| 2.16.840.1.113762.1.4.1222.828 | Balance Assessments |
| 2.16.840.1.113762.1.4.1222.836 | Sit to Stand Ability |
| 2.16.840.1.113762.1.4.1222.844 | Alcohol Use (Revised 2021) |
| 2.16.840.1.113762.1.4.1222.845 | Alcohol Use |
| 2.16.840.1.113762.1.4.1222.864 | Kidney Biopsy Report |
| 2.16.840.1.113762.1.4.1222.867 | Skin Biopsy Report |
| 2.16.840.1.113762.1.4.1222.868 | Muscle Biopsy Report |
| 2.16.840.1.113762.1.4.1222.869 | Gastric Tissue Biopsy Report |
| 2.16.840.1.113762.1.4.1222.870 | Bone Biopsy Report |
| 2.16.840.1.113762.1.4.1222.873 | Echocardiogram |
| 2.16.840.1.113762.1.4.1222.880 | Spinal or Back CT |
| 2.16.840.1.113762.1.4.1222.881 | Chest CT |
| 2.16.840.1.113762.1.4.1222.882 | Abdominal or Pelvic CT |
| 2.16.840.1.113762.1.4.1222.883 | Limb CT |
| 2.16.840.1.113762.1.4.1222.884 | Heart Calcium Score |
| 2.16.840.1.113762.1.4.1222.885 | Coronary CT Angiogram |
| 2.16.840.1.113762.1.4.1222.886 | Limb CT Angiogram |
| 2.16.840.1.113762.1.4.1222.888 | Chest CT Angiogram |
| 2.16.840.1.113762.1.4.1222.889 | Head and Neck CT Angiogram |
| 2.16.840.1.113762.1.4.1222.891 | Gastrointestinal Tract X Ray |
| 2.16.840.1.113762.1.4.1222.892 | Gallbladder X Ray |
| 2.16.840.1.113762.1.4.1222.893 | Kidney X Ray |
| 2.16.840.1.113762.1.4.1222.894 | Abdomen X Ray |
| 2.16.840.1.113762.1.4.1222.895 | Pelvis X Ray |
| 2.16.840.1.113762.1.4.1222.896 | Hand X Ray |
| 2.16.840.1.113762.1.4.1222.897 | Wrist X Ray |
| 2.16.840.1.113762.1.4.1222.898 | Forearm X Ray |
| 2.16.840.1.113762.1.4.1222.899 | Elbow X Ray |
| 2.16.840.1.113762.1.4.1222.900 | Upper Arm X Ray |
| 2.16.840.1.113762.1.4.1222.901 | Shoulder X Ray |
| 2.16.840.1.113762.1.4.1222.902 | Upper Extremity X Ray |
| 2.16.840.1.113762.1.4.1222.903 | Foot X Ray |
| 2.16.840.1.113762.1.4.1222.904 | Ankle X Ray |
| 2.16.840.1.113762.1.4.1222.905 | Shin X Ray |
| 2.16.840.1.113762.1.4.1222.906 | Knee X Ray |
| 2.16.840.1.113762.1.4.1222.907 | Thigh X Ray |
| 2.16.840.1.113762.1.4.1222.908 | Hip X Ray |
| 2.16.840.1.113762.1.4.1222.909 | Lower Extremity X Ray |
| 2.16.840.1.113762.1.4.1222.910 | Abdominal MRI |
| 2.16.840.1.113762.1.4.1222.911 | Adrenal Gland MRI |
| 2.16.840.1.113762.1.4.1222.912 | Kidney MRI |
| 2.16.840.1.113762.1.4.1222.913 | Pancreas MRI |
| 2.16.840.1.113762.1.4.1222.915 | Kidney MRA |
| 2.16.840.1.113762.1.4.1222.916 | Chest Region MRI |
| 2.16.840.1.113762.1.4.1222.917 | Pulmonary MRI |
| 2.16.840.1.113762.1.4.1222.918 | Cardiac MRI |
| 2.16.840.1.113762.1.4.1222.920 | Spine MRI |
| 2.16.840.1.113762.1.4.1222.921 | Head and Neck MRI |
| 2.16.840.1.113762.1.4.1222.922 | Brain MRI |
| 2.16.840.1.113762.1.4.1222.923 | Pelvic Region MRI |
| 2.16.840.1.113762.1.4.1222.924 | Knee MRI |
| 2.16.840.1.113762.1.4.1222.925 | Foot MRI |
| 2.16.840.1.113762.1.4.1222.927 | Shoulder MRI |
| 2.16.840.1.113762.1.4.1222.928 | Lower Extremity MRA |
| 2.16.840.1.113762.1.4.1222.930 | Spine X Ray |
| 2.16.840.1.113762.1.4.1222.933 | Hip MRI |
| 2.16.840.1.113762.1.4.1222.934 | Thigh or Femur MRI |
| 2.16.840.1.113762.1.4.1222.935 | Ankle MRI |
| 2.16.840.1.113762.1.4.1222.936 | Lower Extremity MRI |
| 2.16.840.1.113762.1.4.1222.937 | Forearm MRI |
| 2.16.840.1.113762.1.4.1222.938 | Elbow MRI |
| 2.16.840.1.113762.1.4.1222.939 | Wrist MRI |
| 2.16.840.1.113762.1.4.1222.940 | Hand MRI |
| 2.16.840.1.113762.1.4.1222.942 | Upper Extremity MRI |
| 2.16.840.1.113762.1.4.1222.943 | Abdominal MRA |
| 2.16.840.1.113762.1.4.1222.944 | Chest MRA |
| 2.16.840.1.113762.1.4.1222.945 | Upper Extremity MRA |
| 2.16.840.1.113762.1.4.1222.947 | Head and Neck MRA |
| 2.16.840.1.113762.1.4.1222.948 | Pelvic Region MRA |
| 2.16.840.1.113762.1.4.1222.949 | Functional MRI |
| 2.16.840.1.113762.1.4.1222.951 | Optical Coherence Tomography |
| 2.16.840.1.113762.1.4.1222.954 | Bathing or grooming/hygiene (ADL/IADL) |
| 2.16.840.1.113762.1.4.1222.955 | Dressing (ADL or IADL) |
| 2.16.840.1.113762.1.4.1222.956 | Toileting (ADL or IADL) |
| 2.16.840.1.113762.1.4.1222.957 | Transferring (ADL or IADL) |
| 2.16.840.1.113762.1.4.1222.958 | Walking or ambulation/locomotion (ADL/IADL) |
| 2.16.840.1.113762.1.4.1222.960 | Domestic Duties or Household Tasks (ADL/IADL) |
| 2.16.840.1.113762.1.4.1222.961 | Telephone Use (ADL or IADL) |
| 2.16.840.1.113762.1.4.1222.962 | Bed Mobility (ADL or IADL) |
| 2.16.840.1.113762.1.4.1222.963 | Stair Use (ADL or IADL) |
| 2.16.840.1.113762.1.4.1222.964 | Medication Management (ADL or IADL) |
| 2.16.840.1.113762.1.4.1222.967 | Electromyography |
| 2.16.840.1.113762.1.4.1222.968 | Electroencephalogram |
| 2.16.840.1.113762.1.4.1222.969 | Exercise Stress Test |
| 2.16.840.1.113762.1.4.1222.976 | Sleep Duration, Device |
| 2.16.840.1.113762.1.4.1222.977 | Steps Per Time, Device |
| 2.16.840.1.113762.1.4.1222.978 | Physical Activity Level, Device |
| 2.16.840.1.113762.1.4.1222.979 | Cognitive Function Clinician Interpretation |
| 2.16.840.1.113762.1.4.1222.987 | Psychosis |
| 2.16.840.1.113762.1.4.1222.991 | Suicidal Ideation and Behaviors |
| 2.16.840.1.113762.1.4.1222.994 | Sleep Duration |
| 2.16.840.1.113762.1.4.1222.996 | Pain Intensity or Severity |
| 2.16.840.1.113762.1.4.1222.997 | Pain Quality |
| 2.16.840.1.113762.1.4.1228.1 | Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography |
| 2.16.840.1.113762.1.4.1235.100 | Cardiomyopathy Hypertrophic Condition |
| 2.16.840.1.113762.1.4.1235.12 | Metabolic Syndrome LOINC |
| 2.16.840.1.113762.1.4.1235.15 | MetabolicSyndromeCondition |
| 2.16.840.1.113762.1.4.1235.175 | Systolic Blood Pressure_HD_LOINC |
| 2.16.840.1.113762.1.4.1235.176 | Systolic Blood Pressure_HD |
| 2.16.840.1.113762.1.4.1235.179 | Diastolic Blood Pressure_HD_LOINC |
| 2.16.840.1.113762.1.4.1235.180 | Diastolic Blood Pressure_HD |
| 2.16.840.1.113762.1.4.1235.190 | Pregnancy_HD_Grouping |
| 2.16.840.1.113762.1.4.1235.196 | Lipid Panel_Event_LOINC |
| 2.16.840.1.113762.1.4.1235.198 | Lipid Panel_Event_Grouping |
| 2.16.840.1.113762.1.4.1235.201 | Unknown Glucose_Event_LOINC |
| 2.16.840.1.113762.1.4.1235.204 | Unknown Glucose_Lab_Grouping |
| 2.16.840.1.113762.1.4.1235.251 | Asthma_LOINC |
| 2.16.840.1.113762.1.4.1235.253 | Asthma_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.262 | Heart Failure (CHF)_LOINC |
| 2.16.840.1.113762.1.4.1235.265 | Heart Failure (CHF)_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.284 | HDL_LOINC |
| 2.16.840.1.113762.1.4.1235.285 | HDL_Lab_Grouping |
| 2.16.840.1.113762.1.4.1235.292 | CT Colonography_LOINC |
| 2.16.840.1.113762.1.4.1235.294 | CT Colonography_Event_Grouping |
| 2.16.840.1.113762.1.4.1235.295 | FIT DNA_LOINC |
| 2.16.840.1.113762.1.4.1235.299 | FIT DNA Test_Lab_Grouping |
| 2.16.840.1.113762.1.4.1235.312 | FOBT Lab_LOINC |
| 2.16.840.1.113762.1.4.1235.314 | FOBT Lab Test_Lab_Grouping |
| 2.16.840.1.113762.1.4.1235.330 | High Risk HPV Test_HD_LOINC |
| 2.16.840.1.113762.1.4.1235.332 | High Risk HPV Test_HD_Grouping |
| 2.16.840.1.113762.1.4.1235.335 | Cervical Cytology_HD_LOINC |
| 2.16.840.1.113762.1.4.1235.337 | Cervical Cytology_HD_Grouping |
| 2.16.840.1.113762.1.4.1235.341 | AFib (Atrial Fibrillation)_LOINC |
| 2.16.840.1.113762.1.4.1235.344 | AFib (Atrial Fibrillation)_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.356 | Coronary Artery Disease (CAD)_LOINC |
| 2.16.840.1.113762.1.4.1235.359 | Coronary Artery Disease (CAD)_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.403 | First Trimester_LOINC |
| 2.16.840.1.113762.1.4.1235.406 | First Trimester_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.417 | Obesity_Clinical Grouping Condition |
| 2.16.840.1.113762.1.4.1235.427 | Obesity_Condition_LOINC |
| 2.16.840.1.113762.1.4.1235.428 | Vitals Body Height LOINC |
| 2.16.840.1.113762.1.4.1235.430 | Vitals Body Height |
| 2.16.840.1.113762.1.4.1235.431 | bwell_Vital_Blood Glucose_LOINC |
| 2.16.840.1.113762.1.4.1235.435 | Anxiety_Clinical Grouping Condition_LOINC |
| 2.16.840.1.113762.1.4.1235.436 | Anxiety_Clinical Grouping Condition |
| 2.16.840.1.113762.1.4.1235.437 | bwell_Vital_Blood Oxygen_LOINC |
| 2.16.840.1.113762.1.4.1235.438 | bwell_Vital_Systolic Blood Pressure_LOINC |
| 2.16.840.1.113762.1.4.1235.439 | bwell_Vital_Diastolic Blood Pressure_LOINC |
| 2.16.840.1.113762.1.4.1235.440 | bwell_Vital_Heart Rate_LOINC |
| 2.16.840.1.113762.1.4.1235.441 | bwell_Vital_BMI_LOINC |
| 2.16.840.1.113762.1.4.1235.442 | bwell_Vital_Body Fat_LOINC |
| 2.16.840.1.113762.1.4.1235.443 | bwell_Vital_Body Temperature_LOINC |
| 2.16.840.1.113762.1.4.1235.444 | bwell_Vital_Body Height_LOINC |
| 2.16.840.1.113762.1.4.1235.445 | bwell_Vital_Body Weight_LOINC |
| 2.16.840.1.113762.1.4.1235.446 | bwell_Vital_Respiratory Rate_LOINC |
| 2.16.840.1.113762.1.4.1235.447 | bwell_Vital_Waist Circumference_LOINC |
| 2.16.840.1.113762.1.4.1235.448 | bwell_Vital_Blood Glucose_Clinical Grouping Lab |
| 2.16.840.1.113762.1.4.1235.449 | bwell_Vital_Blood Oxygen_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.450 | bwell_Vital_Systolic Blood Pressure_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.451 | bwell_Vital_Diastolic Blood Pressure_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.452 | bwell_Vital_Heart Rate_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.453 | bwell_Vital_BMI_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.454 | bwell_Vital_Body Fat_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.455 | bwell_Vital_Body Temperature_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.456 | bwell_Vital_Body Height_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.457 | bwell_Vital_Body Weight_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.458 | bwell_Vital_Respiratory Rate_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.459 | bwell_Vital_Waist Circumference_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.460 | Pregnancy_CN_HD_LOINC |
| 2.16.840.1.113762.1.4.1235.465 | Second Trimester_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.468 | Third Trimester_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.469 | Pregnancy Due Date_LOINC |
| 2.16.840.1.113762.1.4.1235.470 | Second Trimester_LOINC |
| 2.16.840.1.113762.1.4.1235.475 | OGTT_LOINC |
| 2.16.840.1.113762.1.4.1235.476 | OGTT_Grouping |
| 2.16.840.1.113762.1.4.1235.494 | PSA Testing _LOINC |
| 2.16.840.1.113762.1.4.1235.495 | PSA Testing_Grouping |
| 2.16.840.1.113762.1.4.1235.498 | Active Pregnancy_LOINC |
| 2.16.840.1.113762.1.4.1235.500 | Active Pregnancy_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.506 | Third Trimester_LOINC |
| 2.16.840.1.113762.1.4.1235.513 | bwell_Vital_Systolic_and_Diastolic Blood Pressure_LOINC |
| 2.16.840.1.113762.1.4.1235.514 | bwell_Vital_Systolic_and_Diastolic Blood Pressure_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.529 | Postpartum_LOINC |
| 2.16.840.1.113762.1.4.1235.531 | Postpartum_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.532 | bwell_Vital_Head Circumference_LOINC |
| 2.16.840.1.113762.1.4.1235.534 | bwell_Vital_Head Circumference_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.535 | bwell_Vital_Body Surface Area_LOINC |
| 2.16.840.1.113762.1.4.1235.537 | bwell_Vital_Body Surface Area_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.538 | bwell_Vital_Vital Signs Panel_LOINC |
| 2.16.840.1.113762.1.4.1235.540 | bwell_Vital_Vital Signs Panel_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.541 | bwell_Vital_Blood Pressure Panel_LOINC |
| 2.16.840.1.113762.1.4.1235.542 | bwell_Vital_Blood Pressure Panel_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.547 | Depression_Clinical Grouping Condition_LOINC |
| 2.16.840.1.113762.1.4.1235.549 | Depression_Clinical Grouping Condition |
| 2.16.840.1.113762.1.4.1235.592 | Polypharmacy_Clinical_Grouping_Condition_LOINC |
| 2.16.840.1.113762.1.4.1235.593 | Polypharmacy_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.605 | Systolic Blood Pressure_Compliant |
| 2.16.840.1.113762.1.4.1235.606 | Diastolic Blood Pressure_Compliant |
| 2.16.840.1.113762.1.4.1235.609 | bwell Systolic Blood Pressure Vitals_UI_LOINC |
| 2.16.840.1.113762.1.4.1235.611 | bwell Diastolic Blood Pressure Vitals_UI_LOINC |
| 2.16.840.1.113762.1.4.1235.613 | bwell Combo Blood Pressure Vitals_UI_LOINC |
| 2.16.840.1.113762.1.4.1235.615 | bwell Systolic Blood Pressure_UI |
| 2.16.840.1.113762.1.4.1235.616 | bwell Diastolic Blood Pressure_UI |
| 2.16.840.1.113762.1.4.1235.617 | bwell Combo Blood Pressure_UI |
| 2.16.840.1.113762.1.4.1235.634 | Lp(a) Test_LOINC |
| 2.16.840.1.113762.1.4.1235.637 | LP(a) Test |
| 2.16.840.1.113762.1.4.1235.94 | Cardiomyopathy Dilated Condition |
| 2.16.840.1.113762.1.4.1235.95 | Cardiomyopathy Dilated LOINC |
| 2.16.840.1.113762.1.4.1235.99 | Cardiomyopathy Hypertrophic LOINC |
| 2.16.840.1.113762.1.4.1247.126 | Social Determinants of Health Screening Assessments |
| 2.16.840.1.113762.1.4.1247.127 | Food Insecurity Screening Assessments |
| 2.16.840.1.113762.1.4.1247.128 | Transportation Insecurity Screening Assessments |
| 2.16.840.1.113762.1.4.1247.129 | Homelessness Screening Assessments |
| 2.16.840.1.113762.1.4.1247.130 | Housing Instability Screening Assessments |
| 2.16.840.1.113762.1.4.1247.131 | Inadequate Housing Screening Assessments |
| 2.16.840.1.113762.1.4.1247.132 | Less Than High School Education Screening Assessments |
| 2.16.840.1.113762.1.4.1247.133 | Unemployment Screening Assessments |
| 2.16.840.1.113762.1.4.1247.134 | Veteran Status Screening Assessments |
| 2.16.840.1.113762.1.4.1247.135 | Social Connection Screening Assessments |
| 2.16.840.1.113762.1.4.1247.136 | Stress Screening Assessments |
| 2.16.840.1.113762.1.4.1247.138 | Financial Insecurity Screening Assessments |
| 2.16.840.1.113762.1.4.1247.139 | Material Hardship Screening Assessments |
| 2.16.840.1.113762.1.4.1247.140 | Intimate Partner Violence Screening Assessments |
| 2.16.840.1.113762.1.4.1247.141 | Health Literacy Screening Assessments |
| 2.16.840.1.113762.1.4.1247.142 | Medical Cost Burden Screening Assessments |
| 2.16.840.1.113762.1.4.1247.143 | Health Insurance Coverage Status Screening Assessments |
| 2.16.840.1.113762.1.4.1247.144 | Elder Abuse Screening Assessments |
| 2.16.840.1.113762.1.4.1247.167 | Inadequate Housing Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.168 | Material Hardship Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.169 | Stress Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.170 | Transportation Insecurity Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.171 | Unemployment Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.172 | Veteran Status Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.173 | Financial Insecurity Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.174 | Food Insecurity Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.175 | Health Literacy Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.176 | Homelessness Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.177 | Housing Instability Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.178 | Inadequate Housing Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.179 | Less Than High School Education Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.180 | Material Hardship Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.181 | Stress Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.182 | Transportation Insecurity Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.183 | Unemployment Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.184 | Veteran Status Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.185 | Health Insurance Coverage Status Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.186 | Health Insurance Coverage Status Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.187 | Medical Cost Burden Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.188 | Medical Cost Burden Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.189 | Elder Abuse Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.190 | Elder Abuse Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.191 | Elder Abuse Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.192 | Veteran Status Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.193 | Financial Insecurity Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.194 | Food Insecurity Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.195 | Health Literacy Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.196 | Homelessness Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.197 | Housing Instability Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.198 | Intimate Partner Violence Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.199 | Less Than High School Education Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.200 | Material Hardship Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.201 | Medical Cost Burden Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.202 | Social Connection Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.203 | Stress Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.204 | Transportation Insecurity Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.205 | Unemployment Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.206 | Social Determinants of Health Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.207 | Social Determinants of Health Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.208 | Social Determinants of Health Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.209 | Intimate Partner Violence Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.210 | Social Connection Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.211 | Intimate Partner Violence Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.212 | Social Connection Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.237 | Digital Access Screening Assessments |
| 2.16.840.1.113762.1.4.1247.238 | Digital Access Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.239 | Digital Access Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.240 | Digital Access Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.248 | Utility Insecurity Screening Assessments |
| 2.16.840.1.113762.1.4.1247.249 | Utility Insecurity Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.250 | Utility Insecurity Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.251 | Utility Insecurity Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.270 | Language Access Screening Assessments |
| 2.16.840.1.113762.1.4.1247.271 | Language Access Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.272 | Language Access Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.273 | Language Access Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1248.109 | aPTT Tests |
| 2.16.840.1.113762.1.4.1248.21 | Creatinine Mass Per Volume |
| 2.16.840.1.113762.1.4.1248.218 | Blood urea nitrogen lab test |
| 2.16.840.1.113762.1.4.1248.219 | Hemoglobin lab test |
| 2.16.840.1.113762.1.4.1248.221 | Albumin lab test |
| 2.16.840.1.113762.1.4.1248.222 | Leukocyte count lab test |
| 2.16.840.1.113762.1.4.1248.223 | Bilirubin lab test |
| 2.16.840.1.113762.1.4.1248.224 | Aspartate transaminase lab test |
| 2.16.840.1.113762.1.4.1248.301 | LDL Cholesterol |
| 2.16.840.1.113762.1.4.1248.34 | Glucose Lab Test Mass Per Volume |
| 2.16.840.1.113762.1.4.1248.359 | DEXA Bone Density for Urology Care |
| 2.16.840.1.113762.1.4.1248.376 | HIV Viral Load Tests |
| 2.16.840.1.113762.1.4.1248.377 | HIV Viral Load Tests |
| 2.16.840.1.113762.1.4.1248.389 | Syphilis Tests |
| 2.16.840.1.113762.1.4.1248.94 | Oxygen Partial Pressure in Arterial Blood |
| 2.16.840.1.113762.1.4.1248.95 | Carbon Dioxide Partial Pressure in Arterial Blood |
| 2.16.840.1.113762.1.4.1248.96 | Arterial Blood pH |
| 2.16.840.1.113762.1.4.1258.1 | Gonorrhea Screening |
| 2.16.840.1.113762.1.4.1259.4 | eGFR Using 2021 Race Free Formulas |
| 2.16.840.1.113762.1.4.1259.5 | Fructosamine in Serum or Plasma |
| 2.16.840.1.113762.1.4.1259.6 | Glucose tests in venous blood, capillary blood, serum/plasma for Diabetes |
| 2.16.840.1.113762.1.4.1259.7 | Creatinine in serum/plasma |
| 2.16.840.1.113762.1.4.1260.10 | Estrogen Receptor Testing for Orserdu |
| 2.16.840.1.113762.1.4.1260.100 | MMR Proficient |
| 2.16.840.1.113762.1.4.1260.11 | Estrogen Receptor Test for Orserdu |
| 2.16.840.1.113762.1.4.1260.12 | Negative |
| 2.16.840.1.113762.1.4.1260.13 | HER2 Negative |
| 2.16.840.1.113762.1.4.1260.130 | FGFR3 Gene Interpretation Positive LOINC |
| 2.16.840.1.113762.1.4.1260.133 | FGFR3 Gene Interpretation Positive |
| 2.16.840.1.113762.1.4.1260.162 | Adolescent depression screening assessment |
| 2.16.840.1.113762.1.4.1260.163 | Adult depression screening assessment LOINC |
| 2.16.840.1.113762.1.4.1260.200 | EGFR Gene Interpretation Positive LOINC |
| 2.16.840.1.113762.1.4.1260.201 | EGFR Gene Interpretation Positive |
| 2.16.840.1.113762.1.4.1260.202 | EGFR Osimertinib Molecular Variants |
| 2.16.840.1.113762.1.4.1260.205 | EGFR Generic Molecular Variant LOINC |
| 2.16.840.1.113762.1.4.1260.206 | EGFR Molecular Variants Osimertinib PM |
| 2.16.840.1.113762.1.4.1260.217 | MET Gene Test |
| 2.16.840.1.113762.1.4.1260.231 | EGFR Amivantamab Molecular Variants |
| 2.16.840.1.113762.1.4.1260.232 | EGFR Molecular Variants Amivantamab PM |
| 2.16.840.1.113762.1.4.1260.234 | ROS1 Molecular Variants Repotrectinib PM |
| 2.16.840.1.113762.1.4.1260.258 | ALK results (HGNC) |
| 2.16.840.1.113762.1.4.1260.286 | Encorafenib PM Molecular variant |
| 2.16.840.1.113762.1.4.1260.289 | BRAF test (HGNC) |
| 2.16.840.1.113762.1.4.1260.29 | HER2 Positive |
| 2.16.840.1.113762.1.4.1260.304 | HER2 Negative (geneinterpretation/Labtestvalue) LOINC |
| 2.16.840.1.113762.1.4.1260.307 | HER2 Negative (geneinterpretation/Labtestvalue) |
| 2.16.840.1.113762.1.4.1260.318 | Solid Cancer T Stage LOINC |
| 2.16.840.1.113762.1.4.1260.32 | HER2 Positive |
| 2.16.840.1.113762.1.4.1260.320 | Solid Cancer T Stage codes |
| 2.16.840.1.113762.1.4.1260.354 | Progesterone_receptor_labtest |
| 2.16.840.1.113762.1.4.1260.356 | Estrogen_receptor_labtest |
| 2.16.840.1.113762.1.4.1260.360 | HER2_IHC_test_Lab |
| 2.16.840.1.113762.1.4.1260.361 | HER2_Fish_test |
| 2.16.840.1.113762.1.4.1260.371 | HER2 test_Lab |
| 2.16.840.1.113762.1.4.1260.376 | RET mutation_Molecular Variants |
| 2.16.840.1.113762.1.4.1260.387 | RET test_Thyroid_cancer (HGNC) |
| 2.16.840.1.113762.1.4.1260.398 | KRAS_gene |
| 2.16.840.1.113762.1.4.1260.417 | KRAS_G12C_PM |
| 2.16.840.1.113762.1.4.1260.444 | MMR_Gene_Lab_LOINC |
| 2.16.840.1.113762.1.4.1260.447 | MMR_Gene_HGNC |
| 2.16.840.1.113762.1.4.1260.49 | MSI Testing |
| 2.16.840.1.113762.1.4.1260.501 | Test 23 |
| 2.16.840.1.113762.1.4.1260.53 | MMR Gene Testing |
| 2.16.840.1.113762.1.4.1260.54 | MSI High |
| 2.16.840.1.113762.1.4.1260.55 | MSI High |
| 2.16.840.1.113762.1.4.1260.59 | MMR Deficient |
| 2.16.840.1.113762.1.4.1260.60 | MMR Deficient |
| 2.16.840.1.113762.1.4.1260.7 | Her2 Test For Orserdu |
| 2.16.840.1.113762.1.4.1260.81 | RAS Genes |
| 2.16.840.1.113762.1.4.1260.82 | RAS Gene Interpretation Negative LOINC |
| 2.16.840.1.113762.1.4.1260.85 | RAS Gene Negative |
| 2.16.840.1.113762.1.4.1260.87 | RAS Gene Interpretation Positive LOINC |
| 2.16.840.1.113762.1.4.1260.88 | RAS Gene Positive |
| 2.16.840.1.113762.1.4.1260.89 | Her2 Testing |
| 2.16.840.1.113762.1.4.1260.93 | MSI Low LOINC |
| 2.16.840.1.113762.1.4.1260.95 | MSI Low |
| 2.16.840.1.113762.1.4.1260.98 | MMR Proficient LOINC |
| 2.16.840.1.113762.1.4.1264.27 | Legionella Presence by Urine Antigen or DNA |
| 2.16.840.1.113762.1.4.1267.1 | Problem Type |
| 2.16.840.1.113762.1.4.1267.13 | Screening and Assessment Survey Codes |
| 2.16.840.1.113762.1.4.1267.17 | Common LOINC Lab Codes |
| 2.16.840.1.113762.1.4.1267.18 | Radiology Procedures (LOINC) |
| 2.16.840.1.113762.1.4.1267.19 | Clinical Tests |
| 2.16.840.1.113762.1.4.1267.21 | Universal Common LOINC Lab Orders |
| 2.16.840.1.113762.1.4.1267.27 | Social History Type (LOINC) |
| 2.16.840.1.113762.1.4.1267.28 | Social History Type |
| 2.16.840.1.113762.1.4.1267.4 | Smoking Status Type LOINC |
| 2.16.840.1.113762.1.4.1267.6 | Smoking Status Type |
| 2.16.840.1.113762.1.4.1290.4 | Sequential Organ Failure Assessment SOFA |
| 2.16.840.1.113883.1.11.20.2.3 | ReferralDocumentType |
| 2.16.840.1.113883.1.11.20.2.4 | TransferDocumentType |
| 2.16.840.1.113883.1.11.20.2.5 | Wound Measurements |
| 2.16.840.1.113883.1.11.20.22 | HPDocumentType |
| 2.16.840.1.113883.10.20.22.5.305 | Microbiology and Antimicrobial Susceptibility Tests |
| 2.16.840.1.113883.10.20.5.9.10 | Codes for Healthcare Personnel Influenza Vaccination (HP FLU) Summary Data |
| 2.16.840.1.113883.10.20.5.9.4 | NHSNDrugSusceptibilityTestMethod |
| 2.16.840.1.113883.11.20.1.1 | SurgicalOperationNoteDocumentTypeCode |
| 2.16.840.1.113883.11.20.4.1 | DischargeSummaryDocumentTypeCode |
| 2.16.840.1.113883.11.20.6.1 | ProcedureNoteDocumentTypeCodes |
| 2.16.840.1.113883.11.20.8.1 | ProgressNoteDocumentTypeCode |
| 2.16.840.1.113883.11.20.9.31 | ConsultDocumentType |
| 2.16.840.1.113883.11.20.9.32 | DIRDocumentTypeCodes |
| 2.16.840.1.113883.11.20.9.47 | ADL Result Type |
| 2.16.840.1.113883.11.20.9.59 | DIRSectionTypeCodes |
| 2.16.840.1.113883.11.20.9.65 | Physical Exam Type |
| 2.16.840.1.113883.11.20.9.68 | Note Types |
| 2.16.840.1.113883.11.20.9.69.4 | Advance Healthcare Directive Categories LOINC |
| 2.16.840.1.113883.11.20.9.69.5 | Advance Directives Content Types |
| 2.16.840.1.113883.11.20.9.81 | Estimated Date of Delivery Including Method |
| 2.16.840.1.113883.11.20.9.82 | Estimated Gestational Age Code Including Method |
| 2.16.840.1.113883.11.20.9.84 | Other Pregnancy Outcome |
| 2.16.840.1.113883.13.15 | NHSNDrugSusceptibilityTestsCode |
| 2.16.840.1.113883.3.117.1.7.1.213 | INR |
| 2.16.840.1.113883.3.117.1.7.1.215 | LDLc |
| 2.16.840.1.113883.3.1444.3.103 | HER2 Presence in Tissue |
| 2.16.840.1.113883.3.1444.3.104 | Depression Screening for Adult |
| 2.16.840.1.113883.3.1444.3.107 | Standardized Assessment Tools for Dyspnea |
| 2.16.840.1.113883.3.1444.3.108 | Nausea or Vomiting Assessment |
| 2.16.840.1.113883.3.1444.3.114 | Karnofsky Performance Status |
| 2.16.840.1.113883.3.1444.3.203 | BRCA1 |
| 2.16.840.1.113883.3.1444.3.204 | BRCA2 |
| 2.16.840.1.113883.3.1444.3.211 | BRCA1 and BRCA2 |
| 2.16.840.1.113883.3.1444.3.213 | BRAF V600 |
| 2.16.840.1.113883.3.1444.3.216 | BRAF V600 Mutation Status |
| 2.16.840.1.113883.3.1444.5.207 | HER2 Presence in Tissue |
| 2.16.840.1.113883.3.1444.5.209 | Depression Screening for Adult |
| 2.16.840.1.113883.3.1444.5.218 | Dyspnea Assessment |
| 2.16.840.1.113883.3.1444.5.219 | Nausea or Vomiting Assessment |
| 2.16.840.1.113883.3.1444.5.220 | Karnofsky Performance Status |
| 2.16.840.1.113883.3.464.1003.108.11.1044 | Pap Test |
| 2.16.840.1.113883.3.464.1003.108.11.1047 | Mammography |
| 2.16.840.1.113883.3.464.1003.108.11.1145 | sDNA FIT Test |
| 2.16.840.1.113883.3.464.1003.108.12.1017 | Pap Test |
| 2.16.840.1.113883.3.464.1003.108.12.1018 | Mammography |
| 2.16.840.1.113883.3.464.1003.108.12.1038 | CT Colonography |
| 2.16.840.1.113883.3.464.1003.108.12.1039 | sDNA FIT Test |
| 2.16.840.1.113883.3.464.1003.110.11.1128 | Lab Tests for Sexually Transmitted Infections |
| 2.16.840.1.113883.3.464.1003.110.11.1129 | Chlamydia Screening |
| 2.16.840.1.113883.3.464.1003.110.11.1135 | HPV Test |
| 2.16.840.1.113883.3.464.1003.110.12.1051 | Lab Tests for Sexually Transmitted Infections |
| 2.16.840.1.113883.3.464.1003.110.12.1052 | Chlamydia Screening |
| 2.16.840.1.113883.3.464.1003.110.12.1059 | HPV Test |
| 2.16.840.1.113883.3.464.1003.111.11.1012 | Lab Tests During Pregnancy |
| 2.16.840.1.113883.3.464.1003.111.11.1013 | Diagnostic Studies During Pregnancy |
| 2.16.840.1.113883.3.464.1003.111.11.1019 | Pregnancy Test |
| 2.16.840.1.113883.3.464.1003.111.12.1007 | Lab Tests During Pregnancy |
| 2.16.840.1.113883.3.464.1003.111.12.1008 | Diagnostic Studies During Pregnancy |
| 2.16.840.1.113883.3.464.1003.111.12.1011 | Pregnancy Test |
| 2.16.840.1.113883.3.464.1003.113.11.1083 | Central DXA of Hip or Spine |
| 2.16.840.1.113883.3.464.1003.113.11.1202 | DXA (Dual energy Xray Absorptiometry) Scan Non Hip or Spine |
| 2.16.840.1.113883.3.464.1003.113.12.1051 | DXA (Dual energy Xray Absorptiometry) Scan |
| 2.16.840.1.113883.3.464.1003.118.11.1077 | Falls Screening |
| 2.16.840.1.113883.3.464.1003.118.11.1097 | CT Colonography |
| 2.16.840.1.113883.3.464.1003.118.12.1028 | Falls Screening |
| 2.16.840.1.113883.3.464.1003.120.11.1004 | HIV Viral Load |
| 2.16.840.1.113883.3.464.1003.120.12.1002 | HIV Viral Load |
| 2.16.840.1.113883.3.464.1003.121.11.1028 | BMI percentile |
| 2.16.840.1.113883.3.464.1003.121.11.1030 | Height |
| 2.16.840.1.113883.3.464.1003.121.11.1031 | Weight |
| 2.16.840.1.113883.3.464.1003.121.12.1006 | Consultant Report |
| 2.16.840.1.113883.3.464.1003.121.12.1012 | BMI percentile |
| 2.16.840.1.113883.3.464.1003.121.12.1014 | Height |
| 2.16.840.1.113883.3.464.1003.121.12.1015 | Weight |
| 2.16.840.1.113883.3.464.1003.1266 | Diabetic Retinopathy Severity Level |
| 2.16.840.1.113883.3.464.1003.198.11.1020 | Fecal Occult Blood Test (FOBT) |
| 2.16.840.1.113883.3.464.1003.198.11.1023 | Group A Streptococcus Test |
| 2.16.840.1.113883.3.464.1003.198.11.1024 | HbA1c Laboratory Test |
| 2.16.840.1.113883.3.464.1003.198.11.1055 | XRay Study |
| 2.16.840.1.113883.3.464.1003.198.12.1011 | Fecal Occult Blood Test (FOBT) |
| 2.16.840.1.113883.3.464.1003.198.12.1012 | Group A Streptococcus Test |
| 2.16.840.1.113883.3.464.1003.198.12.1013 | HbA1c Laboratory Test |
| 2.16.840.1.113883.3.464.1003.198.12.1034 | XRay Study |
| 2.16.840.1.113883.3.464.1004.2616 | Autonomous Eye Exam Result or Finding |
| 2.16.840.1.113883.3.526.2.1069 | Standardized Tools for Assessment of Cognition |
| 2.16.840.1.113883.3.526.2.1073 | Standardized Pain Assessment Tool |
| 2.16.840.1.113883.3.526.2.1238 | Ejection Fraction |
| 2.16.840.1.113883.3.526.2.1341 | Heart Rate |
| 2.16.840.1.113883.3.526.2.1364 | Macular Exam |
| 2.16.840.1.113883.3.526.2.1372 | Tobacco Use Screening |
| 2.16.840.1.113883.3.526.2.1374 | Bone Scan |
| 2.16.840.1.113883.3.526.2.1402 | Cup to Disc Ratio |
| 2.16.840.1.113883.3.526.2.1403 | Optic Disc Exam for Structural Abnormalities |
| 2.16.840.1.113883.3.526.2.1781 | Best Corrected Visual Acuity Exam Using Snellen Chart |
| 2.16.840.1.113883.3.526.3.1006 | Standardized Tools Score for Assessment of Cognition |
| 2.16.840.1.113883.3.526.3.1028 | Standardized Pain Assessment Tool |
| 2.16.840.1.113883.3.526.3.1134 | Ejection Fraction |
| 2.16.840.1.113883.3.526.3.1176 | Heart Rate |
| 2.16.840.1.113883.3.526.3.1251 | Macular Exam |
| 2.16.840.1.113883.3.526.3.1278 | Tobacco Use Screening |
| 2.16.840.1.113883.3.526.3.1333 | Cup to Disc Ratio |
| 2.16.840.1.113883.3.526.3.1334 | Optic Disc Exam for Structural Abnormalities |
| 2.16.840.1.113883.3.526.3.1560 | Best Corrected Visual Acuity Exam Using Snellen Chart |
| 2.16.840.1.113883.3.526.3.1573 | LDL Cholesterol |
| 2.16.840.1.113883.3.526.3.320 | Bone Scan |
| 2.16.840.1.113883.3.526.3.401 | Prostate Specific Antigen Test |
| 2.16.840.1.113883.3.600.1482 | Laboratory Tests for Hypertension |
| 2.16.840.1.113883.3.600.2462 | Laboratory Tests for Hypertension |
| 2.16.840.1.113883.3.666.5.2363 | Creatinine Lab Test |
| 2.16.840.1.113883.3.67.1.101.1.263 | PHQ 9 and PHQ 9M Tools |
| 2.16.840.1.113883.3.67.1.101.1.279 | HBsAg |
| 2.16.840.1.113883.3.67.1.101.1.281 | HBsAg |
| 2.16.840.1.113883.3.67.1.101.11.723 | PHQ-9 Tool |
| 2.16.840.1.113883.3.6929.2.1000 | Estimated Glomerular Filtration Rate |
| 2.16.840.1.113883.3.6929.2.1002 | Urine Albumin Creatinine Ratio |
| 2.16.840.1.113883.3.6929.3.1000 | Estimated Glomerular Filtration Rate |
| 2.16.840.1.113883.3.6929.3.1007 | Urine Albumin Creatinine Ratio |
| 2.16.840.1.113883.3.8420.2.1005 | Pediatric Best Corrected Visual Acuity Exam |
| 2.16.840.1.113883.3.8420.2.1006 | LogMAR Visual Acuity Exam |
| 2.16.840.1.113883.3.8420.3.1003 | Pediatric Best Corrected Visual Acuity Exam |
| 2.16.840.1.113883.3.8420.3.1004 | LogMAR Visual Acuity Exam |
| 2.16.840.1.113883.3.88.12.80.62 | Vital Sign Result Type |
| 2.16.840.1.113883.4.642.3.155 | Care Team Category |
| 2.16.840.1.114222.24.7.280 | NHSNGenotypicTests |
| 2.16.840.1.114222.4.11.3595 | NHSNPopulationSummaryReportTypeCode |
| 2.16.840.1.114222.4.11.7160 | NHSNStaphAureusSpecificTest |
| ImageCategory | ImagingStudy Category Type |
| jdv-acte-obp-cisis | JDV Acte Obp CISIS |
| jdv-addiction-cisis | JDV Addiction CISIS |
| jdv-antecedent-obstetrical-cisis | JDV Antecedent Obstetrical CISIS |
| jdv-antecedent-obstetrical-obp-cisis | JDV Antecedent Obstetrical Obp CISIS |
| jdv-batterie-examen-cisis | JDV Batterie Examen CISIS |
| jdv-bilan-technique-cisis | JDV Bilan Technique CISIS |
| jdv-code-document-imagerie-cisis | JDV Code Document Imagerie CISIS |
| jdv-delimitation-activite-cisis | JDV Delimitation Activite CISIS |
| jdv-disposition-pretherapeutique-cisis | JDV Disposition Pretherapeutique CISIS |
| jdv-evaluation-depression-geriatrique30-cisis | JDV Evaluation Depression Geriatrique 30 CISIS |
| jdv-evenement-accouchement-cisis | JDV Evenement Accouchement CISIS |
| jdv-examen-biochimie-aunv-cisis | JDV Examen Biochimie Aunv CISIS |
| jdv-examen-biochimie-eunv-cisis | JDV Examen Biochimie Eunv CISIS |
| jdv-examen-hematologie-aunv-cisis | JDV Examen Hematologie Aunv CISIS |
| jdv-examen-hematologie-eunv-cisis | JDV Examen Hematologie Eunv CISIS |
| jdv-examen-hemostase-aunv-cisis | JDV Examen Hemostase Aunv CISIS |
| jdv-examen-hemostase-eunv-cisis | JDV Examen Hemostase Eunv CISIS |
| jdv-info-deces-cs8-cisis | JDV Info Deces Cs8 CISIS |
| jdv-investigation-realisee-sunv-cisis | JDV Investigation Realisee Sunv CISIS |
| jdv-mesure-lentille-delivree-cisis | JDV Mesure Lentille Delivree CISIS |
| jdv-mesure-lentille-prescrite-cisis | JDV Mesure Lentille Prescrite CISIS |
| jdv-mesure-type-verre-delivre-cisis | JDV Mesure Type Verre Delivre CISIS |
| jdv-mesure-type-verre-prescrit-cisis | JDV Mesure Type Verre Prescrit CISIS |
| jdv-mesure-verre-delivre-cisis | JDV Mesure Verre Delivre CISIS |
| jdv-mesure-verre-prescrit-cisis | JDV Mesure Verre Prescrit CISIS |
| jdv-nihss-ataxie-cisis | JDV Nihss Ataxie CISIS |
| jdv-nihss-champ-visuel-cisis | JDV Nihss Champ Visuel CISIS |
| jdv-nihss-commandes-cisis | JDV Nihss Commandes CISIS |
| jdv-nihss-conscience-cisis | JDV Nihss Conscience CISIS |
| jdv-nihss-dysarthrie-cisis | JDV Nihss Dysarthrie CISIS |
| jdv-nihss-fonction-cisis | JDV Nihss Fonction CISIS |
| jdv-nihss-langage-cisis | JDV Nihss Langage CISIS |
| jdv-nihss-motricite-membre-inferieur-cisis | JDV Nihss Motricite Membre Inferieur CISIS |
| jdv-nihss-motricite-membre-superieur-cisis | JDV Nihss Motricite Membre Superieur CISIS |
| jdv-nihss-negligence-cisis | JDV Nihss Negligence CISIS |
| jdv-nihss-occulomotricite-cisis | JDV Nihss Occulomotricite CISIS |
| jdv-nihss-paralysie-faciale-cisis | JDV Nihss Paralysie Faciale CISIS |
| jdv-nihss-questions-cisis | JDV Nihss Questions CISIS |
| jdv-nihss-sensibilite-cisis | JDV Nihss Sensibilite CISIS |
| jdv-obp-resultat-evenement-cisis | JDV Obp Resultat Evenement CISIS |
| jdv-observation-enfant-cisis | JDV Observation Enfant CISIS |
| jdv-observation-grossesse-cisis | JDV Observation Grossesse CISIS |
| jdv-score-braden-activite-cisis | JDV Score Braden Activite CISIS |
| jdv-score-braden-component-cisis | JDV Score Braden Component CISIS |
| jdv-score-braden-friction-cisaillement-cisis | JDV Score Braden Friction Cisaillement CISIS |
| jdv-score-braden-humidite-cisis | JDV Score Braden Humidite CISIS |
| jdv-score-braden-mobilite-cisis | JDV Score Braden Mobilite CISIS |
| jdv-score-braden-nutrition-cisis | JDV Score Braden Nutrition CISIS |
| jdv-score-braden-perception-sensorielle-cisis | JDV Score Braden Perception Sensorielle CISIS |
| jdv-score-performance-ecog-cisis | JDV Score Performance Ecog CISIS |
| jdv-score-rankin-cisis | JDV Score Rankin CISIS |
| jdv-signe-vital-cisis | JDV Signe Vital CISIS |
| jdv-signe-vital-cs24-cisis | JDV Signe Vital Cs24 CISIS |
| jdv-signe-vital-cs8-cisis | JDV Signe Vital Cs8 CISIS |
| jdv-signe-vital-cs9-cisis | JDV Signe Vital Cs9 CISIS |
| jdv-social-history-code-cisis | JDV Social History Code CISIS |
| jdv-type-de-mesure-acuite-visuelle-cisis | JDV Type De Mesure Acuite Visuelle CISIS |
| jdv-type-de-mesure-de-refraction-cisis | JDV Type De Mesure De Refraction CISIS |
| jdv-type-de-mesure-dispositif-oculaire-cisis | JDV Type De Mesure Dispositif Oculaire CISIS |
| jdv-type-de-test-realise-ccu-cisis | JDV Type De Test Realise Ccu CISIS |
| jdv-type-directive-anticipee-cisis | JDV Type Directive Anticipee CISIS |
| jdv-ufcv-code-entree-cisis | JDV UFCV Code Entree CISIS |
| myhealthway-doc-type-codes | MyHealthWay Document Type Codes |
| myhealthway-loinc-codes | MyHealthWay LOINC Codes |
| anforderung-histologischeAbklaerung | ValueSet - nNGM - Anforderung Histologische Abklärung |
| ecog | nNGM: ValueSet ECOG |
| raucherstatus | ValueSet - nNGM - Raucherstatus |
| tnm-art | ValueSet - nNGM - TNM-Art |
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: CodeSystem v3-loinc
Language: en
This case-sensitive code system http://loinc.org defines codes, but no codes are represented here
FHIR{
"resourceType": "CodeSystem",
"id": "v3-loinc",
"language": "en",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/codesystem-properties-mode",
"valueCode": "not-present"
}
],
"url": "http://loinc.org",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.6.1"
},
{
"use": "official",
"type": {
"coding": [
{
"system": "http://hl7.org/fhir/namingsystem-identifier-type",
"code": "iri-stem"
}
]
},
"system": "urn:ietf:rfc:3987",
"value": "http://loinc.org/rdf/",
"assigner": {
"display": "LOINC as per User Guide S12.7.2 at https://loinc.org/kb/users-guide/recommendations-for-best-practices-in-using-and-mapping-to-loinc/#using-uris-to-identify-loinc-artifacts, retrieved 2022-11-22"
}
}
],
"version": "3.1.0",
"name": "LOINC",
"title": "Logical Observation Identifiers, Names and Codes (LOINC)",
"status": "active",
"experimental": false,
"date": "2022-11-22",
"publisher": "LOINC and Health Data Standards, Regenstrief Institute, Inc.",
"contact": [
{
"name": "LOINC and Health Data Standards, Regenstrief Institute, Inc."
}
],
"description": "LOINC provides a set of universal names and ID codes for identifying laboratory and clinical test results.1,2 LOINC facilitates the exchange and pooling of results, such as blood hemoglobin, serum potassium, or vital signs, for clinical care, outcomes management, and research. LOINC's universal identifiers (names and codes) can be used in the context of order and observation exchanges between information systems that use syntax standards such as HL73, CEN TC251, ISO TC215, ASTM4, and DICOM. Specifically, the identifier can be used as the coded value for an observation in any other standard that uses the observation/observation value paradigm, whether messages, documents, application programming interface (API), etc. For example, LOINC codes are used widely in the OBX segment Observation Identifier field (OBX-3) of an ORU HL7 (HL7 version 2.x or ASTM 1238-9410) message that may be sent between a Clinical Laboratory Information Management Systems (LIMS) and Electronic Health Record Systems (EHR).5, 6 In this way, LOINC codes provide universal identifiers that allow the exchange of clinical data between heterogeneous computing environments.",
"copyright": "Per the LOINC License \"Permission is hereby granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the Licensed Materials for any commercial or non-commercial purpose, subject to the following terms and conditions\" Please also note that some content (for example some of the assessment scale content) within LOINC is subject to copyright from third parties and is present in LOINC with permission or under the applicable terms of use from the third party. Some included third party content requires attribution specific to a particular LOINC code or codes. Such third party content is identified in the LOINC Table and LOINC Table Core by the applicable copyright notice stored in the EXTERNAL_COPYRIGHT_NOTICE field. For further information and for details of how implementers should manage use of third party content (including license obligations) please see https://loinc.org/kb/license/",
"caseSensitive": true,
"content": "not-present"
}